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Abstract 
Major surgeries, such as cardiac or orthopaedic procedures in particular, expose the 
patient to extensive trauma, blood loss, and tissue injury; all of these factors 
effectively modulate the immune system to ultimately trigger an inflammatory 
response.  Postoperative cognitive dysfunction (POCD), the condition being 
characterized by impairment of short and long-term memory, is one of common 
complicates following surgery.  Recently, our data have demonstrated that 
neuroinflammation and microglia activation in the hippocampus following surgery are 
associated with cognitive decline.  
The aim of this thesis is to investigate the inflammatory signaling pathways 
specifically involved with POCD, with a particular interest between systemic 
inflammation and local inflammation in the brain following surgery.  
The data presented in this thesis introduce the general concepts and the involvement 
of inflammation in the etiology of cognitive dysfunctions using a mouse model of 
POCD. Upon the identification of specific pro-inflammatory markers both 
systemically and centrally and the delineation of the time course of events that 
characterize the inflammatory response following aseptic orthopaedic surgery, I 
describe how specific cellular signal pathways interact, mediate, and sustain this 
response. Following an initial non-specific approach using a general anti-
inflammatory compound to identify whether inflammation plays a role in this 
scenario, I have exploited this model into a wide range of knockouts animals in the 
attempt of identifying specific signaling mechanisms and upstream receptors that 
mediate the behavioral abnormality following surgery.  In order to achieve this, I have 
compared the inflammatory events after aseptic surgery with the response after a 
defined infectious stimulus, to ultimately joint the two in the context of a 
postoperative complication. 
In conclusion, inflammation clearly plays a pivotal role in mediating physiological as 
well as behavioral changes after surgery and infection.  This thesis has started to 
unmask the signaling pathways involved with surgery and how anti-cytokine therapy 
can potentially ameliorate the associated cognitive dysfunction. 
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Preface   
Human nature has always been attracted by the need to know and discover.  Since the 
ancient time, the human mind has been attracted by the complexity of phenomena. 
Often this interest has been described as an uncontrollable drive, which has been 
illustrated in many legends and tales.  Greek mythology offered a great example of 
the concept of “insatiable curiosity” in the Pandora’s box story, which exemplifies 
how inquisitiveness can lead to great sorrow to humankind.   The endless human thirst 
for knowledge has been classically personified by Ulysses, initially by Homer in the 
Odyssey and then by Dante Alighieri in “La Divina Commedia” (The Divine 
Comedy).  Ulysses, or Odysseus, has been described as a man with a strong 
personality, no limits or fear; with an irrepressible drive for discovery that led him to 
travel beyond the Pillars of Hercules, the limits of the known world.  
 
“Considerate la vostra semenza: fatti non foste per viver come 
bruti, ma per seguir virtute e canoscenza” 
“Consider you origin: you were not born to live like brutes, but to 
follow virtue and knowledge” 
Ulysses famous caption: Dante, Inferno, canto XXVI, lines 118-120 
 
Ulysses, both in Homer and Dante, embodies the human dichotomy between fear and 
attraction to the unknown.  With the establishment of the “scientific method” with 
Aristotle, innovative concepts based on empirical investigations were introduced in an 
ancient society.  Philosophy, in particular epistemology (the theory of knowledge) has 
attempted to explain the source and limit of human knowledge, defeating old and 
preexisting assumptions.  Science embodies this continuous effort to implement 
human knowledge using controlled and disciplined methods.  Testing of hypothesis, 
data collection both with empirical and measurable corroborations provides an 
exquisite example of applied human reasoning and intellect.  
 
 
N.T. 
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1 Chapter 1: General introduction 
1.1 General considerations and immunity 
Naturally, anything we are unable to explain raises some discomfort and 
simultaneously intrigues us to further understand it.  Complex phenomena are 
commonly dissected into simple entities to be subsequently reassembled and 
fully appreciated into the “bigger picture”.  Especially in the field of biology and 
medicine this concept is widely applied and became essential for advancing 
knowledge. Besides experimentation, observations and serendipity also 
contribute to the progress of human knowledge. For instance the concept of 
immunity, derived from the Latin immunis, meaning “exempt” dates back to 
430 BC with the historian Thucydides in his description of the war in the 
Peloponnesus (Thucydides). In the History of the Peloponnesian War, he 
exhaustively described the devastating plague in Athens giving an account on 
how people who survived the previous outbreak could look after sick people 
without contracting the disease.   
 
ἐπὶ πλέον δ' ὅµως οἱ διαπεφευγότες τόν τε θνῄσκοντα καὶ τὸν πονούµενον 
ᾠκτίζοντο διὰ τὸ προειδέναι τε καὶ αὐτοὶ ἤδη ἐν τῷ θαρσαλέῳ εἶναι· δὶς γὰρ 
τὸν αὐτόν, ὥστε καὶ κτείνειν, οὐκ ἐπελάµβανεν.  
“Yet it was with those who had recovered from the disease that the sick and 
the dying found most compassion. These knew what it was from experience, 
and had now no fear for themselves; for the same man was never attacked 
twice- never at least fatally”  
Thucydides on the plague, Second book, Chapter VII 
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The idea that people respond better to an illness after having contracted the 
disease was also previously observed in China.  Back in the 15th century in 
Asia immunity was obtained by deliberately infecting individuals with 
pathogens.  The technique was known as variolation and consisted of 
exposing healthy people with material from convalescing smallpox patients 
(Eyler 2003).  Even if with risks, beneficial effects were achieved with a clear 
improvement in mortality rate.  In 1719, Lady Mary Wortley Montagu, wife of 
the British ambassador to the Ottoman Empire, observed and witnessed the 
positive effects of variolation on her son whilst living in Constantinople.  She 
brought this concept back into Europe and soon after in England, Edward 
Jenner significantly improved on this methodology and successfully provided 
immunity to smallpox after inoculating individuals with the fluid from a cowpox 
pustule (Belongia and Naleway 2003). In the 19th century Louis Pasteur 
developed the concept of vaccination by demonstrating, almost 
serendipitously, that an attenuated form of a pathogen could be administered 
to healthy individuals to protect against the disease (Parish 1965).  This 
provided a major breakthrough in immunology and the current standard of 
many vaccines.  The great achievements in vaccine therapies alongside the 
technological innovation allowed novel studies to evolve in better 
understanding the cellular components of the immune system and its 
mechanisms of action.   
 
The interaction of multiple cellular entities and their function soon became the 
central theme of immunology.  Over a century ago, in 1908, Elie Metchnikoff 
and Paul Ehrlich received the Nobel Prize for the identification of two distinct 
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aspects of the immune response: the innate and adaptive (acquired) immunity 
(Kaufmann 2008). Since the first description of immune cells and their 
mechanisms of action, significant advances in the field have been made. The 
past decade has entered a new era based on signaling mechanisms, 
transduction pathways, gene expression, and molecular interactions. 
Immunity is no longer only connected to infection and pathogens, but also 
tissue injury, auto-inflammation and autoimmunity became of paramount 
interest.  
 
This thesis will focus on how the mechanisms of innate immunity affect a 
postoperative condition that may reach epidemic proportions in the future. 
 
 
 
1.2 Cells and mechanisms of innate immunity  
Each living organism has developed a system to counteract potential life 
threatening events such as infection and tissue injury. The innate immunity is 
the most conserved defense system shared throughout evolution from simple 
organisms including prokaryotes (bacteria), invertebrates (insects, worms), 
plants to human beings (Kimbrell and Beutler 2001). It is considered the 
basic, phyologenetically ancient mechanism of protection.  Its molecules are 
shared between plants and animals and constitute the first line of defense 
juxtaposed to the more complex adaptive response, which only characterizes 
evolved systems (table 1.1) (Medzhitov and Janeway 2000; Matzinger 2002).  
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Table 1-1:   Innate and adaptive immunity 
 
Abbreviations: IL: interleukin, INF: interferon 
 
 
 
Aside the physical barriers, such as the skin, innate immunity evolved 
different mechanisms to fight infections.  The initial observation by Metchnikoff 
that some white cells could phagocyte foreign materials established the 
concept of innate immunity.  Neutrophils, monocytes and macrophages can 
directly engulf and destroy microorganisms as well as rapidly produce 
inflammatory mediators such as cytokines, reactive oxygen species (ROS), 
reactive nitrogen species (RNS), enzymes and lipid mediators.  According to 
the phenotype (e.g. inflammatory, cytotoxic) and the nature of a threat, 
circulating monocytes can either differentiate into dendritic cells and function 
as antigen-presenting cells, or colonize organs such as liver (Kupffer cells), 
lungs (alveolar macrophages) and brain (microglia cells), becoming tissue 
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macrophages.  Macrophages, literally meaning “big eaters” (from the Greek 
macros, meaning “large” and phagein, meaning “eat”) are classically 
associated with phagocytosis but also mediate protective actions by releasing 
trophic factors and anti-inflammatory molecules, making their function 
paradoxical and necessary for healing and restoring a correct homeostasis 
(Block and Hong 2005).  These cells are also necessary to elicit an adequate 
immune response by directing and recruiting immune cells to specific sites in 
a process known as chemotaxis. Mechanical and molecular processes 
(adhesion molecules, chemokines and complement activation) are required to 
initiate this process that is fundamental in response to infection and, if this 
fails it results in poor prognosis and increase mortality rate for example in 
sepsis or multiple organ failure (Tavares-Murta et al. 2002). Neutrophils and 
monocytes are primarily associated with the margination process and 
movement across cellular compartments and sites (Wilson et al. 2009). 
However, it was also observed how these white cells could recruit 
lymphocytes and other immunocompetent cells at the site of infection to 
initiate an appropriate immune response, thus interfacing with the acquire 
component too (figure 1.1). It is important to note how the optimal host 
defense is achieved by synergism of innate and adaptive response, which 
shall not be seen as two separate entities.  
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Figure 1-1: Interaction between innate and adaptive immunity.  
Innate immunity (leukocytes, macrophages, and dendritic cells) rapidly 
recognizes and engulfs pathogens and microbes.  Dendritic cells in particular 
have the ability to present antigents to T cells, thus actively interfacing with 
the adaptive component. This bidirectional communication allows both 
systems to cooperate and to activate mechanisms to protect and defend the 
organism against a threat. Adapted from (Akira 2009). 
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1.3 Cytokines and the acute-phase response  
Besides the cellular component, innate immunity also relies on the release of 
soluble mediators (complement, cytokines, acute-phase proteins). These 
molecules are able to affect multiple biological processes both locally and in 
target organs.  Due to the widespread expression of receptors, 
communication and amplification of the inflammatory response can be 
achieved by diverse mode of actions, usually in a short-range (paracrine – 
affecting other cells, or autocrine – affecting themselves) but sometimes over 
long distance (like hormones).    
Cytokines (from the Greek cyto, meaning cell and kinos, movement) have a 
pivotal role in orchestrating the inflammatory response after viral or bacteria 
infection and are essential in restoring homeostasis after a challenge in the 
host organism (Matzinger 2002; Harris and Raucci 2006); they also affect 
behaviour, especially memory and cognition (Kelley et al. 1997; Pugh et al. 
1998).  Cytokines can be broadly categorized as interferons (anti-viral 
substances), interleukins (generated by leukocytes), monokines (generated 
by monocytes), chemokines (chemotactic factors), haematopoietic colony 
stimulating factors and connective tissue growth factors.  In the past thirty 
years, cytokines and their cognate receptors have been extensively studied in 
many conditions from inflammatory diseases to cancer. Already found in 
invertebrates and evolved into the animal kingdom, they are very ancient 
molecules (Bird et al. 2002; Opp 2004).  This large family of low-molecular 
weight protein mediators typically acts on a short-range distance and its role 
can be appreciated in almost every biological process ranging from 
inflammation, cell proliferation, fibrosis, healing, and angiogenesis (Feldmann 
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2008). Since the identification of these molecules in the pathogenesis of many 
disease states, cytokines became of great interest especially as plausible 
targets for specific therapeutics. Lipopolisaccharide (LPS), a predominant 
glycolipid in the outer membrane of Gram-negative bacteria, is a classic 
compound that stimulates monocytes, macrophages, and neutrophils to 
produce cytokines and a plethora of other pro-inflammatory mediators 
(Morrison and Ryan 1987).   Although in the past decade far less effort has 
been devoted in understanding basic mechanisms of the innate immunity, 
recent work is revaluating its function.  Innate immunity is essential in the 
process of counteracting possible threats without requiring clonal selection 
and expansion or receptor rearrangement, thus ensuring a rapid initiation of 
the immune system.  
 
 
 
1.4 Signaling processing and inflammation 
Innate immune response has been classically associated with the recognition 
of pathogen-associated molecular patterns (PAMPs) or damage-associated 
molecular patterns (DAMPs).  The mechanisms of PAMPs recognition 
exemplify the basic concept of self / non-self discrimination in activating a first 
line defense mechanism that alerts and protects the host organism against a 
possible threat.  Microbes, bacteria and viruses all express highly conserved 
molecular patterns, for example peptidoglycan or LPS, which are distinctively 
recognized by immune cells.  Recognition of these patterns is achieved via a 
set of structurally and functionally heterogeneous proteins known as pattern 
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recognition receptors (PRRs), the most important being the C-type lectin 
domain, scavenger receptor cysteine-rich domain and leucine-rich repeat 
(LRR) domain, which activate the innate immunity to release pro-inflammatory 
molecules such as cytokines (Medzhitov and Janeway 1997).  Opsonization 
(activation of the complement system), coagulation, phagocytosis, activation 
of downstream signaling pathways, release of pro-inflammatory molecules, 
induction of transcription factors and apoptosis are all phenomena mediated 
by PRRs and all constitute crucial mechanisms of the innate immunity 
(Medzhitov and Janeway 2000; Janeway and Medzhitov 2002). PRRs are 
ubiquitously expressed in the body and highly conserved across species.  
The phylogenetic conservation of these receptors throughout evolution has 
facilitated the understanding of inflammatory processes from simpler 
organisms to ultimately human complexity.  Infection is a classic instigator of 
the inflammatory response and has been repeatedly used to better 
understand the inflammatory process.  The pathological aspects of 
inflammation, from the Latin inflamatio, meaning “to set on fire” have been 
long known since the first description by Aulus Cornelius Celsus (25 B.C – 45 
A.D circa).  In his treatise De Medicina, a major source of information on early 
medical procedures, diseases and treatments, he described the four cardinal 
signs of inflammation: rubor (redness), dolor (pain), calor (heat), and tumor 
(swelling).  Nevertheless the physiological role of inflammation yet remains 
elusive.  Generally regarded as a necessary response to restore the correct 
homeostasis in the host organism after a challenge, inflammation can become 
uncontrolled and potentially fatal for instance during septic shock (Waage et 
al. 1989; Ackland et al. 2009).  Acute inflammation in particular is correlated 
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with a rapid activation of the innate immunity and the production of a plethora 
of local inflammatory mediators.  Toll-like receptors (TLRs) and NOD 
(nucleotide-binding oligomerization-domain protein)-like receptors (NLRs) are 
the two most important families of PRRs essential in counteracting a danger 
signal and initiating an inflammatory response (Castellheim et al. 2009).  
 
 
 
1.5 Toll-like receptors 
TLRs are molecules whereby innate immunity gets activated and 
communicates with the immune system.  The discovery of TLRs started in the 
Drosophila fruit fly with the identification of Toll.  Initially associated with 
dorsoventral polarity during embryonic development, in adults it was later 
described to protect flies against fungal infections (Lemaitre et al. 1996).  
Loss-of-function mutations in the Toll gene prevent the synthesis of a major 
antifungal peptide, drosomycin, making Drosophila extremely vulnerable to 
fungal infection and leading to a rapid death.  Mutations on other members of 
the TLR subfamily such as the 18 wheeler have also been demonstrated to be 
key participants in the antimicrobial response in Drosophila (Williams et al. 
1997). These findings really illustrated the involvement of these receptors in 
recognizing pathogens and specifically activating the immune response, 
theory that Charles Janeway postulated almost thirty years ago in his 
significant prediction of the link between innate and adaptive immunity 
(Rudensky and Chervonsky 2003).  
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At present, twelve members of TLRs have been found in mammals and they 
share different degrees of homology with another membrane-bound class of 
receptors of the innate immunity as part of a larger superfamily that includes 
the interleukin-1 receptor (IL-1R).  TLR1 – 9 are shared between humans and 
mice. Most of what is known about their ligands and signaling is coming from 
mice lacking in the expression of a particular receptor.  TLRs are type I 
integral membrane glycoproteins; the cytoplasmic region shares a significant 
homology with the IL-1R, thus it is referred as the Toll/IL-1R (TIR) domain 
(Medzhitov 2001; Takeda and Akira 2004; Frantz et al. 2007).  By contrast, 
the extracellular domain largely differs between TLRs and IL-1Rs since the 
former has 19-25 tandem copies of the LRR motif and the latter contains three 
immunoglobulin-like domains (Akira and Takeda 2004).  Classification of 
TLRs has been conveniently made according to their cellular localization, 
which correlates to some extent to the ability of recognizing specific ligands.  
TLR1, 2, 4, 5, and 6 are expressed on the cell surface and generally 
recognize microbial component such as lipids, lipoproteins, and peptides.  By 
contrast, TLR3, 7, 8 and 9 are involved in the recognition of nucleic-acid-like 
structures and are expressed in intracellular vesicles such as the endoplasmic 
reticulum or lysosomal compartments (Zhang and Ghosh 2001; Yang et al. 
2008; Kawai and Akira 2009). Even if TLRs share different degrees of 
homology and structural conservation, several unique molecular patterns 
originated both by pathogens and endogenous ligands are recognized by 
each receptor (table 1.2). 
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Table 1-2:  List of TLR2 and TLR4 ligands 
Modified from (Kanzler et al. 2007; Miyake 2007) 
 
Abbreviations: HSP: heath shock protein, HMGB-1: high-mobility group box-1, LDL: low 
density lipoprotein, ECM: extracellular matrix, TLR: toll-like receptor, LPS: lipopolysaccharide 
 
 
 
1.6 TLR signaling  
Amongst all TLRs, TLR4 can be considered the human homologue of the 
Drosophila Toll and is the most active interface to bridge microbial infection 
with inflammation (Levy et al. 2006; Mollen et al. 2006; Kigerl et al. 2007).  Its 
role in mediating inflammation after LPS-endotoxemia has been extensively 
studied (Hoshino et al. 1999), thus I will use it to exemplify the signaling 
pathway and the molecules which are involved in this process.  Initiation of 
the innate effector response and activation of transcription factors to induce 
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synthesis of pro-inflammatory mediators strongly relies on conformational 
changes and dimerization of the TIR domain after ligand binding to the 
receptor.  Key molecules in this downstream signaling include the myeloid 
differentiation factor (MyD88), IL-1R-associated kinase (IRAK), tumour-
necrosis-factor-receptor-associated factor 6 (TRAF6) and nuclear factor-
kappa B (NF-κB).   
MyD88 was initially found in response to IL-6 stimulation, but only in 1997 was 
discovered in mediating signaling in the IL-1R, and soon thereafter in TLRs 
(Burns et al. 1998).  This small protein has a modular structure composed of a 
C-terminal TIR domain and an N-terminal death-domain (D-D). This enables 
interaction both with the receptor (TIR domain) and in mediating 
phosphorylation of IRAK (D-D), providing significant signaling capabilities 
(Wesche et al. 1997; Janssens et al. 2002).  Largely utilized by all TLRs, with 
the exception of TLR3, MyD88 is an essential component in activating 
transcription factors including NFκB and two mitogen-activated protein 
kinases (MAPK), p38 and JUN N-terminal kinase (JNK). Signaling specificity 
of individual TLRs is achieved by selective recruitment of signaling adaptors. 
Four main positive regulators have been described in TLRs signaling: MyD88 
(all except TLR3), Mal (MyD88-adaptor like – in TLR2 and TLR4), TRAM 
(TRIF-related adaptor molecule – only in TLR4), and TRIF (TIR-domain-
containing adaptor protein inducing IFN-β – in TLR4).  
MyD88 signaling is essential in orchestrating several inflammatory pathway; 
MyD88-deficinet mice have reduced cytokines and appear protected in sepsis 
and infection (Kawai et al. 1999; Takeuchi et al. 2000; Weighardt et al. 2002). 
Recruitment of MyD88 leads to activation of IRAK4 through D-D interactions, 
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which subsequently phosphorylate IRAK1 (Janssens and Beyaert 2003).  It 
has been also observed that also IRAK1-deficient mice have impaired, but not 
abolished, production of cytokines in response to both LPS and IL-1; however 
no response is found in IRAK4-deficient mice, thus making IRAK1 a direct 
substrate of IRAK4 and not vice versa (Thomas et al. 1999; Suzuki et al. 
2002).  Interestingly, also human patients with mutations in IRAK4 show 
unresponsiveness to IL-1, IL-18 and failed to respond to five TLRs ligands (at 
TLR2, TLR3, TLR4, TLR5 and TLR9) (Picard et al. 2003).  Downstream 
signaling from IRAK converges to TRAF6, an evolutionary conserved ubiquitin 
protein ligase.  TRAF6 activates TGF-β-activated kinase 1 (TAK1), leading to 
activation of the IKK complex and MAPK pathway, which activates NFκB and 
JNK/ p38 MAPKs, respectively. This signaling pathway is illustrated in figure 
1.2. 
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Figure 1-2: TLR4 signaling.   
TLR4 signaling shares many homologies both with the IL-1R and other TLRs. 
Activation of MyD88-dependent signaling relies on recruitment of Mal 
(MyD88-adaptor like), which is an intermediate membrane proximal adaptor in 
the TLR4 signaling. This leads to the recruitment of the IL-1R-associated 
kinase (IRAK).  Phosphorylation of IRAK signals to tumor-necrosis-factor-
receptor-associated factor 6 (TRAF6), which affects two distinct downstream 
pathways: NFkB and activator protein 1 (AP-1). p38 MAPK and JUN N-
terminal kinase (JNK) mainly signal to AP-1 promoting a rapid activation of 
pro-inflammatory genes (Lotze and Tracey 2005).  Nuclear translocation of 
NFkB and translation of inflammatory cytokines is driven by phosphorylation 
of the IkB kinase (IKK) complex and also depends on the activation of TRAF6 
(O'Neill 2000).   
MyD88-independent signaling via TRAM (TRIF-related adaptor molecule), 
and TRIF (TIR-domain-containing adaptor protein inducing IFN-β) can also 
activate NFkB. However, this signaling also activates interferon regulatory 
factor 3 (IRF-3) to induce interferon β (INF-β) (Takeda et al. 2003).  It is 
suggested that MyD88 mediates the early phase activation of NFkB, whereas 
TRAM perpetuates the signaling to a deferred stage (Takeda and Akira 2005). 
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Recently a MyD88 independent pathway has been proposed both in TLR4 
and IL-1R signaling (Watters et al. 2007; Kenny and O'Neill 2008). Signaling 
via TRAM and TRIF bypasses MyD88 in TLR4, leading to alternative 
activation of NFkB and IRF (IFN regulatory factors).  Despite the existence of 
Myd88-independent pathways, this adaptor molecule maintains a pivotal role 
in promoting transcription of many pro-inflammatory genes in different disease 
states. 
 
 
 
1.7 Interleukin 1 signaling 
Since the first description of IL-1 as the endogenous pyrogen, numerous 
functions of this molecule have been described in controlling endocrine, 
immune, and nervous functions (Saper and Breder 1992).  IL-1 is a classic 
mediator of the body’s response to inflammation and has a pivotal role in 
immune-to-brain signaling and in modulating many innate immune processes 
(Dinarello and Savage 1989). The IL-1 family is composed of 11 members: IL-
1α, IL-1β, IL-1 receptor antagonist (IL-1 Ra) and IL-18 have been extensively 
studied cell cultures, animal models, and humans.  IL-1β can be considered 
the prototypic multifunctional and pleiotropic cytokine especially due to its 
widespread effects on immunity and diseases, appetite regulation, synaptic 
plasticity, sleep modulation, endocrine functions, and memory functions 
(Dinarello 1996; Murray and Lynch 1998; Luheshi et al. 1999; Rachal Pugh et 
al. 2001; Ikegaya et al. 2003; Spencer et al. 2004; Yasuda et al. 2005; Lai et 
al. 2006).  Blood monocytes, tissue macrophages and dendritic cells primarily 
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account for the production of this cytokine, however a self-induction 
mechanisms has also been demonstrated both in vitro and in vivo (Dinarello 
et al. 1987).  
Production of both IL-1β and IL-18 is initially achieved by an inactive 
cytoplasmic precursors (i.e. pro-IL-1β and pro-IL-18), which require enzymatic 
cleavage by caspase-1 in order to become active (Dinarello 1998). This 
process usually occurs in specialized secretory lysosomes or in the cytoplasm 
but a number of pathways seem to mediate processing and exiting the cell 
(exocytosis, microvesicles shedding, and transporters) (Andrei et al. 1999; 
Andrei et al. 2004; Qu et al. 2007).  Several intracellular proteins constitute 
the molecular platform known as the NALP3 inflammasome that regulates the 
cleavage and release of IL-1β into the mature and active form.  Activation of 
caspase-1 is regulated by the NALP3 gene, or cryopyrin/CIAS1/PYPAF1, 
which is a member of the aforementioned NLR family (Ogura et al. 2006). 
Multiple pathways lead to activation of caspase-1 and are summarized in 
figure 1.3.  
 
 
 
 
 
 
 
 
 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 29 
 
 
 
 
 
Figure 1-3: Signaling and regulation of IL-1β 
Production and regulation of IL-1β is controlled by several mechanisms. 
Direct stimulation of the IL-1 R, via IL-1, or activation of TLR4, via PAMPs or 
DAMPs signaling, leads to de novo production of IL-1 and other pro-
inflammatory cytokines. Activation of NFkB allows transcription of IL-1β 
mRNA. Translation to the functional protein occurs by enzymatic cleavage of 
the 31 kDa precursor molecule, which gets translated to the bioactive 17 kDa 
form. This process is regulated by the inflammasome and caspase 1, which is 
affected by cytokines as well as other factors including ATP and increased K+ 
release. Synthesis of new IL-1 engages in a positive feedback loop with the 
receptors; endogenous regulators like the IL-1 receptor antagonist interfere 
with this process blocking the interaction of the bioactive form with the type I 
IL-1 receptor. Modified from (Netea et al. 2008). 
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Activation of caspase-1 inflammasome complex relies also on cytosolic 
receptors, NLRs, which are mainly involved with the immune regulation and 
apoptosis (Kawai and Akira 2009). Tightly controlled and well-regulated 
mechanism, apoptosis requires efficient signaling to induce blebbing and 
structural shrinkage of the cell combined with DNA fragmentation, chromatin 
condensation and formation of the membrane bound vesicles (apoptotic 
bodies).  This process is energy adenosine triphosphate (ATP)-dependent 
and engages in a complex signaling pathway requiring both external and 
internal signals (“death activators”, cytochrome c, caspases); apoptosis is a 
normal and essential process that elicits a controlled response or “quiet” 
death of the cells, without incurring in an inflammatory response.  Tissue 
injury (mechanical stimulation) or toxic compounds can however directly 
disrupt cells leading to inflammation of the surrounding tissues in an 
antithetical process referred as necrotic cell death.  
IL-1 has been chiefly correlated with both sickness behaviour and cognitive 
impairments (Takao et al. 1990; Gibertini et al. 1995; Gibertini et al. 1995; 
Nguyen et al. 1998; Pugh et al. 1999; Rachal Pugh et al. 2001), however is 
still unknown known how IL-1β in particular leads to cognitive dysfunction. 
Concentration of cytokines in the normal brain is usually negligible and the 
main source of brain IL-1β is from activated microglia (Pinteaux et al. 2002; 
Caza et al. 2008).  Additional physiological (pyrexia), endocrinological, 
especially the resetting of the hypothalamic-pituitary-adrenal (HPA) axis, and 
metabolic (synthesis of acute phase response proteins) changes fully 
complete this adaptive behaviour (Dantzer 2004). Several downstream 
effectors have been implicated with this process, including stress-related 
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MAPK, transcription factors and microglial activation (Ma et al. 2005), 
alongside the elaboration of further molecular markers including TNF-α, 
metalloproteinases, cyclo-oxygenase 2, and corticotrophin releasing factor 
(Roe et al. 1998; Serou et al. 1999). Complementary interactions and 
synergism with other pro-inflammatory cytokines such as TNF-α and IL-6 
enhance the behavioural depression, providing great complexity in dissecting 
the signaling pathways and roles of each mediator (Dantzer et al. 1998; Pugh 
et al. 1999; Konsman et al. 2002; Allan et al. 2005; Godbout et al. 2005).   In 
particular, IL-1 and TNF-α can act directly but also synergize with each other 
(Dinarello et al, 1986). 
 
 
 
1.8 TNF signaling  
Many cell types can produce TNF, however monocytes / macrophages are 
considered to be the major producers.  LPS can be considered the prototypic 
and best characterized inducer of TNF, making it an essential molecule in 
many inflammatory processes as well as disease pathogenesis.  With a 
defined physiological and homeostatic role in protecting against infections or 
in the healing process (review Aggarwal & Natarajan, 1996), excessive 
production or chronic expression make TNF a key target for many diseases 
including rheumatoid arthritis.  Since its first identification over 10 years ago 
for the ability of killing tumors in vitro, the TNF superfamily has been 
extensively studies especially in relationship to infection and injury.  Due to 
the ability of this molecule to rapidly recruit and induce adhesion molecules as 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 32 
well as producing a myriad of chemoattractant molecules, is considered a 
putative target for many therapeutic avenues.   
Two different receptors mediate downstream signaling: p55 (TNF-R1) and 
p75 (TNF-R2).  The p55 TNF-R is widely expressed on almost every cell, p75 
TNF-R is found on cells of the immune system and primarily on endothelial 
cells.  Proteolytic cleavage of these receptors results in the production of 
soluble TNFRs, which can antagonize the biological role of TNF (Gray et al, 
1990).  Downstream signaling also activates NFkB and MAP kinases (ERK, 
p38 and JNK) leading to cytokines up regulation, and regulation of apoptotic 
and cell-death signaling (figure 1.4) (Liu 2005). 
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Figure 1-4: TNF-α signaling  
TNF has a crucial role in regulating both pro- and anti-inflammatory cytokines, 
including IL-1, IL-6, IL-10, IL-1 Ra, sTNFR. Upon stimulation of the receptor, 
plasma membrane-associated TNF-receptor I trimerize and recruits TRADD 
(tumor necrosis factor receptor type 1-associated death domain protein) via 
D-D interactions. Downstream of TRADD, two main pathways are activated: 
apoptosis via the caspases cascade, and inflammation via NFkB and JNK 
regulation (Verstrepen et al. 2008). 
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1.9 Sickness behavior 
Systemic infection and inflammation are often associated with physiological 
and behavioral changes in humans and animals alike (Hart 1988).  The body’s 
response to infection can be ancestrally correlated to a protective mechanism 
that limits and prevents an animal to become exposed in a potentially 
dangerous context.  The ensuing “sickness behaviour” is classically 
characterized by a decline in cognitive function, fever, decreased food intake, 
somnolence, hyperalgesia, and general fatigue (Konsman et al. 2002; Dantzer 
2004). These symptoms usually associate with a systemic release of 
cytokines and neuroinflammation in different brain regions including the 
hippocampus, amygdala and limbic system (Annane 2009).  For peripheral 
immune messages to reach the brain and cause neuroinflammation, two main 
pathways are activated.  Nerve conduction, especially from the primary 
afferent neurons that innervate the site of injury, or via afferent vagal 
projections to the brainstem act as a fast processor that directly conveys to 
the brain (Wan et al. 1994).  The secondary pathway is slower and relies on 
the production of cytokines to ultimately reach the central nervous system 
(CNS) (Konsman et al. 2002; Quan and Banks 2007).  Diffusion of cytokines 
into the brain occurs either via specific transporters and in the 
circumventricular organs (CVOs), resulting in a direct activation of brain 
resident immune cells (microglia) (Banks et al. 1995; Plotkin et al. 1996; Pan 
and Kastin 2002; Pittman 2003; Quan 2008).  Furthermore, inflammatory 
mediators including cytokines (Wan et al. 2007; Kobbe et al. 2008), 
chemokines (Gao et al. 2005), and matrix metalloproteinases (Rosenberg 
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2002; Colnot et al. 2003) are likely to compromise the stability of the blood-
brain barrier (BBB) itself, resulting in an increased permeability by a direct 
proteolytic action on the tight junctions, thus allowing the aforementioned 
molecules and potential pathogens in the brain (Huang et al. 2006; Zhao et al. 
2007; Rudolph et al. 2008; Wang et al. 2008). Thus sickness behaviour 
becomes a tangible consequence of neuroinflammation (Dantzer 2004).  
The transduction of peripheral inflammation into the brain results in the 
activation of microglia, the intrinsic macrophages of the CNS (Aloisi 2001) 
(figure 1.5). Upon sensing changes in brain homeostasis, for instance in the 
presence of inflammatory molecules, microglia shift from the normal resting 
state becoming reactive and mount macrophage-type innate immunity within 
the CNS (Raivich et al. 1999; Schubert et al. 2000; van Rossum and Hanisch 
2004; Bianco et al. 2005; Bernardino et al. 2008).  During this process the 
cells undergo stereotypical conformational changes both in morphology, 
acquiring an amoeboid shape, and function (Kim and de Vellis 2005).  They 
also release cytotoxic factors and cytokines, but they also mediate protective 
actions by releasing neurotrophic and anti-inflammatory molecules, making 
their function paradoxical and yet not fully understood (Block and Hong 2005). 
Activated microglia secrete pro-inflammatory cytokines (including IL-
1 and TNF-α) (Aloisi 2001), ROS, excitotoxins (such as glutamate and ATP) 
(van Rossum and Hanisch 2004), putative neurotoxins such as amyloid 
precursor protein and as well as blood-derived factors, serum factors, 
chemokines and pathological proteins (Farber et al. 1995; Garden and Moller 
2006).  Activated microglia can inhibit neurogenesis in the hippocampus 
following LPS, thereby impairing synaptic plasticity and hippocampal-
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dependent memory processes (Barrientos et al. 2002; Ekdahl et al. 2003; 
Monje et al. 2003). Interestingly, activation of microglia is also causally related 
to impairment of long-term potentiation (LTP) in advanced age (Griffin et al. 
2006). Activation of microglia appears necessary for cognitive dysfunction 
associated with several neurological insults including sickness behaviour and 
hypoxia-ischaemia and associates with the neuroinflammation in many 
neurodegenerative processes ranging from Alzheimer’s disease (AD), to 
surgery-related complications (postoperative cognitive dysfunction [POCD]) 
(Fan et al. 2006) (Kim and de Vellis 2005; Tanaka et al. 2006; Wan et al. 
2007). Nonetheless the putative association between cytokine release, 
microglial activation, and memory dysfunction remains elusive. 
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Figure 1-5: Immune-to-brain communication pathways.  
1) Cytokines penetrate the BBB via selective transporters that actively pump 
cytokines in the brain.   
2) CVOs and the choroid plexus lack a patent BBB and cytokines directly leak 
into the brain. CVOs act as a crucial interface in transducing peripheral 
inflammation to the brain and sensing inflammatory mediators thanks to the 
high vascularization and expression of PRRs.    
3) Peripheral afferents arising from the site of injury mediate immune-to-brain 
signaling and activate microglia in the CNS.  Inflammatory mediators from the 
blood vessels, especially MMP-9 and chemokines, directly damage the BBB 
by compromising the tight junction (TJ) integrity.  This process produces new 
fenestrations in the BBB allowing cytokines as well as immunocompetent cells 
(macrophages, monocytes) from the periphery into the brain.  Overall, 
entrance of pro-inflammatory mediators into the brain is sensed by PRRs on 
microglia cells.  Their activation will trigger release of new cytokines in the 
brain producing neuroinflammation and eventually affecting higher cognitive 
functions.  
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1.10 Learning and behaviour 
Virtually every organism, from simple animals to the complexity of human 
beings, has developed mechanisms to learn from the environment and 
acquire knowledge about the world.  Both innate and learned responses play 
a pivotal role in determining the personality of each individual.  Innate 
responses are inherited processes that have evolved to protect and help 
organisms towards primary necessities and survival (food, reproduction, 
avoidance of dangerous situations). These stereotypical responses are often 
inflexible and hard to modify but provide a basic tool to respond and adapt to 
unpredictable events in a given environment. Learning and memory are basic 
mechanisms in adaptation and evolution, influencing the nervous system at 
multiple levels (morphology, biochemistry, functions). Whereas learning is the 
process whereby the knowledge and new information are acquired, memory is 
defined as the ability of retaining and storing this information.  
In the mid-twentieth century, the field of learning and memory was influenced 
by a great uncertainty whether memory was a discrete function localizable to 
specific brain regions. The discoveries of Broca in defining specific language 
deficits restricted to the posterior portion of the frontal lobe on the left side of 
the brain posed the question whether memory functions could also be 
localized to specific brain areas.  In the 1950s Wilder Penfield begun to 
explore and map motor, sensory, and language functions in human patients 
undergoing neurosurgery, introducing the concept that memory may rely and 
use multiple systems.  Soon after, Brenda Milner studied the effects of 
temporal lobe removal and bilateral hippocampal ablation in patients suffering 
from epilepsy.  The fascinating story of the patient Henry Molaison, perhaps 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 39 
better known by neuroscientists and psychologists as H.M., revealed the 
crucial role of the hippocampus in forming new memories.  After bilateral 
removal of the medial portion of the temporal lobes due to untreatable 
epilepsy, the seizures that daily affected H.M. were greatly reduced.  
However, as a consequence of this procedure, H.M. lost the ability of 
producing new long-term memories, what in clinical terms is referred as 
anterograde amnesia.  Despite a good use of language and vocabulary, the 
ability of retaining past memories prior to the operation and the maintenance 
of short-term memories, H.M. was unable to retain new information after few 
minutes. After the hippocampal ablation, the transfer of information from the 
short to long-term storage was impaired. This demonstrated that the 
hippocampus is necessary for forming new long-term memories but is not 
required for maintaining or retrieving them.   Furthermore, H.M. maintained a 
relatively intact learning of motor skills. This led Milner to differentiate between 
procedural memory (memory for a skill) and declarative memory (conscious 
recall of having used that skill, memory for facts) (Bear 2001).  
 
 
 
1.11 Classical conditioning 
Human studies asides, memory and ensuing behavioural changes have been 
thoroughly studied also in animals.  The serendipitous discovery by the 
Russian physiologist Ivan Pavlov introduced the basic concept of classical 
conditioning, or Pavlovian conditioning.   Interested in understanding neuronal 
mechanisms of glandular secretion during digestion, Pavlov studied salivation 
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in dogs by administering food powder in the animal’s mouth and measuring 
the amount of secreted saliva.  He found that food elicited salivation in dogs, 
but more remarkably, once that dogs became experienced after several trials, 
they started salivating as soon as they saw the laboratory assistant coming in 
to feed the animals.  Pavlov designed a more controlled experiment in which 
before offering food powder a bell or another auditory stimulus was played.  
Similarly, after a number of pairings, the dogs learnt to salivate when the bell 
rang in the absence of food, which was no longer needed to trigger salivation.  
Thus Pavlov concluded that a similar response to the original reflex 
(salivation) could be elicited if a neutral stimulus predicts the occurrence of a 
significant incentive, such as food (Carlson 2003).   Food, a natural reward 
that can elicit an innate response is known as the unconditional stimulus (US) 
and produces an unconditional response (UR), the salivation.  When a 
previously neutral stimulus (a tone) is paired with the US and produces a 
similar effect (salivation), it is referred as a conditional stimulus (CS), and the 
following behavioural response is known as conditional response (CR). After 
the association, the former neutral stimulus (US) acquires a positive value and 
can act as a predictor of a pleasant event, establishing memory. The 
significance of classical conditioning can be appreciated in accomplishing two 
main functions:  
 
1) to allow an organism to respond faster and more effectively to a 
stimulus that predicts an important event (this requires the 
subject to learn to recognize the stimuli and remember the 
association of events) 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 41 
2) this behavioural modification is a product of a previously neutral, 
perhaps futile, stimulus that acquired importance and properties 
to be subsequently remembered 
 
The essence of classical conditioning is based on the association of two 
stimuli, the CS and US.  Classical conditioning relies on different phases and 
several learning principles. Indeed the cause – effect relationship occurs only 
when the rewarding (or warning) stimulus is carefully sequenced and timed in 
order for an initially neutral stimulus to elicit reflexive behaviour.  
Establishment of learning and memory hardly relies on a single event; after 
different trials an innate reflexive behaviour can be eventually elicited.  Only 
with repeated CS – US pairings the conditional response gradually appears. 
Both stimuli have to be presented simultaneously, or with a small delay in 
which the CS always precedes the US, and no other confounding cues should 
be provided during this phase.  
 
 
 
1.12 Fear conditioning  
The principles of classical conditioning have been exploited in many 
behavioural models, and this thesis will focus on the use of fear conditioning.   
Innate responses, both in animals and humans, are able to trigger strong 
outcomes; fear learned response requires rapid associations and reliable 
actions during learning and memory processes.  Primordially correlated with 
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survival, learning of fearful events can be extremely rapid (even limited to a 
single association) and long lasting, making fear a suitable tool for many 
experimental settings.  In the model presented in this thesis mice learnt a 
conditioned fear response in which a neutral stimulus  (tone – CS) is 
temporally associated with a noxious stimulus (foot shock – US). Intensity of 
the US and timing of the CS greatly affect the speed and rate of learning, 
making it faster if both stimuli are intense and carefully timed; this phase is 
known as acquisition. After pairing the neutral and aversive stimuli, the neutral 
cue will itself be able to elicit an aversive response from the animal.  The 
innate reaction to fear in rodents is immobility (freezing), an element that can 
be scored as an index of memory (Quinn et al. 2005). Freezing is defined as 
the complete absence of mobility with the exception of respiratory movements 
(Kim and Fanselow 1992). Because of the type of conditioning used in these 
experiments that does not purely rely on a unique sensorial modality, different 
brain areas can be assessed, including the hippocampus (Fanselow 1980; 
Phillips and LeDoux 1992).  Contextual fear conditioning relies on the same 
tone – shock principle but the subject also learns to associate the 
environment with the US. Contextual fear conditioning is modulated by two 
key elements: forming a memory of the context and associating that memory 
with the shock.  Learning, memory consolidation and reproduction of the 
context require higher faculties that strongly rely on the hippocampus. There 
are substantial evidence to support the role of this structure in spatial learning 
and contextual fear memory through the use of other techniques like surgical 
lesions, pharmacological manipulations, or genetic manipulations (McEchron 
et al. 1998; Quinn et al. 2002; Koh et al. 2009).  Using this paradigm, 
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hippocampal functioning is pivotal during the acquisition phase when CS – US 
stimuli become associated but also, once this association is made, the 
hippocampus is required to create a uniform reconstruction of the context. 
The contextual retrieval test (context task) aims to target and primarily assess 
this hippocampal-dependent memory. Hippocampal damage following fear 
conditioning reflects many parallels to clinical cases of amnesia following 
hippocampal damage (Kim and Fanselow 1992). Trace fear conditioning also 
allows assessment of non-hippocampal pathways, in particular the prefrontal 
cortex and the amygdala (Han et al. 2003; Runyan et al. 2004; Misane et al. 
2005).  In particular, monosynaptic projections from the geniculate nucleus 
and neocortical pathways present auditory information to the lateral 
amygdala, which encodes emotional memories (LeDoux 2000). By testing in a 
novel environment (tone task), the assessment is not tainted by the fear 
instilled by the acquisition environment and this can be relates to hippocampal 
functioning (Romanski and LeDoux 1993). This thesis will primarily focus on 
the hippocampal-dependent component of the behavioral dysfunction, other 
brain regions are currently under investigation. 
 
 
 
1.13 Memory and neuroinflammation 
The hippocampus (from the Greek hippos, “horse” and kampos, “sea 
monster”) is a primitive C-shaped structure in the limbic system composed of 
three distinct regions known as the dentate gyrus (DG), the hippocampus 
proper (CA1, CA2 and CA3) and the subiculum.  Situated in the deep caudal 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 44 
part of the brain, it plays a pivotal role in learning, processing and storing 
long-term memories (only declarative memories), navigation and cognitive 
maps. Learning and memory processes largely rely on the hippocampus and 
this brain region expresses the highest density of IL-1 binding sites, making it 
particularly vulnerable to the adverse consequences of neuroinflammation 
(Kim and Fanselow 1992; Ban 1994; Parnet et al. 1994; Gemma et al. 2005). 
Although IL-1β is required for normal learning and memory processes, 
exogenous administration or excessive endogenous levels produce 
detrimental cognitive behavioral effects (Oitzl et al. 1993; Gibertini 1998; 
Barrientos et al. 2008; Chen et al. 2008).  The neurobiological correlate of 
memory consolidation involves LTP in several hippocampal pathways. In 
mammals, an increase in synaptic strength, or LTP, is considered to 
constitute the cellular mechanism for encoding memories (Bliss and Lomo 
1973).   This phenomenon is observed in brain areas, such as the 
hippocampus, amygdala, cerebellum and cerebral cortex.  LTP improves the 
ability of two neurons, one presynaptic, and the other, postsynaptic, to 
communicate with each other across a synapse.  IL-1β directly inhibits LTP by 
modulating surface expression and phosphorylation of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPARs), an ionotropic 
transmembrane receptor for glutamate fundamental in mediating fast synaptic 
transmission in the CNS (Lai et al. 2006). Synergistic interaction between IL-
1β and other cytokines, such as TNF-α and IL-6, enhances this cognitive 
dysfunction (Dantzer et al. 1998; Pugh et al. 1999; Konsman et al. 2002; Allan 
et al. 2005; Godbout et al. 2005). TNF-α also affects LTP by changing the 
balance between AMPARs and gamma-aminobutyric acid A (GABAA) in the 
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hippocampus and IL-6 can enhance glial activation and inflammation, directly 
affecting working memory (Stellwagen et al. 2005; Sparkman et al. 2006).  
 
 
 
1.14 Surgery-induced memory dysfunctions 
Systemic and central release of cytokine after a surgical procedure has 
become a noteworthy event associated with cognitive dysfunction (Moller et 
al. 1998; Gao et al. 2005; Kalman et al. 2006; Beloosesky et al. 2007). The 
observation that after an operation some patients are more likely to develop 
cognitive deterioration and changes in personality has also been long known.  
Hippocrates introduced the concept of mental confusion when describing the 
symptoms of “phrenitis”, which was characterized by fluctuating 
unpredictability and associated with acute illness and fever (Morandi et al. 
2008).  Aulus Cornelius Celsus in De Medicina further described the milieu of 
symptoms including sudden confusion, cognitive decline, inertia, impairment 
in attention and circadian rhythm that defined as delirium (from the Latin de – 
lira, in agricultural terminology meaning “to be away from plowing in a straight 
line”, thus be deranged).  Diagnosis was generally associated with head 
trauma, fever or mental disorders, mainly involving the elderly, and the 
terminology of confusion, delirium and dementia was often interchanged and 
used inappropriately, as synonyms.  In 1887 George Savage associate the 
delirium with surgical procedures and how surgery and anaesthesia may 
contribute to the development of “insanity”. 
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“One or two practical questions arise for the surgeon, one of 
the most important being whether neurotic inheritance or 
neurosis in the individual, as proved by previous attacks of 
insanity, should in any way affect the prognosis in operations, 
and to what degree it should interfere with operations of 
convenience not essential for the prolonging or saving life.” 
George Savage, British Medical Journal, December 1887 
 
 
This observation failed to make POCD a plausible hazard of surgery until 
more recent reports revamped the concept and focused in particular on the 
role of anaesthetics as possible cause of cognitive dysfunction. Especially in 
the context of cognitive dysfunctions anesthesia has been, and currently is, 
studied as a likely contributor in the genesis of this phenomenon.  Thanks to 
the inestimable value of anesthetic agents in providing a reversible, drug-
induced loss of consciousness and a balanced amnesia, immobility, muscle 
relaxation and analgesia (Franks 2006), their association with impairment in 
cognitive performance became utterly probable.  Mortality and morbidity after 
surgery in the past has been chiefly associated with anesthesia.  Nowadays 
critical incidents rarely happen during the deep sleep; anaesthesia is 
innovative, safer, and better tolerated, but the question “is anesthesia safe 
enough?” still remains unanswered. Until quite recently, the prevailing wisdom 
was that the CNS effects of general anesthesia are transient and completely 
reversible; general anesthesia is known though to affect the brain at many 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 47 
different molecular targets (Franks 2008) and there are evidence for several 
general anesthetic agents to produce neurotoxicity and detrimental effects in 
synaptic circuitry and behavior (Slikker et al. 2007). Animal studies suggest 
that anesthetics may be responsible for modifications in the brain that outlast 
their elimination from the body (Futterer et al. 2004). Developmental 
neurotoxicity in rodents by exposure to ketamine, nitrous oxide, propofol, 
midazolam, barbiturates, and isoflurane, alone or in anesthetic “cocktails”, is 
classically associated with apoptosis and delayed behavioral abnormalities 
(Culley et al. 2007; Sanders et al. 2008; Sanders et al. 2009).   
Aside developmental toxicity in the newborn, also the elderly patients (>65 
year-old) appear to be more vulnerable to the deleterious effects of 
anesthetics. Co-morbidities and physiological changes induced by the aging 
process generally reflect to higher vulnerability and greater risks per se. With 
the fastest growing segment of the population in the industrialized world and 
the highest probability of requiring anesthesia and surgical resources, this age 
group is becoming the largest segment of surgical patients by 2020 (Etzioni et 
al. 2003). The number of major surgical interventions requiring anesthesia 
already exceeds 230 million world-wide (Weiser et al. 2008), making surgery 
a putative instigator of poor prognosis, increased likelihood of complications 
and development of neurodegenerative conditions and permanent dementia 
such as Alzheimer’s disease.  Animal studies in aged rats suggest that 
cognitive dysfunction persists several weeks after exposure to a commonly 
used anesthetic regimen (Culley et al. 2003) and this is associated with 
change in gene expression in the hippocampus (Culley et al. 2006). Yet, 
some anesthetics do not produce any disturbance in cognition post-exposure 
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even in aged rats (Lee et al. 2008) and clinically-evident POCD also occurs 
after regional anesthesia (Rasmussen et al. 2003).  
A relationship between anesthesia, β-amyloid and tau phosphorylation 
metabolism in particular has been suggested, however mechanisms are still 
unclear and a number of limitations need to be addressed in these studies 
(Planel et al. 2007; Dong et al. 2009).  Despite the evidence from cell culture 
data or animal models, randomized clinical trials in older patients undergoing 
major non-cardiac surgery have reported similar incidence in POCD after 
regional or general anesthesia, thus making the role of anesthesia yet 
controversial (Williams-Russo et al. 1995; Rasmussen et al. 2003). 
 
 
 
1.15 Postoperative cognitive dysfunction (POCD) 
Recently, we explored the role of the neuroinflammatory response to surgery 
as a possible cause for cognitive dysfunction.  POCD is now an emblem in the 
field of surgery-induced complications, with a significant burden on health 
care management.  Postoperative dysfunctions have been generally classified 
according to the duration of the behavioral abnormality after surgery and can 
follow two patterns: early POCD or interval delirium and late POCD (Cohendy 
et al. 2005).  Delirium is commonly seen after surgery, usually soon after 
surgery (hours to days) and fluctuating over time. Perturbed behavior is 
characterized by impairments in consciousness, cognition, emotions and 
stereotypical psychosis may vary between patients ranging from hyperalert to 
hypoalert, or mixed.  Although the dysfunction lasts over a short period of 
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time, delirium is associated with increased mortality (Ely et al. 2004), greater 
care dependency, costs (Milbrandt et al. 2004) and prolonged hospitalization 
(Ely et al. 2001).  Due to the dynamic and complex processes that underlie 
this phenomenon and the significant impact on the intensive care unit, many 
strategies are looking into prevention and treatment of delirium, especially in 
older patients that are at higher risk (Ely et al. 2002; McNicoll et al. 2003).  
It is possible to diagnose POCD a considerable time after surgery and is 
defined as a subtle dysfunction in one or more cognitive domains also 
characterized by impairment of short and long-term memory (i.e. reduced 
ability to learn or recall information), mood, consciousness and circadian 
rhythm (Bekker and Weeks 2003; Caza et al. 2008).  POCD has been 
thoroughly studies in the first prospective multicenter study, International 
Study of Postoperative Cognitive Dysfunction (ISPOCD), involving more than 
1200 patients over the age of 60 undergoing major non-cardiac surgery with 
general anesthesia (Moller et al. 1998).  Neuropsychological tests showed 
that 25.8% of the patients had POCD one week after surgery, and 9.9% 
showed persistent cognitive deficit 3 months postoperative.  This investigation 
first reported that advanced age, duration of surgery, additional operations, 
postoperative respiratory and/or infectious complications were significant risk 
factors in the development of cognitive abnormalities. By deliberately using a 
less stringent criterion including pre-operative cognitive dysfunction, 
depressive symptomatology, and the ability to perform daily routines, up to 
19.1% of patient over the age of 64 undergoing orthopaedic surgery had 
POCD at 3 months (Ancelin et al. 2001). Neurological and cognitive 
complications were first described after cardiac surgery with cardiopulmonary 
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bypass (CPB), however POCD also affects non-cardiac surgeries (McKhann 
et al. 1997). The neurocognitive impairment clearly correlates with an 
increased vulnerability of these patients to further neurological degeneration / 
dementia, longer hospitalization time, greater co-morbidity and higher 
mortality risk compared to those that do not develop this postoperative 
complication.  Although age and surgery are consistently reported as 
important risk factors in the development of cognitive dysfunction, the etiology 
of POCD remains elusive (Monk et al. 2008). Further studies have sought to 
identify pathogenic mechanisms due to perioperative factors [such as general 
vs regional anesthesia (Wu et al. 2006), hyperventilation, hypotension, 
hypoxia, psychoactive drugs and/or alcohol withdrawal], as well as patient-
related factors including polymorphisms {apolipoprotein ε [APO ε] (Heyer et al. 
2005)}, and co-morbidities such as underlying neurovascular / 
neurodegenerative disease and cancer (Newman et al. 2007).  Although 
these studies have often been underpowered, lacking appropriate controls 
and not using similar batteries of tests for assessment, they also missed to 
prioritize the contribution of these factors in the development of this 
phenomenon (Newman et al. 2007).  
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1.16 Animal models of POCD 
Due to the complexity of this condition and is classical definition as 
multifactorial pathology, animal models have been developed to identify 
pathogenic mechanisms and define putative targets for treatment. The first 
association between surgery and cognitive dysfunction in an animal model 
was developed in adult rats subjected to laparotomy and splenectomy.  
Herein, cognitive dysfunction persisted for up to three days postoperatively 
and was associated with an increase in transcription and expression of key 
pro-inflammatory cytokines together with glia activation in the hippocampus 
(Wan et al. 2007). In particular, increased IL-1β mRNA expression and glia 
activation in the hippocampus of splenectomized rats have bridged pro-
inflammatory cytokines with memory impairment and POCD after a surgical 
procedure (Wan et al. 2007).  Similarly, increased expression of IL-1β mRNA 
in the hippocampus of old mice has been reported following minor surgery, 
further elucidating that surgical trauma produces neuroinflammation, which 
results in cognitive impairment (Rosczyk et al. 2008).  
The above-mentioned findings, alongside the clinical findings suggest that to 
trigger this process, a so-called danger signal is required to alert the immune 
system and elicit an adequate response to the original threat (Matzinger 2002; 
Harris and Raucci 2006).  A surgical procedure is likely to trigger danger 
signals, hence producing an immune response. Surgical patients exhibit 
elevations of pro-inflammatory cytokines in both the central nervous system 
and in the systemic circulation and these may be associated with 
postoperative cognitive dysfunction (Buvanendran et al. 2006; Di Vita et al. 
2006; Beloosesky et al. 2007).  Major surgeries such as cardiac surgery or 
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orthopedic procedures in particular expose the subject to extensive trauma, 
blood loss, and tissue injury; all of these factors closely engage with the 
immune system to produce an inflammatory response (Buvanendran et al. 
2006; Di Vita et al. 2006; Kobbe et al. 2008).  Originally the concept of danger 
signal was only restricted to exogenous molecules, previously referred as 
PAMPS.  Besides PAMPs, several endogenous molecules have now been 
found to interact and signal via the same receptors (Termeer et al. 2000; 
Johnson et al. 2004; Zedler and Faist 2006). The initiating mechanism 
whereby surgical trauma stimulates innate immunity is likely to involve 
DAMPs that are released from dead or dying (through non-apoptotic 
mechanisms) cells (Lotze et al. 2007); DAMPs can also be released during 
surgical trauma and include markers such as high-mobility group box 1 
(HMGB1), which bind and signals through a family of relatively evolutionarily 
conserved PRRs (Levy et al. 2007).   
TLR2, and TLR4, (and possibly TLR9) may be unique among TLR family 
members in their ability to recognize both exogenous and endogenous 
ligands, thus suggesting similarities between the mediators that drive the 
systemic inflammatory response to sepsis and aseptic tissue injury (Ohashi et 
al. 2000; Paterson et al. 2003; Akira and Takeda 2004; Kaczorowski et al. 
2008).  More recently, a correlation between endogenous proteins released 
after tissue injury and TLR4 has been suggested (Paterson et al. 2003; Mollen 
et al. 2006; Levy et al. 2007).  A series of studies have been conducted using 
TLR4 deficient mice looking at the danger signal after acute tissue injury 
including hemorrhagic shock (Barsness et al. 2004), cardiac (Oyama et al. 
2004), and hepatic (Tsung et al. 2005) ischemia/reperfusion models, showing 
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reduced inflammation and injury compared to wild types.  Endogenous 
inducers not only engage with TLRs, but other PRRs are also involved in 
perpetuating and amplifying the inflammatory response (Medzhitov 2008).  
Advance glycation end-products, HMGB-1 and some S100 proteins activate 
the receptor for advance glycation end-products (RAGE), leading to 
downstream activation MAPK and NF-κB (Erlandsson Harris and Andersson 
2004; Bianchi 2007). HMGB1 is a ubiquitous non histone DNA-binding protein 
which stabilizes the nucleosomal structure and facilitates gene transcription 
(Agresti and Bianchi 2003).   Active and passive release of HMGB1 is seen in 
many inflammatory conditions ranging from sepsis to arthritis, acute lung 
injury, and stroke (Wang et al. 1999; Abraham et al. 2000; Kokkola et al. 
2002; Lotze and Tracey 2005; Qiu et al. 2008).  Recently HMGB-1 has been 
reported to bind to RAGE and TLR4 to mediate cytokine release, coagulation 
activation and neutrophil recruitment (Yu et al. 2006; van Zoelen et al. 2008). 
TLRs and the IL-1R also affect NFκB gene expression, and their signaling 
largely depends on the adaptor protein MyD88 (Kimbrell and Beutler 2001; 
Akira and Takeda 2004; Li and Qin 2005; Lotze and Tracey 2005). 
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1.17 Summary 
In summary, major surgeries expose patients to extensive trauma, blood loss, 
and tissue injury; all of these factors effectively modulate the immune system 
to ultimately trigger an inflammatory response.  Few studies have yet started 
to unmask the inflammatory component in POCD, in particular how 
neuroinflammation and microglia activation in the hippocampus following 
surgery associate with cognitive decline. The involvement of inflammation and 
cytokines has now been examined in this thesis, unveiling novel signaling 
pathways and mediators of the inflammatory cascade, representing feasible 
therapies to be translated into clinical trials.  
 
 
1.18 Hypothesis  
The hypothesis of this project is that inflammation plays a key role in the 
etiology of POCD. 
 
 
1.19 Aim 
The aim of this thesis is to investigate the inflammatory signaling pathways 
specifically involved with POCD, with a particular interest between systemic 
inflammation and local inflammation in the brain following surgery.  
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2 Chapter 2: Material and methods   
2.1 Animal care 
This research protocol complies with the regulation regarding the care, 
welfare and use of experimental animals published by the United Kingdom 
Animals (Scientific Procedures) Act of 1986 and under the Home Office (UK) 
license.  Every effort was made to limit the number of animals and to ensure 
that any of the experimental groups experienced unnecessary suffering.  Male 
C56BL/6 mice (Harlan, UK) 12-14 weeks old, weighting 25 - 30 g were used 
in this experiment and housed in groups of five in a 12-h-12-h light dark cycle, 
with controlled temperature (22-23°C) and humidity and free access to 
standard laboratory food and water. IL-1R-/- (kindly provided by Nancy 
Rothwell, Manchester (Labow et al. 1997)) were bred in house on a C57BL/6 
background and age-matched to wild type counterparts. MyD88-/- (Adachi et 
al. 1998), TLR2-/- and TLR4-/- were obtained from the Kennedy Institute of 
Rheumatology and bred in house on a C57BL/6 background.  Seven days of 
acclimatization were allowed before starting any experiment. All the animals 
were checked on a daily basis and evidence of poor grooming, huddling, 
piloerection, weight loss, back arching and abnormal activity, were excluded 
in the experiments.  
 
 
 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 56 
2.2 Surgery 
Animals were anesthetised with isoflurane (Total minimum alveolar 
concentration [MAC] of 1.5 ± 2 corresponding to air concentration of 2.1% - 
30% FiO2) (Abbot Laboratories Ltd., Queensborough, Kent, UK) (Engelhardt 
et al. 2006).  Delivery of volatile agent was achieved with a semi-closed 
circuit.  Concentration of volatile agent and oxygen were monitored before 
skin incision and at the end of each procedure (Datex-Engstrom AS/3; 
Instrumentarium Corp, Helsinki, Finland).  Analgesia (buprenorphine - 
Buprenex®, 0.1 mg/kg) was given subcutaneously to reduce pain and pain-
related systemic response and was administered immediately after 
anaesthetic induction and before producing the incision. Temperature was 
monitored throughout the surgical procedure with a subcutaneous 
thermometer (CSi8D Series, Omega, USA) and maintained within normal 
parameters between 36 and 37°C.  Warming pads (Harvard apparatus) and a 
temperature-controlled light were used to achieve optimal equilibrium. Aseptic 
conditions were maintained throughout the procedure.  The surgical area 
localized on the dorsal aspect of the left hind paw was meticulously shaved 
and disinfected with chlorhexidine gluconate 0.5% (BDH Laboratory Supplier, 
England).  Sterile drapes were applied on the surgical field and onto the 
animal to limit risks of contaminations; autoclaved instruments were used 
throughout.  The open diaphyseal procedure on the tibia was adopted from 
(Hiltunen et al. 1993) with some modifications.  A longitudinal incision was 
made from the knee to the midshaft of the tibia under a dissecting microscope 
(Leica). The subcutaneous tissue was dissected and muscles isolated until 
revealing the patellar tendon and the tibial periosteum.  A 0.5mm hole in the 
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proximal tibia was drilled with a 25-gauge needle just beneath and medial to 
the patellar tendon to enter the intramedullary canal.  A 0.38 mm stainless 
steel rod was then inserted in the canal for 15mm circa until resistance was 
felt (figure 2.1). Subsequently, the fibula and the muscles surrounding the tibia 
were isolated, the periosteum stripped over a distance of 10mm 
circumferentially and an osteotomy was performed with scissors at the 
junction of the middle and distal third of the tibia.   
 
 
 
 
 
Figure 2-1: Stabilized tibia fracture in a mouse.  
Adapted from (Gardner et al. 2006) 
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After producing the fracture the wound was irrigated and the skin sutured with 
8/0 Prolene; intra-opaerative fluid loss was replaced with 0.5 ml of 
subcutaneously injected normal saline. The animal was allowed to recover in 
a warm box, once fully awake placed a clean standard cage.  The entire 
procedure from induction of anesthesia to recovery lasted 15 ± 5 min. 
 
 
 
2.3 Treatments 
Minocycline (40 mg/kg in 0.1 ml/volume, Sigma, UK) was given 
intraperitoneally 2 hours prior surgery and daily thereafter until termination.  
Dosage was comparable to previous studies to achieve neuroprotective 
effects (Yrjanheikki et al. 1999; Bye et al. 2007).  Minocycline was made fresh 
accordingly to the experimental schedule by dissolving it in phosphate buffer 
solution (PBS) (Sigma, UK) and minimizing precipitates formation. IL-1 
receptor antagonist (IL-1 Ra) (Amgen, Kineret® 100 mg/kg, Nederlands) was 
given subcutaneously immediately before intervention. TNF neutralizing 
antibody (clone TN3, Sigma, UK, 100 µg in 0.1 ml/volume (Sheehan et al. 
1989)) was dissolved in normal saline and injected either 18 hours before 
surgery or immediately after. Enrofloxacin (10 mg/kg, Baytril®) was given 2 
hours prior to surgery and twice daily thereafter until assessment of outcome. 
Lipopolysaccharide (LPS) derived from Escherichia Coli endotoxin (0111:B4, 
InvivoGen, USA, 1 mg/kg) was dissolved in normal saline and injected 
intraperitoneally.  Mice in the anesthesia without surgery treatment group 
received isoflurane (1.5 MAC for 20 minutes) and analgesia (buprenorphine 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 59 
0.1 mg/kg) with no surgical intervention or other treatment. Control animals 
were injected with equivalent volumes (0.1 ml) of saline.  
 
 
 
Figure 2-2: Experimental groups flow chart.  
Mice were randomly assigned and treated according to each experimental 
setting. Animals were independently assessed for inflammatory markers and 
behavior using TFC. Blood was obtained from every animal for cytokine 
analyses (ELISA). Due to the differences in processing brain tissue for IHC or 
q-PCR, separate cohorts of animals have been used in each investigation. 
Assessment of hippocampal-dependent memory using TFC was also 
performed in different cohorts in order to obviate possible confounding effects 
of behavioral testing on inflammatory markers; no other analyses were 
performed on these animals.  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2.4 ELISA  
2.4.1 Blood collection  
Blood was sampled transcardially after thoracotomy under terminal 
anesthesia 30 minutes, 2, 6, 12 hours and 1, 3, 7 days after experiments in 
the different cohorts and centrifuged at 3,600 rpm for 7 minutes at 4°C.  Blood 
samples taken from animals without any interventions severed as controls.  
Plasma samples were stored at -20°C for further analysis. Plasma cytokine 
and HMGB-1 were measured using commercially available ELISA kits from 
Biosource, CA and Shino-test Corporation, Japan, respectively.  The 
sensitivities of the assays were <3 pg/ml for TNF, <7 pg/ml for IL-1β, <3 pg/ml 
for IL-6 and 1 ng/ml for HMGB1.  
 
 
 
2.4.2 Cytokine analyses  
Cytokine levels were assessed with sandwich enzyme-linked immunosorbent 
assay (ELISA).  Pre-coated 96-wells ELISA plates commercially available 
were used with few modifications.  Briefly, standards and samples (50 µL) 
were incubated for 90 min at 37°C with 50 µL of biotin conjugate (protocol for 
IL-1β).  All samples were run in duplicates.  After washing all wells four times 
with washing buffer, samples were incubated with 50 µL of Streptavidin-HRP 
Working Solution for 30 min at room temperature (RT) on a shaker, and then 
washed again four to five times.  50 µL of Stabilized Chromogen was added 
to each well; after 30 min of incubation in the dark, the reaction was stopped 
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with 50 µL of Stop Solution.  A colour reaction would occur in each well 
changing the solution from blue to yellow and the absorbance is read on a 
micro-platelet reader at 450 nm.  Cytokine levels were calculated by a 
standard curve of the assessed cytokine.  Manufacturer's data reported assay 
sensitivities and tested cross-reactivity for other cytokines.  Mice from each 
treatment group were randomly assigned for assessment of either cytokine 
response or cognitive behavior, in order to obviate possible confounding 
effects of behavioral testing on inflammatory markers (Nguyen et al. 1998).  
 
 
 
2.4.3 Brain ELISA 
Each mouse was euthanized and quickly perfused with PBS.  The 
hippocampus was dissected under microscopy on a frosted glass plate placed 
on top of crushed ice, then snap frozen and stored at -80˚C until processing.  
Each hippocampus was added to Iscove’s culture medium containing 5% fetal 
calf serum (FCS) and a cocktail of enzyme inhibitors (in mM: 100 amino-n-
caproic acid, 10 EDTA, 5 benzamidine-HCl, and 0.2 phenylmethylsulfonyl 
fluoride). The proteins were mechanically dissociated from tissue by means of 
sonication in a container plunged in ice.  This consisted of 3 cycles of cell 
disruption each lasting 3 seconds.  Sonicated samples were centrifuged at 
10000 rpm for 10 minutes at 4˚C.  Supernatants were collected and stored at -
80°C until the ELISA was carried out.  IL-1β was measured in the supernatant 
from hippocampal extracts, which were appropriately diluted prior to 
measurement to fall on the linear portion of the sigmoid curve, using a 
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commercially available ELISA kit (Bender Medsystem, CA). The sensitivity of 
the assay was 1.2 pg/ml. The ELISA kit was validated for use with brain 
tissues. Samples collected from mice treated with LPS (0111:B4, Invivogen, 
CA) 3 mg/kg i.p. were used to confirm reliability of dilution linearity and spike 
recovery.   
 
 
 
2.4.4 Protein quantification  
Protein quantification using the Bradford assay was carried out.  Bradford dye 
concentrate (Bio-Rad) was diluted with double distilled water (ddH2O) in a 1:4 
ratio respectively, following manufacturer’s instructions. To make protein 
standard samples, a known concentration of bovine serum albumin (Bio-rad) 
was serially diluted with ddH2O to range in concentration from 1000, 500, 
250, 125, 12.5 and 1.25 µg/mL. On ice, 10 µL of protein samples and 10 µL of 
protein standard samples were loaded in triplicate into a 96-microwell flat-
bottomed clear plate. Bradford dye (200 µL) was pipetted into each well and 
left to incubate for 5 minutes. The plate was then placed in a 
spectrophotometer to measure the optical density of each sample at 595 nm. 
The standard curve created from the protein standard samples allowed for 
determination of the protein sample concentration and their subsequent 
normalisation to the ELISA readouts.   
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2.5 q-PCR  
2.5.1 RNA Extraction 
The hippocampus was rapidly extracted under a dissecting microscope, 
placed in RNAlater solution (Applied Biosystems, Ambion, Austin, TX) and 
stored at 4°C.  Total RNA was isolated using RNeasy Kit (Qiagen, Valencia, 
CA) following manufacturer’s instructions.  Extracted RNA was treated with 
recombinant DNase I (rDNasa I) using a DNA-free™ kit (Applied Biosystems, 
Ambion, Austin, TX) and quantified using spectrophotometry (Nanodrop 
Spectrophotometer, Labtech, East Sussex, UK) to determine the volume of 
RNA equivalent to 1 µg to be used in the following PCR. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) reverse transcription polymerase chain 
reaction (RT-PCR) was carried out to very the absence of any DNA 
contamination (figure 2.2). 
 
 
 
 
Figure 2-3:  RT-PCR product to verify absence of DNA contaminations.  
From left to right: 1kD protein ladder, cDNA (positive control), x3 samples 
assayed.  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2.5.2 Production of cDNA 
For the reverse transcription reaction, Moloney Murine Leukaemia Virus (M-
MLV) reverse transcriptase (Promega, Madison, WI) was used following 
manufacturer’s instructions.  PCR amplification was carried out using 
oligo(dT) (MWG Biotech, London, UK) and recombinant Taq DNA polymerase 
(Invitrogen, CA) for GAPDH and cytokines of interest, following 
manufacturer’s protocol (total reaction volume: 20 µL, including 1 µL cDNA).  
A T3 Thermocycler (Biometra, Goettingen, Germany) was used with the 
following settings: initialization step at 94ºC for 4 minutes, denaturation step at 
94ºC for 30 s, extension step at 60ºC for 40 s for 30 thermal cycles, final 
elongation at 72ºC for 45 s and final hold at 4ºC. Oligonucleotide primers 
were purchased by MWG Biotech (London, UK). 
PCR products were analyzed using 1.5% agarose gels. Briefly, 1.5 g of 
ultrapure agarose (Invitrogen, CA) was dissolved in 100 mL 1x tris-acetate 
EDTA (TAE) buffer under microwave heating.  After cooling, 10 µL (1:10000 
dilution) SYBR safe DNA stain (Invitrogen, CA) was added to the mixture to 
enable DNA visualization under ultraviolet light (UVP BioDoc-It System, 
Upland, CA).  10 µL of each PCR product was mixed with 2 µL of loading 
buffer (40% glycerol and bromophenol blue) and loaded onto the gel.  Electric 
field was kept at 110 V for 30 minutes (figure 2.3). 
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Figure 2-4: RT-PCR product to verify presence of DNA for q-PCR.  
From left to right: 1kD protein ladder, cDNA (positive control), water (negative 
control), x5 samples assayed. 
 
 
 
2.5.3 Quantitative real time polymerase chain reaction (q-PCR) 
q-PCR was carried out to determine the level of mRNA expression of each 
cytokine in relation to endogenous control ACTB (β-actin). The endogenous 
control had a constant expression within cells that remained unchanged after 
treatment, thus allowing normalization to this value. Quantification was based 
on the fluorescent reporter probe method.  A probe is a short DNA sequence 
complementary to part of the gene of interest, onto which a quencher dye (5’ 
end) and a fluorescent reporter dye (3’ end) are attached. When the two dyes 
are in close proximity, no fluorescence can be detected. However, during 
polymerisation, DNA polymerase cleaves the probe separating it from the 
quencher, hence the fluorescence increases.  
The one-step q-PCR was performed on a Rotor-Gene 6000 (Corbett Life 
Science, Australia), using Assay-On-Demand premixed Taqman probe master 
mixes (Applied Biosystems, Ambion, Austin, TX). A ready-made reaction mix 
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was used containing Taq DNA polymerase, MgCl2 and deoxyribomucleotides 
(Platinum® Quantitative PCR SuperMix-UDG, Invitrogen, CA) with gene-
specific primers and fulorogenic probes. Total reaction volume was 20 µL of 
which cDNA was 5 µL (1:5 dilution of reverse transcription product). Taqman® 
gene expression assays for the gene of interests and controls were used for 
optimizing and validating the PCR.  Precise primer sequences remain under 
proprietary copyright. Each sample was run in triplicate following the 
programme: 2 min incubation at 50ºC, 3 min pre-incubation at 95ºC, followed 
by 45 thermal cycles of 15 s at 95ºC and 40 s at 60ºC. Fluorescence was 
measured at the end of each cycle.  
Relative gene expression was calculated using the comparative threshold 
cycle 2-∆∆Ct method (Livak and Schmittgen, 2001; Wong and Medrano, 2005) 
and normalized to ACTB. This consists of setting a threshold cycle (Ct) value 
that represents a fixed value of fluorescence. Relative fluorescence of the 
gene of interest to the relative endogenous control (∆Ct, sample) is calculated by 
(∆Ct, cytokine – ∆Ct, ACTB). Expression levels are then related to an external 
control, hippocampus from untreated animals, to give the Ct value by (∆Ct, 
sample – ∆Ct, untreated). Relative expression can be obtained by 2-∆∆Ct. Results are 
expressed as fold-increases relative to controls.  
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2.6 Perfusion and cryostat sectioning:  
 
Table 2-1:  Solutions 
0.2 M Phosphate buffer (PB) (2 L)  
46 g  Na2HPO4  
9.1 g  Na2H2PO4   
2 L  dH2O  
  
0.1 M Phosphate-buffered saline (PBS) (2 L)  
1 L 0.2 M PB  
1 L dH2O  
18 g NaCl  
  
0.1 M Phosphate-buffered saline with 0.3 % triton (PBS-T) (2 L)  
2 L  PBS  
6 mL Triton X-100 (Promega)  
  
0.1M Phosphate-buffered saline with 0.3 % H2O2  / 70 % methanol (30 mL)  
9 mL  0.1 M PBS  
21 mL  Methanol  
300 µL  30% H2O2  
  
Heparinised phosphate-buffered saline (PBS-Hep) (2 L)  
2 L PBS  
2 mL (1000 U / mL) heparin sodium solution (Sigma)    
 
10 % paraformaldehyde (2 L)  
Prepare under fume hood and store at 4ºC  
1.6 mL dH2O (heat to ~70ºC)  
200 g paraformadehyde (dissolve in water)  
1 mL NaOH (to aid dissolution)  
2 L dH2O  
Cool solution to room temperature  
Titrate to pH to 7.4 with HCl and/or NaOH  
Filter and store at 4ºC 
  
4 % Paraformaldehyde (2 L)  
Prepare under hood, make immediately before use and store at 4ºC 
1 L 0.2 M PB  
0.8 L 10 % paraformaldehyde  
Top up to 2 L with dH2O  
 
30 % Sucrose solution (2 L)  
600g sucrose  
2 L  0.1 M PBS  
  
1 M Sodium hydroxide (NaOH) (2 L)  
50 g  sodium hydroxide pellets  
Dissolve to 2 L with dH2O  
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Mice were euthanized and perfused transcardially with ice-cold heparinized 
0.1M PBS followed by 4% paraformaldehyde in 0.1M PBS at pH 7.4 (VWR 
International, UK). The brains were harvested and post-fixed in 4% 
paraformaldehyde in 0.1M PBS at 4°C and cryoprotected in 0.1M PBS 
solutions containing 15% sucrose for 24 hours (VWR International, UK) and 
then 30% sucrose for a further 48 hours. Brain tissue was freeze-mounted in 
OCT embedding medium (VWR International, UK). A metallic base was 
allowed to cool down to -20°C. OCT embedding medium was applied to the 
metallic base covering an area and the specimen attached vertically onto the 
prepared base.  Additional embedding medium was placed around the 
specimen to completely cover it; rapid freezing aerosol spray was used to 
ensure that specimen maintained its vertical position. The specimen was left 
in the cryostat for at least 30 minutes until it was completely frozen. Once the 
specimen was ready, the metallic base was attached firmly onto the cryostat 
(Bright Instruments Huntingdon, UK). 25µm thick coronal sections of the 
hippocampus were cut sequentially in groups of 6 and mounted on 
Superfrost® plus slides (Menzel-Glaser, Germany). Slides were air dried 
overnight and stored at -20°C until further use. 
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2.7 Immunohistochemistry (IHC) 
Sections from all of the treatment groups were run together in order to reduce 
variability. To begin the staining procedure, the sections were left at room 
temperature for 20 minutes before being transferred to 0.1M PBS. To reduce 
background staining caused by endogenous peroxidase the sections were 
quenched with a solution of 0.3% H2O2, 70% methanol and 0.1M PBS for 30 
minutes. Sections were rinsed 3 times with 0.1 M PBS and incubated in 3% 
normal goat serum (NGS) blocking solution for 30 minutes. The rat 
monoclonal antibody, OX-42 (low endotoxin, clone M1/70.15) 1:200, directed 
against mouse CD11b (Serotec, UK) was used to label microglia. 
Visualization of immunoreactivity for OX-42 was achieved using the avidin-
biotin technique (Vector Labs, UK) and a goat anti-rat secondary antibody 
(Chemicon International, USA) at a concentration of 1:200. After rinsing in 
phosphate buffer saline with triton X (PBST, 0.3% triton X, pH 7.5) all sections 
were incubated with ABC Vectastain Elite solution, but using a dilution of 1 in 
200 for reagent A and B, instead of that suggested in manufacturers the user 
guidelines. ImmPACT DAB was used for the staining and colour was allowed 
to develop for 1 minute and 15 seconds. A negative control omitting the 
primary antibody was performed in all experiments (figure 2.4). 
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Figure 2-5. Validation of microglia staining using CD11b.  
Panel A represents a slide in which the primary antibody has been omitted, 
thus reflecting the background staining. Panel B shows the complete 
technique with the staining (scale bar 50 µm, 20X). 
 
 
 
The slides were then dehydrated in a stepwise manner through 50, 75, 90 and 
100% ethanol for 10 minutes each. They were submerged in xylene for further 
10 minutes and mounted under a cover slip using depex polystyrene (DPX) 
mounting medium (Raymond A Lamb, East Sussex, UK). Slides were air dried 
overnight under a fume hood and later kept in plastic boxes for storage. 
Immunohistochemical photomicrographs were obtained with an Olympus BX-
60 microscope and captured with a Zeiss KS-300 colour 3CCD camera. The 
assessment of staining, by an observer blinded to the interventional group, 
was based upon a 4-point categorical scale (Colburn et al. 1997).  
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2.8 Behavioral assessment   
2.8.1 Fear conditioning chamber 
The memory assessment was performed in a dedicated conditioning chamber 
manufactured by Med Associates Inc. The back and the sidewalls of the 
chamber were made of aluminium, whereas the front door and the ceiling 
were of transparent Plexiglas. The floor of the chamber consisted of 36 
stainless steel rods (1 mm diameter) spaced 0.5 cm apart (center-to-center). 
The rods were wired to a shock generator and scrambler for the delivery of 
foot shock. Prior to testing, the chambers were cleaned with a 5% sodium 
hydroxide solution. Background noise (60dB) was provided by means of a fan 
positioned on one of the sidewalls. An infrared video camera, mounted in front 
of the chamber captured behavior. The data acquired by the camera was 
automatically scored through a computer programme (Freezeframe, Med 
Associates Inc.). 
 
 
 
2.8.2 Trace fear conditioning 
On each day of testing, mice were transported to the behavioral room and left 
undisturbed for at least 20 minutes before placing them into the conditioning 
chamber. Freezing was recognized by the software as a total lack of 
movement, including absence of fur, vibrissae and skeletal movement (except 
for breathing). The percentage of time spent freezing over the total time spent 
in the chamber to accomplish the test was used to score memory and learning 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 72 
abilities. A decrease in the percentage of time spent freezing indicated 
impairment of these abilities. Mice were trained and tested on two separate 
days. Training consisted of placing a mouse in a chamber, illuminating 
stimulus and house lights, and allowing exploration for 100 seconds. 
Thereafter, an auditory cue [2 kHz clicking via the solenoid; conditional 
stimulus (CS)] was presented for 20 s. The 2 seconds foot shock [0.95 mAmp; 
unconditional stimulus (US)] was administered 18 seconds after the CS 
(figure 2.5). This procedure was repeated twice, and mice were removed from 
the chamber 30 s later. With the termination of the trial, every mouse was 
taken individually within 30 minutes to the surgery room.  
Seventy-two hour after training, mice were returned to the same chambers in 
which training occurred (context), and freezing behavior was recorded by the 
experimenter using time sampling (10 s intervals). At the end of the 5 min 
context test, mice were returned to their home cage. The time spent freezing 
as a percentage of the total time spent in the chamber during the context 
phase was used to score for hippocampal-dependent memory resulting from 
prior learning. A smaller percentage of freezing behaviour is indicative of 
greater degree of cognitive impairment.  
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2.8.3 Acoustic-cued behavioral chamber 
Approximately 3 hours later the context test, freezing was recorded in a novel 
environment and in response to the cue. The shape of the chamber was 
changed from rectangular to triangular, ceiling colour was black instead of 
white, flooring rods were covered with a smooth surface, background noise 
was removed, and chamber was cleaned with 70% alcohol to provide a 
different smell. This made the environment substantially different, thereby 
limiting the influence of the hippocampus in the recognition of the chamber 
features. Mice were placed in the novel environment, and time sampling was 
used to score freezing for 3 min. The auditory cue (CS) was then presented 
for 3 min, and freezing was again scored (figure 2.5). Freezing scores for 
each subject were expressed as a percentage for each portion of the test. 
Memory for the context (contextual memory) for each subject was obtained by 
subtracting the percent freezing in the novel environment from that in the 
context.  
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Figure 2-6: Trace fear conditioning paradigm.  
Training consisted of exploration of the conditional box for 100 seconds (s) 
followed by an auditory cue (75-80 dB, 2 kHz), the CS, which was presented 
for 20 s. A trace interval of 18 seconds occurred before the 2 s foot-shock 
(0.75 mAmp), the US. This procedure was repeated twice, after an inter-trial 
interval (ITI) of 100s for a total duration of ~ 5 minutes. Mice were removed 
from the chamber 30 s later.  After three days, rodents were returned to the 
same chamber for 270 s exposure to the context. Three hours thereafter they 
were placed in a different environment for the tone retrieval. After 135 
seconds baseline, a tone was played, lasting 135 seconds. Overall 
percentage of time spent freezing was recorded at all stages, as a marker of 
memory performance. 
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2.9 Data analysis 
Statistical analyses were performed using GraphPad Prism version 5.0a 
(GraphPad Software, San Diego, CA). The results are expressed as mean ± 
SEM. Data were analyzed with one-way analyses of variance followed by 
Newman-Keuls post hoc test wherever appropriate. For categorical data, non-
parametric Kruskal-Wallis followed by Dunn’s test was used.  A p<0.05 was 
considered to be statistical significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 76 
3 Chapter 3: results   
3.1 RATIONALE  
In order to initiate an appropriate immune response, living organisms have 
developed a system to counteract potential life threatening events such as 
infection and tissue injury. The mechanisms underlying this process are 
known as the inflammatory response, which ultimately aims to restore the 
correct homeostasis in the host organism after a challenge.  To trigger this 
process, a so-called danger signal is required to alert the immune system and 
elicit an adequate response to the original threat (Matzinger 2002; Harris and 
Raucci 2006).  A surgical procedure is likely to trigger danger signals, hence 
producing an immune response.  Major surgeries, including cardiac surgery 
and orthopaedic procedures expose the subject to extensive trauma, blood 
loss, and tissue injury; all of these factors will engage with the immune system 
to produce an inflammatory response (Buvanendran et al. 2006; Di Vita et al. 
2006; Kobbe et al. 2008).  Originally the concept of danger signal was only 
restricted to exogenous molecules, described as pathogen-associated 
molecular patterns (PAMPs).   PAMPs, such as bacteria, lipopolysaccharide 
(LPS), and viruses interact with specific receptors known as pattern 
recognition receptors (PRRs) and activate the innate immunity by releasing 
pro-inflammatory molecules such as cytokines.  Besides PAMPs, several 
endogenous molecules have now been found to interact and signal via the 
same receptors (Termeer et al. 2000; Johnson et al. 2004; Zedler and Faist 
2006).  These endogenous molecules are described as alarmins and they 
include high-mobility-group box (HMGB) proteins, interleukins, cytosolic 
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calcium-binding proteins of the S100 family, heat-shock proteins (HSPs), 
defensins, cathelicidin, eosinophil-derived neurotoxin (EDN) and nucleosomes 
(Oppenheim and Yang 2005; Harris and Raucci 2006).  Alarmins are rapidly 
secreted after tissue injury or necrotic cell death as well as from 
immunocompetent cells that can directly release them without dying. Alarmins 
also function as chemoattractant molecules to both recruit and activate 
antigen-presenting cells (APCs) of the innate immunity as well as other PRRs.  
Furthermore, they can mediate adaptive responses and they are essential to 
restore homeostasis and to reconstruct tissues after an insult (Bianchi 2007; 
Lenz et al. 2007).  Thus, not only do pathogens elicit an inflammatory 
response, but also mechanical damage to the cells (i.e. trauma) can activate 
similar downstream effects (Zedler and Faist 2006).   
Systemic and central release of cytokines after a surgical procedure may be 
associated with cognitive dysfunction (Moller et al. 1998; Gao et al. 2005; 
Kalman et al. 2006; Beloosesky et al. 2007).  POCD is the emblem of this 
phenomenon and is defined as a subtle dysfunction in one or more cognitive 
domains (Caza et al. 2008).  Some risk factors associated with POCD may 
not be easily modifiable and include patient-related factors (advanced age, 
genetic polymorphisms and co-morbidities), perioperative factors (general 
anesthesia, hyperventilation, hypotension, hypoxia, benzodiazepine use 
and/or alcohol withdrawal), and surgery (type, duration, complications, 
multiple interventions). The complexity as well as the multifactorial etiology of 
POCD requires animal models to further dissect each of these components to 
attempt a better understanding of this pathology.  Based upon the findings 
that adult rats showed signs of cognitive decline and inflammation within the 
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hippocampus following splenectomy (Wan et al. 2007), we sought to 
understand the inflammatory response following orthopedic surgery in a 
mouse model of POCD.  The putative role of inflammation and its correlation 
with memory abnormalities was also suggested after minor surgery in aged 
mice (Rosczyk et al. 2008). Evidence both from animal models and clinical 
studies report increased pro-inflammatory molecules both systemically and 
centrally following surgery (Buvanendran et al. 2006; Kobbe et al. 2008).  
Herein the cytokine time-course and the postoperative inflammatory changes 
are described, both systemically and centrally.  This suggests a time-
dependent association between increased production of cytokines and 
cognitive abnormality following surgery.  Targeting of the inflammatory 
challenge with minocycline, a non-specific anti-inflammatory compound, 
prevents the development of postoperative cognitive dysfunction. 
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3.2 Establishment of a surgery-induced cognitive dysfunction   
To elucidate the consequences of surgery on learning and memory abilities, 
different groups of mice received one of the following interventions: surgery of 
the tibia under inhaled isoflurane (surgery), isoflurane only (anesthesia), or no 
interventions (naïve). 
Trace fear conditioning is characterized by a brief interval between the 
termination of the tone and the onset of the shock. Such interval allows 
accurate assessment of hippocampal function by analyzing the freezing 
response (Chowdhury et al. 2005). Animals were conditioned during the 
training phase irrespectively of the treatment they received.  Each animal was 
exposed to the same acquisition environment during the training phase prior 
to the intervention. Establishment of learning and working memory was rapidly 
achieved with no significant differences between groups. During the initial 
seconds, when the animal is placed in the new environment for the fist time, 
the low baseline freezing is indicative of no distress / anxiety (figure 3.1A).  
This reflects curiosity and interest for the subjects to explore the novel 
environment.  The increase in freezing following the CS – US pairing is 
indicative of functional working memory (figure 3.1B-C), thus the animals are 
able to learn and form a similar working memory or short-term memory (figure 
3.1E). 
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Figure 3-1:  Training phase during trace fear conditioning.   
Animals were collectively trained and then subdivided in three groups: 
untreated (naïve), tibia fracture under inhaled isoflurane (surgery), and 
isoflurane only with no intervention (anesthesia). Baseline freezing at the time 
of first exposure of these animals in the context is very low, indicating low 
levels of stress (A). Figure B indicates the increase of freezing response from 
Tone 1 to Tone 2, indicating working memory. Figure C indicates the increase 
of freezing response from Trace Interval 1 to 2, an indicator of working 
memory. Figure D indicates the working memory freezing response to context 
between tone – shock pairings. All animals demonstrate an equal working 
memory performance (E). 
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Immediately following training, animals were treated according to the group in 
which they were randomized. Mice in the surgical group or anesthesia 
underwent treatment within 30 minutes after training.  Three days after 
treatment, rodents were taken back to the conditioning chamber and re-
exposed to the same environment as during the acquisition phase. This time 
no cues (tone or shock) were used and the memory assessment relies only 
on the ability of each animal to retain memory for the environment (context) in 
which they were previously trained. When exposed to the context, the 
contextual retrieval task revealed a significant reduction of freezing behavior 
compared to the naïve littermates or animals undergoing anesthesia (figure 
3.2A).  Moreover, when the auditory-cued test was carried out two hours after 
the context retrieval task, a significant difference between surgical and naïve 
subjects was found in auditory cued-dependent freezing, with a significant 
reduction in surgical animals but no impairments in the overall freezing 
baseline (figure 3.2B).  
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Figure 3-2:  Hippocampal-dependent memory recall is impaired following 
surgery.  
Contextual fear response, as measured by freezing behavior, is impaired in 
animals receiving surgery compared to naïve and anesthesia groups (A)  
(*p<0.05 vs naïve and anesthesia groups). Surgery-induced memory 
impairment is shown in the auditory-cued test in mice trained with trace fear 
conditioning (B). There is a significant difference between the groups in 
auditory-cued-related freezing behavior, suggesting disruption of auditory-
cued, hippocampal-dependent, retrieval of memories after surgery. No 
difference was shown in the baseline freezing behavior showing no signs of 
anxiety (*p<0.05 vs naïve and anesthesia groups). Data are expressed as 
mean ± SEM (n = 10) and compared by one-way analysis of variance and 
Student-Newman-Keuls method.  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3.3 Surgery elevates plasma concentration of inflammatory cytokines  
In order to assess the temporal relationship between peripheral injury and 
systemic inflammation, plasma concentrations of IL-1β, IL-6 and TNF-α were 
measured postoperatively by ELISA. While the plasma concentrations of IL-
1β and IL-6 were unchanged at 2 hours, these peaked at 6 hours increasing 
by 7-fold (IL-1β: 44.13 ± 7.35 pg/ml, p<0.001) and 20-fold (IL-6: 94.08 ± 
15.68pg/ml, p<0.001) above baseline levels (IL-1β: 6.09 ± 1.31 pg/ml; IL-6: 
4.08 ± 2.10 pg/ml), respectively. Levels of IL-1β and IL-6 remained 
unregulated 6-fold (IL-1β: 36.89 ± 6.54 pg/ml, p<0.001) and 5-fold (IL-6: 27.21 
± 4.53 pg/ml, p<0.01) compared to naïve animals 24 hours following surgery 
(figure 3.3A-B). Surgery did not significantly impact on systemic TNF-α 
release although a trend towards increase was noted during the early time -
points (30-90 minutes). Intraperitoneal administration of LPS was used to 
establish the early changes that occur after PAMPs (figure 3.3C; 104.18 ± 
17.36 pg/ml, p<0.001).  
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Figure 3-3: Surgery-induced systemic inflammation.  
IL-1β and IL-6 levels in plasma were measured by ELISA at 2, 6, 24 or 72 
hours post-intervention. Surgery resulted in increased plasma levels of IL-1β 
(A) and IL-6 (B) compared to naïve animals (**p<0.001 vs naïve).  Levels of 
TNF remain undetected throughout the time points, with a positive trend at 30 
and 60 minutes following surgery.  Validation of these findings was achieved 
by administering LPS (1 mg/kg), which served as positive control (***p<0.001 
vs naïve). Data are expressed as mean ± SEM (n = 6) and compared by one-
way analysis of variance and Student-Newman-Keuls method. 
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In order to isolate the possible role of anesthesia in the inflammatory 
response following surgery, cytokines levels were measured following 
exposure to isoflurane.  Administration of anesthetics alone produced no 
changes from baseline levels of any of these cytokines (figure 3.4).  
Furthermore, no changes in plasma cytokines were measure if the isoflurane 
exposure was increased from 20 minutes to 45 minutes.  Also if the 
concentration of the volatile agent was increased from MAC 1.5 to 2 for 20 
minutes, no effects on cytokines were detected. 
 
 
Figure 3-4:  No effects of anesthetics on pro-inflammatory cytokines in 
plasma.   
Mice were exposed to isoflurane MAC 1.5 (2.1% isoflurane, 30% FiO2) for 20 
minutes.  None of the assayed cytokines, IL-1β, IL-6, and TNF were 
significantly increased from baseline levels (A, B, C). Data are expressed as 
mean ± SEM (n = 6) and compared by one-way analysis of variance and 
Student-Newman-Keuls method. 
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3.4 Surgery leads to central inflammation  
Since IL-1β was increased in plasma after surgery and due to the association 
of this molecule with memory and cognitive abnormalities (Dinarello and 
Savage 1989; Lai et al. 2006), I investigated the putative central role for 
hippocampal IL-1β in this model of POCD.  The first aim was to understand if 
the expression of IL-1β was influenced by surgery.  Transcription of cytokines 
in the hippocampus was measured by qPCR at 4, 6 and 24 hours after 
surgery.  Levels of IL-1β increased 2-fold in mice subjected to surgery at 6 
hours following operation (figure 3.5A, p<0.01).  In order to better define the 
central role of inflammation following surgery, I also measured levels of IL-6 
as a downstream pro-inflammatory cytokine.  As with IL-1, gene expression of 
IL-6 was also increased (approximately 4.5-fold) when compared to naïve 
animals at 6 hours (figure 3.5B, p<0.001).  
 
 
Figure 3-5: IL-1β and IL-6 mRNA up regulation in the hippocampus.   
After extracting the mRNA, qPCR was used to measure the expression of IL-
1β and IL-6 in the hippocampus.  Levels of IL-1β peaked at 6 hours (p<0.01) 
and, to further corroborate these findings looking at a downstream effector, IL-
6 was significantly up-regulated at 6 hours (p<0.001). Data are expressed as 
mean ± SEM (n = 6) and compared by one-way analysis of variance and 
Student-Newman-Keuls method with Bonferroni corrections. 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 87 
 
These findings led to further investigate whether other inflammatory markers 
were induced in the hippocampus.  Microglia cells are the resident 
macrophages of the CNS and is used to assess neuroinflammation in the 
brain.  Post-surgical animals exhibited immunoreactive microglia in the 
hippocampus.  Minimal immunoreactivity was reported in naïve animals in 
which cells maintained small cell bodies with thin and long ramified 
pseudopodia (figure 3.6A).  Resting microglia shifted their state to a “reactive 
profile” after surgery, acquiring an amoeboid morphology with hypertrophy of 
the cell body and retraction of the pseudopodia. Reactive microglia displayed 
morphological changes including increased cell body dimensions, shortened 
and clumpy processes with higher levels of CD11b immunoreactivity 
compared to naïve animals.  Microglial activation was reported at days 1 and 
3 post surgery, returning to the baseline, resting state, by day 7 (figure 3.6 B-
C-D; p<0.01, p<0.05 vs control).  No changes in morphology were detected 
after exposure to isoflurane only.  
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Figure 3-6: Microglia activation following surgery.  
Hippocampi were harvested at days 1, 3, 7 after treatment and stained with 
anti-CD11b to indicate microglia activation following interventions. 
Photomicrographs were blindly scored and microglia activation was graded on 
a scale 0 (lowest) – 3  (highest). Reactive microglia were found at days 1 (B) 
and 3 (C) but not a day 7 (D) compared to untreated animals (A). Resting 
microglia (box A, 40X) shifted to a “reactive state” characterized by amoeboid 
hypertrophy of cell bodies, thickening of the proximal processes, decreased 
ramifications and clumped processes (box B, 40X). No changes were visible 
at day 7 (pictures show CA1, scale bar 50 µm, 20X). Immunohistochemical 
grading (0-3) (E, F, G) was presented for data illustration.  At POD 1 clear 
microgliosis was present (E, *p<0.05 vs control, +p<0.05 vs anesthesia).  
Three days after treatment there were remaining signs of microglia activation 
in the surgery group (F, day 3, *p<0.05 vs control), but within 7 days levels 
returned normal (G) (n = 4). Non parametric data are presented with Kruskal-
Wallis followed by Dunn’s test. 
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3.5 Targeting of the inflammatory response ameliorates POCD.  
After having defined the inflammatory response in POCD, I aimed to 
understand whether targeting this component would ameliorate cognitive 
dysfunctions by reducing pro-inflammatory cytokines.  The basic attempt 
looked at the effects of minocycline, a non-specific inhibitor of the 
inflammatory response (Amin et al. 1996). Minocycline, a second-generation 
tetracycline antibiotic with anti-inflammatory properties, has widespread 
effects on immunomodulators (MMPs, iNOS, COX-2, TNF, IL-1, 
macrophages, B cells, T lymphocytes, microglia) (Giuliani et al. 2005).   This 
non-specific approach targets both the peripheral and central inflammatory 
response. Pre-operative administration of minocycline was able to effectively 
reduce the amount of systemic inflammation.  Levels of IL-1β were 
significantly reduced by minocycline treatment both at 6 and 24 hours 
following surgery (figure 7.7A; 20.11 ± 3.35 pg/ml, 15.67 ± 2.62 pg/ml, p<0.01 
vs surgery respectively).  Minocycline had profound effects on IL-6, with a 
dramatic reduction at 6 hours and a significant decrease at 24 hours (figure 
7.7B; 30.91 ± 5.15 pg/ml, 8.36 ± 1.39 pg/ml, p<0.001 vs surgery respectively). 
No significant changes were reported at any of the other time points 
assessed.  
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Figure 3-7: Attenuation of the inflammatory response after minocycline.   
Mice were injected with minocycline (40 mg/kg) before surgery and daily 
thereafter until termination. Minocycline was able to significantly attenuate the 
amount of plasma IL-1β (A) and IL-6 (B) both at 6 and 24 hours post-
intervention (+ p<0.01 vs surgery, ++p<0.001 vs surgery respectively). Data 
are expressed as mean ± SEM (n = 6) and compared by one-way analysis of 
variance and Student-Newman-Keuls method. 
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In order to correlate the role of minocycline to the surgical-induced behavioral 
abnormality, I first investigated the effects of this compound on microglia 
activation.  There was a significant reduction in the amount of reactive 
microglia at day 1 post intervention (figure 3.8 B-C, p<0.05 vs surgery). 
Consistently, no signs of microgliosis were reported at POD 3 and 7.  
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Figure 3-8: Effects of minocycline on surgery-induced microgliosis.  
Hippocampi were harvested at days 1, 3, 7 after treatment and stained with 
anti-CD11b to indicate microglia activation following interventions. 
Photomicrographs were blindly scored and microglia activation was graded on 
a scale 0 (lowest) – 3  (highest).  Administration of minocycline (40 mg/kg) 
pre-operatively and daily thereafter until termination was able to effectively 
reduced the level of reactive microglia at 1 day post-operatively (B). No 
significant changes were found at POD day 3 (C) (pictures show CA1, scale 
bar 50 µm, 20X). Figure A represent naïve animals.  Immunohistochemical 
grading (0-3) (D, E, F) was presented for data illustration.  At POD 1 the clear 
microgliosis present following surgery was effectively reduced by minocycline  
(D, +p<0.05 vs surgery).  Both at POD 3 (E) and 7 (F) levels returned to 
normal (n = 4). Non parametric data are presented with Kruskal-Wallis 
followed by Dunn’s test. 
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In order to establish a definite correlation between transcription of pro-
inflammatory cytokines in the hippocampus and microglia activation, we also 
explored translation of IL-1β.  Consistently with the 2-fold increase in IL-1β 
measured by qPCR, the expression of this cytokine was up-regulated 2-fold 
after 6 hours from surgery in the hippocampus  (5.53 ± 0.89 pg/100µg of 
proteins, p<0.05) compared to naïve counterparts (figure 3.9A; 3.34 ± 0.39 
pg/100µg of proteins). IL-1β expression in the hippocampus was not changed 
in animals treated with minocycline (figure 3.9A; 3.73 ± 0.21 pg/100µg of 
proteins).  
In order to obviate the role of infection as a potential confounding factor in this 
model, an antimicrobial agent with no anti-inflammatory properties, 
enrofloxacin, was also given prior to surgery.  Enrofloxacin failed to reduce 
levels of IL-1β centrally (5.19 ± 0.77 pg/mg of proteins, p<0.05 vs naïve) as 
well as in the systemic circulation.  Furthermore enrofloxacin did not reduce 
the surgery-induced behavioral effect (figure 3.9B). These experiments were 
performed by Dr Mario Cibelli. 
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Figure 3-9: Effects of enrofloxacin on POCD-associated behavior.  
Tissue collection was carried out 6 hours after treatment. Surgery (sx) 
resulted in increased expression of IL-1β in the hippocampus compared to 
naïve and anesthesia groups. Administration of minocycline (mino), but not 
enrofloxacin (enfl), mitigated surgery-induced hippocampal inflammation 
(*p<0.05 vs naïve and minocycline groups (A).  Rodents underwent fear 
conditioning followed by tibia surgery under anesthesia (surgery), or the same 
surgical procedure with enrofloxacin (enrofloxacin) administration. 
Administration of enrofloxacin did not mitigate the surgery-induced, 
hippocampal-dependent, memory impairment (*p<0.05 vs naïve) (B). Data 
are expressed as mean ± SEM (n=7 for ELISA and n=34 for behavior) and 
compared by one-way analysis of variance and Student-Newman-Keuls 
method. Data presented with the permission of Mario Cibelli. 
 
In order to assess the connection between systemic and central challenges in 
inflammation with POCD-associated behavior, animals were treated with 
minocycline and trace fear conditioning was carried out in order to assess 
memory retention. Conversely to what was reported following administration 
of the antibiotic enrofloxacin, which has no anti-inflammatory properties, 
contextual retrieval task revealed a significant improvement in memory 
retention following minocycline administration compared to untreated animals 
undergoing tibia surgery (figure 3.10A, p<0.05). In the auditory-cued test there 
was no difference in animals treated with minocycline (figure 3.10B).  No 
changes were reported in the baseline freezing.  
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Figure 3-10: Effects of minocycline on surgery-induced behavioral 
abnormality.  
Mice received either surgery under anaesthesia (surgery), Surgery under 
anaesthesia with minocycline (40 mg/kg, i.p.). Control comprised naive 
animals. Testing was conducted 3 days after intervention. Contextual fear 
response was significantly ameliorated after administration of minocycline (A) 
(+p<0.05 vs surgery). Hippocampal-dependent, surgery-induced memory 
impairment is shown in the auditory-cued test, in mice trained with trace fear 
conditioning (B). No difference was shown in the baseline freezing behavior or 
in the auditory – cued after treatment with minocycline. Data are expressed as 
mean ± SEM (n = 10) and compared by one-way analysis of variance and 
Student-Newman-Keuls method.  
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3.6 Discussion  
The main objectives of this study were: 
a) to characterize the inflammatory response associated with 
orthopedic surgery 
b) to evaluate whether cytokines can mediate and ultimately 
orchestrate the behavioral abnormality associated with orthopedic 
surgery 
To demonstrate the causal role of inflammation, minocycline has offered a 
protection to animals following surgery, suggesting that inflammation plays a 
pivotal role in the pathogenesis of POCD.  Three main results have been 
accomplished:  (i) anesthesia does not affect cytokine release;  (ii) tibia 
fracture elevates systemic, namely IL-1β and IL-6;  (iii) minocycline effectively 
reduces inflammation. 
Anesthesia is known to affect the brain and nervous system at many 
molecular targets and these changes can alter brain functions for several 
days after exposure (Franks and Lieb 1994; Futterer et al. 2004).  One of the 
most important features, and perhaps the reason why anesthesia accounts for 
a major breakthrough in modern medicine and surgery, lies on its ability of 
inducing temporarily loss of consciousness that is fully reversible.  However, 
this concept of “entire reversibility” has been challenged from many authors 
and in different contexts.   In particular, anesthetic agents have been 
correlated with memory impairment and as capable of interfering with different 
synaptic functions in the hippocampus (Culley et al. 2003; Wise-Faberowski et 
al. 2005).  In this study the administration of a clinically used volatile 
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anesthetic agent, isoflurane, did not increase plasma concentrates of key pro-
inflammatory cytokines including IL-1β, IL-6, and TNF-α.  Despite a vivid 
debate on the role of anesthesia in POCD, these data provide no evidence of 
any causative relationship between anesthesia, cytokine production, and 
POCD (Simpson et al. 1961; Rasmussen et al. 2003; Wan et al. 2007).   
It has been speculated on the possible role of cytokines in the development of 
POCD and it has now become a noteworthy concept in this area of research 
(Gao et al. 2005; Mathew et al. 2007).  Few studies have described the effect 
of neuroinflammation in interfering with hippocampal-dependent memory 
processes (Wan et al. 2007; Rosczyk et al. 2008).  Cytokine release is 
classically associated with “sickness behavior”, which per se implies cognitive 
changes and even depression (Raison et al. 2006; Dantzer 2009; O’Connor et 
al. 2003).  The peripheral cytokine response after surgery is a well-described 
phenomenon and the extent of the procedure / insult seems to directly 
correlate with the amount of inflammatory compounds released in the 
bloodstream.  After skin incision, immunocompetent cells at the site of 
intervention rapidly release IL-6 and plasma concentrates peak at 8-24 hours 
(Minetto et al. 2006). Many factors have found to regulate IL-6 release (age, 
severity of trauma, length of operation) and have been proportionally 
correlated with the amount of cytokine released in the blood (Shenkin et al. 
1989).  Although there was an insignificant increase in TNF-α, this cytokine 
may still be responsible for the activation and release of IL-1β in the systemic 
circulation. This concept will be further analyzed in the following chapters.  
Plasma IL-1β was significantly high after 6 and 24 hours post-surgery.  Both 
IL-1β and IL-6 are able to gain entry to the brain via relatively permeable 
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areas, especially in the CVOs and periventricular regions.  Also, it has been 
shown that IL-1β can bind receptors and get through the intact BBB (Van 
Dam et al. 1993; Watkins et al. 1995).  Neural afferents are known to be a fast 
and reliable pathway in the immune-to-brain communication, thus cytokines 
can gain free access to the CNS (Watkins et al. 1995).  Elegant studies have 
reported that vagotomy attenuates classical symptoms of sickness behavior 
after systemic LPS or IL-1β administration (Bluthe et al. 1994; Dantzer 2004; 
Wieczorek et al. 2005).  Since the orthopedic procedure performed in this 
study does not directly affect vagal afferent inputs, humoral, rather than, or in 
addition to, neural factors are likely to be involved. However, the rapid up 
regulation in mRNA expression in the hippocampus after 6 hours following 
surgery may suggest an involvement of neural afferents in this fast 
communication. 
Within the CNS, cytokines closely converse with microglia cells, the 
immunocompetent cells of the brain.  Pro-inflammatory cytokines such as IL-
1β and IL-6 directly interact with the PRRs expressed on the surface of these 
cells.  Upon activation, microglia exhibit discernible morphologic changes 
including enlargement of the cell body, thickening of the proximal processes 
and decreased ramification.  In the active state, microglia are capable of 
mounting macrophage-type innate immunity and secrete pro-inflammatory 
cytokines, reactive oxygen species (ROS), excitotoxins (such as calcium and 
glutamate) and neurotoxins such as β-amyloid (van Rossum and Hanisch 
2004). Activated microglia also inhibit neurogenesis in the hippocampus 
following endotoxemia, thereby exacerbating the extent of injury (Monje et al. 
2003).  Microglia are able to increase the synthesis and de novo production of 
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cytokines as well as ROS and MMPs within the brain, and this may account 
for the memory disruption found in POCD.  The effects of the stress response, 
in particular the activation of purino receptors (P2X), may also intensify 
cellular degeneration and cytokine release by reducing intracellular K+ levels 
and increasing caspase-1 activity (Di Virgilio 1995; Ferrari et al. 1997).  In the 
CNS cytokines seem to have a biphasic effect; at low concentration and in the 
normal brain they are essential for a correct neuronal development and 
memory formation.  However, at pathophysiological levels, they become 
dangerous and possibly responsible for the cognitive decline and 
neurodegeneration (Simi et al. 2007).  This close interaction between 
cytokines and microglia may be responsible for the production of a highly 
hostile environment, and especially in a very vulnerable area such as the 
hippocampus, it may account for the inhibition of long-term potentiation (LTP), 
hence memory loss (Rothwell and Hopkins 1995; Griffin et al. 2006).  An 
increase in the concentration of IL-1β, together with microglia activation, are 
causally related to the impairment of LTP as well as for a possible β-amyloid 
induced deficit in hippocampal function (Wang et al. 2004).  Considering the 
resembling features of POCD with Alzheimer’s disease (AD), also the action 
of isoflurane has been directly associated with increased Aβ oligomerization 
in H4 human neuroglioma cells stably transfected to express β-amyloid 
precursor protein – full length (APP – FL) (Xie et al. 2006; Xie et al. 2006).  
Thus cytokines and microglia are capable of producing a synergism whereby 
the signaling pathways involved in memory formation become damaged 
(Maher et al. 2006).   
A significant increase in plasma concentrates of IL-1β was reported at 1 day 
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post-intervention.  IL-1 activates distinct cellular signaling pathways to 
ultimately affect NFkB and p38 MAPK (Pinteaux et al. 2002; Hua et al. 2005).  
Post-receptor events greatly affect cytokine synthesis and de novo 
production.  Besides acting on its cognate receptor, IL-1R, systemic IL-1β is 
likely to closely engage with TLRs, therefore enhancing the inflammatory 
effects seen in this model (Beutler 2004).  Evidence for this mechanism will be 
later discussed in the context of LPS and endotoxemia.  
To determine the contribution of peripheral cytokines with surgery-related 
cognitive dysfunction, minocycline, a tetracycline derivative with 
immunomodulatory properties was administered to surgical animals (Giuliani 
et al. 2005).  Minocycline exerts its anti-inflammatory effects both systemically 
and centrally; it impairs the production of cytokines such as TNF-α and IL-1β 
but also up regulates anti-inflammatory cytokines such as IL-10 (Ritchlin et al. 
2000; Bye et al. 2007). It also dampens systemic inflammation as a result of a 
direct inhibition of MMP-9 and T-lymphocyte transmigration and by blocking 
phospholipase A2 (Pruzanski et al. 1992; Brundula et al. 2002).  Furthermore, 
neuroprotective effects including down regulation of proliferating microglia, 
inhibition of caspase-3 activity and apoptosis have all been reported after 
minocycline administration (Lee et al. 2003).  It is likely that some of the 
effects we have reported after injecting minocycline, especially in the 
reduction of IL-1β, could be mediated by a direct inhibition of p38 MAPK, 
which would then turn off gene expression and release of pro-inflammatory 
cytokines (Hua et al. 2005; Nikodemova et al. 2006).  Minocycline is known to 
inhibit microglia activation (Ekdahl et al. 2003) and, by also reducing 
cytokines, it was able to ameliorate the cognitive deficit following surgery.  
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These data suggest that cytokines production is a direct effect of surgery and 
no other confounding factors including infection and / or pain.  In this attempt 
of reproducing a routine clinical setting, analgesia (buprenorphine) was 
administered and no clinical evidence of infection were seen in any of the 
animals. Previous studies using this murine tibial fracture model reported no 
evidence of clinical or histological sign of infection in any case (Harry et al. 
2008). Administration of enrofloxacin, a wide spectrum antibiotic with no anti-
inflammatory properties, did not improve any of the surgery-induced effects.  
Current work in the laboratory is looking at pain in greater details (hot plate for 
pain threshold and activity box for locomotor activity) without reporting any 
significant differences following surgery.  Furthermore, using the trace fear 
conditioning, pain or movement impairment would reflect in increased 
immobility, thus higher freezing, whereas the opposite was observed in the 
surgical animals. 
These data corroborate two other previous reports (Wan et al. 2007; Rosczyk 
et al. 2008) showing the association between surgery, inflammation and 
cognitive dysfunction. The mechanism whereby a peripheral surgical 
intervention initiates hippocampal neuroinflammation still remains unclear. 
Here we have reported a significant up regulation of key inflammatory 
cytokines in plasma after major orthopedic surgery.  Despite these changes 
being transient and fully reversed by postoperative day 3, the memory 
impairment persists. This may hinge on the disruption of memory 
consolidation pathways, possibly by an effect of cytokines, during the 
processing of information from short-term (hippocampus) to long-term 
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memories in the neocortex (Kim and Fanselow 1992; Squire and Alvarez 
1995; Anagnostaras et al. 1999; Frankland and Bontempi 2005).  
We may be looking at a subtle form of POCD rather than a more chronic 
dysfunction.  The incidence of both delirium and POCD is increased in 
surgical patients with advanced age, possibly due to the normal physiological 
changes in the immune activity / response.  In the critically ill patients this 
translates in higher morbidity and mortality (Rockwood et al. 1999; Ely 2003).  
An increase in the concentration of IL-1β, together with activation of microglia, 
may contribute to the persistence of hippocampal-dependent cognitive 
dysfunction in the elderly (Miller and O'Callaghan 2005).  Apart from age, 
there may be other factors capable of either increasing the duration and / or 
severity of the neuroinflammatory response to surgery.  The supervention of a 
secondary infection may produce an anamnestic response.  Furthermore, 
factors including co-morbidities such as underlying neurodegeneration (mild 
cognitive impairment [MCI]), cancer, metabolic syndrome, and gene 
polymorphism (APOe4) may produce a milieu in which the addition of surgery-
induced neuroinflammation, creates a sustained cognitive dysfunction (Heyer 
et al. 2005; Caselli et al. 2007; Adamson et al. 2008).  Because attenuation of 
the neuroinflammatory response with minocycline reduces circulating levels of 
pro-inflammatory cytokines and prevents the occurrence of post-surgical 
cognitive dysfunction, this represents a realistic target for therapeutic 
interventions in the clinical setting.  Subsequent studies are aiming to 
elucidate the mechanisms whereby inflammation is produced and whether we 
can find novel and more specific targets for effective therapies.  
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4 Chapter 4: results   
4.1 RATIONALE  
Up regulation of peripheral pro-inflammatory cytokines, CNS inflammation, 
and the ensuing sickness behavior associate with innate immunity (Dantzer 
2001). The mechanisms that underlie inflammation following surgery and 
general trauma share a number of similarities with infective pathways, but yet 
remain unclear.  Following the effects ascribed to minocycline on the 
inflammatory response and POCD-associated behavior, I aimed to further 
investigate the putative pathways associated with the cognitive abnormality.  
The inhibitory effects of minocycline both on peripheral and central 
inflammation can be associated to p38 MAPK signaling and NFkB, the 
canonical pathways in IL-1 / TLRs signaling (Nikodemova et al. 2006; Cui et 
al. 2008). 
TLRs and the IL-1 are pivotal structures whereby the innate immunity gets 
activated and communicates with the other components. The homologies 
between these PRRs are mostly found across the cytoplasmic region, 
whereas the extracellular domain largely differs between TLRs and IL-1Rs 
since the former has a leucine-rich repeat (LRR) motif and the latter contains 
three immunoglobulin-like domains (Akira and Takeda 2004; Takeda and 
Akira 2004).  Despite the LRR motif being conserved across TLRs, several 
unique molecular patterns originated by both pathogens and endogenous 
ligands are recognized by each TLR in different cellular compartments (cell 
surface, endoplasmic reticulum, lysosomal compartments) (Zhang and Ghosh 
2001; Yang et al. 2008). The involvement of PRRs in recognizing a wide 
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variety of microbial and infective agents is well recognized and described. 
PRRs are expressed on immune cells; macrophages and microglia in 
particular sense minimal changes in body’s homeostasis thanks to the variety 
of PRRs expressed on their surfaces. Recognition of pathogens and 
potentially harmful substances strongly relies on TLRs, but many of the 
ligands that activate these receptors still remain to de discovered.  Amongst 
all TLRs, TLR4 seems the most active interface to bridge microbial infection 
with sterile inflammation (Levy et al. 2006; Mollen et al. 2006; Kigerl et al. 
2007).  Its role in mediating inflammation after endotoxic shock and LPS in 
particular are now well established (Hoshino et al. 1999).  More recently, a 
correlation between endogenous proteins released after tissue injury and 
TLR4 has been suggested (Paterson et al. 2003; Mollen et al. 2006).  A series 
of studies have been conducted using TLR4 deficient mice looking at the 
danger signal after acute tissue injury including hemorrhagic shock (Barsness 
et al. 2004), cardiac (Oyama et al. 2004), and hepatic (Tsung et al. 2005) 
ischemia/reperfusion models, showing reduced inflammation and injury 
compared to wild types. Activation of these receptors by both exogenous and 
endogenous molecules leads to complex downstream signaling mostly relying 
on MAPK, JNK and NFkB transcription factors.   
Despite the improved outcomes reported in TLR4 deficient mice following 
acute tissue injury and ischemia/reperfusion (Mollen et al. 2006), I aimed to 
first define the involvement of these receptors using animals devoiding the 
expression of MyD88 (figure 4.1).   
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Figure 4-1: Study plan  
Following the results with minocycline on inflammation and POCD-associated 
behavior, the aim was now to indentify putative signaling pathways involved 
with this dysfunction. The first set of experiments involved reagents devoiding 
in MyD88 expression (MyD88 KO). To follow-up from this initial investigation, I 
aimed to localize possible receptors involved in this inflammatory signaling.  
As MyD88 is shared in a number of pathways and receptors, I have focused 
on the role of IL-1R, TLR4 and TLR2 in POCD-associated inflammation.   
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Both TLRs and IL-1Rs affect NFkB gene expression, and their signaling 
largely depends on the downstream adaptor protein myeloid differentiation 
factor (MyD88), which constitutes the focal pathway to promote de-novo 
transcription of pro-inflammatory genes (Kimbrell and Beutler 2001; Akira and 
Takeda 2004; Li and Qin 2005; Lotze and Tracey 2005). Its involvement in 
mediating, sustaining, and facilitating the signaling following infection is 
pivotal.  Upon understanding the role of MyD88 in the context of POCD, I 
sought to then target specific receptors as putative mediator of the 
inflammatory response and behavioral abnormality.  Due to the involvement of 
TLR2 and TLR4 in sterile inflammation and trauma, alongside the importance 
of the IL-1 signaling in mediating sickness behavior and memory dysfunction, 
these mechanisms have been elucidated in POCD (Rachal Pugh et al. 2001; 
Paterson et al. 2003; Levy et al. 2006; Kaczorowski et al. 2008).  
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4.2 MyD88  
4.2.1 Targeting MyD88 abrogates surgery-induced cognitive 
dysfunction  
The effects of minocycline both on systemic and central inflammation 
highlighted the key role of the inflammatory response in the etiology of 
surgery-induced behavioral abnormality.  Despite its putative action via p38 
MAPK (Nikodemova et al. 2006), the non-specificity of this compound has 
only begun to answer the many questions associated with the signaling 
mechanisms in POCD. In order to address some of these questions, I opted 
to more selective approaches.  Genetic reagents are able to offer this 
specificity, and, in particular, they have the potential to clarify the role of many 
biological functions in the absence of specific target molecules.   
Adaptor molecules are crucial in signaling mechanisms; MyD88 has a pivotal 
role in activating and sustaining different inflammatory pathways in innate 
immunity. Animals lacking in the expression of MyD88 appear a suitable 
model to exploit the findings of POCD and investigate more specifically the 
role of putative pathways associated with surgery-induced cognitive 
dysfunctions. Indeed, one major limitation of genetic reagents concerns the 
ability of assuring a comparison with what is referred as “normal”, at least 
from a phenotypic standpoint.  My first aim was then to establish a congruent 
learning curve in knockouts (KO), which would allow direct comparison with 
the wild type (WT) counterparts and the data obtained up to this time.   
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Trace fear conditioning was carried out as previously described.  Acquisition 
and establishment of working memory during the training was also achieved 
with no significant differences between groups (figure 4.2).  
 
 
 
 
Figure 4-2:  Training phase during trace fear conditioning in MyD88-/-.   
Animals were collegially trained and then subdivided in two groups: untreated 
(naïve) and tibia fracture under inhaled isoflurane (surgery). Baseline freezing 
at the time of first exposure of these animals in the context is very low, 
indicating low levels of stress (A). Figure B indicates the increase of freezing 
response from Tone 1 to Tone 2, indicating working memory. Figure C 
indicates the increase of freezing response from Trace Interval 1 to 2, an 
indicator of working memory. Figure D indicates the working memory freezing 
response to context between tone – shock pairings. All animals demonstrate 
an equal working memory performance (E). 
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Immediately following training, animals were treated accordingly. Due to the 
limitations in the availability of these reagents due to their low reproductive 
rate, I limited this investigation by comparing MyD88-/- naives with surgery 
only. Mice in the surgical group underwent treatment within 30 minutes after 
training.  Three days after treatment, rodents were taken back to the 
conditioning chamber and re-exposed to the same environment as during 
training. Contextual retrieval task revealed no significant changes in freezing 
behavior when comparing naïve MyD88-/- to animals receiving tibia surgery 
(figure 4.3A).  Also, during the auditory-cued test, no changes in freezing were 
reported.  No changes in baseline freezing were reported as shown before 
(figure 4.3B).  Data from WT counterparts are illustrated for comparison.  
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Figure 4-3: Hippocampal-dependent memory following surgery in MyD88-
/-. 
Contextual fear response, as measured by freezing behavior, is the same in 
animals receiving surgery compared to naïve (A). Surgery-induced cognitive 
dysfunction in WT is illustrated for comparison. Surgery-induced memory 
impairment is shown in the auditory-cued test in mice trained with trace fear 
conditioning (B). There is no reduction in freezing following the auditory-cued 
retrieval test in MyD88-/-. No difference was shown in the baseline freezing 
behavior showing no signs of anxiety. Data are expressed as mean ± SEM (n 
= 10) and compared by one-way analysis of variance and Student-Newman-
Keuls method.  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4.2.2 Surgery-induced elevation of systemic cytokines is significantly 
reduced  
In order to further elucidate the putative relationship between systemic 
inflammation and behavioral abnormality, plasma levels of cytokines were 
measured in MyD88-/- animals. Based upon the findings on the WT, levels of 
IL-1β and IL-6 were assessed using ELISA at 6 and 24 hours.  Following 
surgery, IL-1β was significantly reduced both at 6 hours (figure 4.4A; 14.27 ± 
2.4 pg/ml, p<0.001) and 24 hours (10.04 ± 1.7 pg/ml, p<0.01) [WT values for 
comparison: 44.13 ± 7.35 pg/ml and 36.89 ± 6.54 pg/ml at 6 and 24 hours 
respectively].  IL-6 response was also attenuated in MyD88-/- with only a 1.5-
fold increase at 6 and 24 hours (figure 4.4B; 19.79 ± 3.23 pg/ml; 6.89 ± 1.15 
pg/ml, p<0.001 respectively) [WT values for comparison: 94.08 ± 15.68pg/ml 
and 27.21 ± 4.53 pg/ml at 6 and 24 hours respectively].  In order to 
understand the effects of anesthesia in these mice, MyD88-/- were exposed to 
isoflurane MAC 1.5 for 20 minutes and plasma cytokines were measured at 
24 hours.  Levels of both IL-1β and IL-6 remained at baseline (figure 4.4C, D). 
Corroboration and validation of the assays was also achieved by 
administration of LPS (1 mg/kg i.p.). LPS-injected animals served as negative 
controls. A drastic reduction in the amount of systemic inflammation was 
observed when compared to WT injected counterparts that displayed 8-fold 
increase in IL-1β (73.49 ± 12.24 pg/ml; at 24 hours, p<0.001 respectively) and 
14-fold increase in IL-6 at 24 hours (figure 4.4C, D; 126.47 ± 21.07 pg/ml, 
p<0.001 respectively) (Adachi et al. 1998).  
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Figure 4-4: Surgery-induced systemic inflammation in MyD88-/-.  
IL-1β and IL-6 levels in plasma were measured by ELISA at 6 and 24 hours 
post-intervention. Surgery resulted in reduced plasma levels of IL-1β (A) and 
IL-6 (B) in MyD88-/- compared to WT  (++p<0.001, +p<0.01 vs WT).  LPS-
induced systemic inflammation was not present in KO animals compared to 
exposed WT animals (C, D ++p<0.001 vs WT). No changes in systemic 
cytokines were reported following exposure to anesthesia only (C, D). Data 
are expressed as mean ± SEM (n = 6) and compared by two-way analysis of 
variance and Student-Newman-Keuls method. 
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4.2.3 Reduced neuroinflammation in MyD88-/-  
From the systemic effects of surgery in MyD88-/-, I moved to the brain to 
investigate the central response following surgery. The strategy adopted here 
was to understand whether the reduced peripheral cytokines was 
accompanied by an attenuation of surgery-induced neuroinflammation. To 
address this question I focused on the hippocampus, looking at both the 
expression of IL-1β and the subsequent microglia activation.  Translation of 
IL-1β in the hippocampus was significantly reduced at 6 hours following tibia 
surgery comparing to WT animals (figure 4.5; 3.47 ± 0.19 pg/100µg of 
proteins). Values from WT animals following surgery are illustrated for 
comparison (5.98 ± 1.23 pg/100µg of proteins, p<0.01 vs naive). No changes 
in IL-1β translation were found in naïve animals, either KO or WT. 
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Figure 4-5: Hippocampal IL-1β response following surgery in MyD88-/-.  
Tissue collection was carried out 6 hours after treatment. Surgery in MyD88-/- 
resulted in no changes in the expression of IL-1β compared to naïve KO.  
There was a significant difference between KO and WT following the same 
surgical procedure (**p<0.001 comparison between surgery KO vs surgery 
WT). A positive control from LPS (1 mg/kg) treated animals was used to 
validate the readings. Data are expressed as mean ± SEM (n = 6) and 
compared by one-way analysis of variance and Student-Newman-Keuls 
method. 
 
 
 
The findings on reduced hippocampal IL-1β prompted to me to investigate 
whether translation of IL-1 is casually related to microglia activation.  Staining 
with CD11b in the hippocampus revealed no evident signs of reactive 
microgliosis in any of the treatments in MyD88-/- animals.  In particular, no 
morphological changes in microglial conformation 24 hours post intervention 
were observed in MyD88-/- undergoing surgery. Resting microglia were found 
in animals undergoing anesthesia alone or LPS-exposure (figure 4.6). 
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Figure 4-6: Microglia activation following surgery.  
Hippocampi were harvested 24 hours post intervention and stained with anti-
CD11b to indicate microglia activation following interventions. Animals were 
exposed to anesthesia only, underwent surgery of the tibia, or exposed to 
LPS.  Untreated animals served as naïve. Photomicrographs were blindly 
scored and microglia activation was graded on a scale 0 (lowest) – 3  
(highest). No signs of reactive microgliosis were observed in any of the 
treatments (A – naïve, B – anesthesia, C – surgery, D – LPS) (pictures show 
CA1, scale bar 50 µm, 20X).  LPS slides from WT were used as positive 
control.  Immunohistochemical grading (0-3) (E) was presented for data 
illustration. No significant changes in microgliosis were reported (n = 4). Non 
parametric data are presented with Kruskal-Wallis followed by Dunn’s test. 
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4.3 IL-1  
4.3.1 IL-1 receptor: a putative target dependent on MyD88 signaling  
The findings on the MyD88-/- animals prompted interest for identifying putative 
targets (i.e. receptors) associated with POCD.  A prime candidate with a 
downstream signaling pathway largely dependent on MyD88 is the IL-1 
receptor (IL-1R).   In order to understand the putative role of IL-1β and the IL-
1R, I began my investigation looking at the inflammatory profile in animals 
lacking this receptor (IL-1R-/-).  Experiments focused on the crucial time points 
obtained from WT data, as previously highlighted.  Levels of IL-1β and IL-6 
were reduced in IL-1R-/- animals following surgery at 6 hours (IL-1β: 18.6 ± 
3.1 pg/ml; IL-6: 29.78 ± 4.96 pg/ml, p<0.001 respectively) and 24 hours (figure 
4.7A, B; IL-1β: 8.722 ± 1.45 pg/ml, p<0.001; IL-6: 14.79 ± 2.47 pg/ml, p<0.01).  
Consistently with the previous data, no changes were reported after 
anesthesia in either of these cytokines.  The systemic response following 
administration of LPS was also significantly reduced in IL-1R-/- (figure 4.7C, D; 
p<0.001).  
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Figure 4-7: Surgery-induced systemic effects in IL-1R-/-.  
IL-1β and IL-6 levels in plasma were measured by ELISA at 6 and 24 hours 
post-intervention. Surgery resulted in reduced plasma levels of IL-1β (A) at 6 
and 24 hours (++p<0.001 vs WT respectively). IL-6 (B) was also reduced in 
IL-1R-/- (++p<0.001 and +p<0.01 vs WT) at 6 and 24 hours post intervention.  
LPS-induced systemic inflammation was not present in KO animals compared 
to exposed WT animals (C, D ++p<0.001 vs WT). No changes in systemic 
cytokines were reported following exposure to anesthesia only (C, D). Data 
are expressed as mean ± SEM (n = 6) and compared by two-way analysis of 
variance and Student-Newman-Keuls method. 
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4.3.2 Neuroinflammation is significantly reduced in IL-1R-/-   
The systemic changes prompted me to look for neuroinflammatory effects.  
Levels of IL-1β in the hippocampus were significantly reduced at 6 hours in IL-
1R-/-, with no differences from naïve KOs (figure 4.8; 3.27 ± 0.15 pg/100µg of 
proteins). Injection of LPS in WT animals served to validate the readings. 
Levels of IL-1β following surgery in WT (5.98 ± 1.23 pg/100µg of proteins) are 
shown for comparison.  
 
 
 
Figure 4-8: No increase in hippocampal IL-1β following surgery in IL-1R-/-.  
Tissue collection was carried out 6 hours after treatment. Surgery in IL-1R-/- 
resulted in no changes in the expression of IL-1β compared to naïve KO. 
There was a significant difference between KO and WT following the same 
surgical procedure (**p<0.001 comparison between surgery KO vs surgery 
WT). A positive control from LPS (1 mg/kg) treated animals was used to 
validate the readings. Data are expressed as mean ± SEM (n = 6) and 
compared by two-way analysis of variance and Student-Newman-Keuls 
method. 
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The reduction in the expression of IL-1β in the hippocampus led me to assess 
microglia activation 24 hours after surgery.  Reactive microgliosis was 
significantly reduced following tibial fracture in IL-1R-/- (figure 4.9). Microglia 
maintained a resting state in all of the treatments, including anesthesia and 
LPS.  Slides from LPS treated WT were used as positive control to assure 
validity of the immunohistochemical technique. 
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Figure 4-9: Absence of microglia activation following surgery in IL-1R-/-.  
Hippocampi were harvested 24 hours post intervention and stained with anti-
CD11b to indicate microglia activation following interventions. Animals were 
exposed to anesthesia only, underwent surgery of the tibia, or exposed to 
LPS.  Untreated animals served as naïve. Photomicrographs were blindly 
scored and microglia activation was graded on a scale 0 (lowest) – 3  
(highest). No signs of reactive microgliosis was observed in any of the 
treatments (A – naïve, B – anesthesia, C – surgery, D – LPS) (pictures show 
CA1, scale bar 50 µm, 20X).  LPS slides from WT were used as positive 
control. Immunohistochemical grading (0-3) (E) was presented for data 
illustration. No significant changes in microgliosis were reported (n = 4). Non 
parametric data are presented with Kruskal-Wallis followed by Dunn’s test. 
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4.3.3 Blockade of IL-1 signaling ameliorates surgery-induced 
behavioral abnormality   
In order to translate the information concerning the inflammatory profile in IL-
1R-/- animals to cognitive behavior following surgery, trace fear conditioning 
was carried out to assess memory retention.  Due to the limited availability of 
these reagents in the short-term, the involvement of IL-1 in POCD-associated 
behavioral abnormality was investigated using the IL-1 receptor antagonist 
(IL-1 Ra).  Preemptive administration of IL-1 Ra (100mg/kg s.c.) to WT 
animals effectively ameliorated the surgery-induced cognitive dysfunction at 
three days post intervention as shown in the contextual retrieval task (figure 
4.10). These experiments were performed by Mr Antonio Rei Fidalgo. 
 
 
 
Figure 4-10: Effects of IL-1RA on behavioural outcome following surgery.  
Contextual fear response following IL-1RA administration (100 mg/kg s.c.) 
mitigated the contextual fear memory impairment after surgery (*p<0.05 vs 
naïve, +p<0.05 vs surgery). Data are expressed as mean ± SEM (n = 8) and 
compared by one-way analysis of variance and Student-Newman-Keuls 
method. Data presented with the permission of Antonio Rei Fidalgo.  
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4.4 TLR4  
4.4.1 POCD is not reduced in TLR4-/- following surgery   
MyD88 is shared in a number of innate immune signaling pathways. Aside the 
IL-1R, TLRs largely rely on MyD88 signaling. Recently, the association 
between TLRs and endogenous ligands during aseptic inflammation has been 
reported (Mollen et al. 2006; Zedler and Faist 2006).  This would suggest a 
putative role for TLRs in the development and / or sustainment of the 
inflammatory challenge in POCD. A role for TLR4 has been described 
following bilateral tibia fracture (Levy et al. 2006), thus I sought to investigate 
the role of this receptor in POCD-associated behavior in our model.  In order 
to validate and conduct a reliable memory assessment, learning and 
acquisition was measured in TLR4-/-.  Similarly to the previous findings both 
from WT and MyD88-/-, also TLR4-/- showed consistent and uniform learning, 
with no differences in working memory between groups (figure 4.11). 
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Figure 4-11:  Training phase during trace fear conditioning.   
Animals were collegially trained and then subdivided in two groups: untreated 
(naïve) and tibia fracture under inhaled isoflurane (surgery). Baseline freezing 
at the time of first exposure of these animals in the context is very low, 
indicating low levels of stress (A). Figure B indicates the increase of freezing 
response from Tone 1 to Tone 2, indicating working memory. Figure C 
indicates the increase of freezing response from Trace Interval 1 to 2, an 
indicator of working memory. Figure D indicates the working memory freezing 
response to context between tone – shock pairings. All animals demonstrate 
an equal working memory performance (E). 
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Immediately following training, animals were treated accordingly. Mice in the 
surgical group underwent treatment within 30 minutes after training.  Three 
days after treatment, rodents were taken back to the conditioning chamber 
and re-exposed to the same environment as during training. When exposed to 
the context three days later, there was an evident reduction in the freezing 
response, resembling what shown in WT (p<0.05).  The degree of behavioral 
abnormality present in TLR4-/- was very similar to what previously observed in 
WT. WT data are illustrated for comparison (figure 4.12A). Following the 
auditory-cued test, a significant reduction in the auditory-cue was also 
reported in TLR4-/- (p<0.05).  No changes were reported comparing the 
auditory-cued response in KO and WT or in baseline freezing (figure 4.12B).  
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Figure 4-12: Hippocampal-dependent memory impairment in TLR4-/- 
following surgery.  
Contextual fear response, as measured by freezing behavior, is impaired in 
TLR4-/- animals undergoing tibia surgery compared to naïve (A)  (*p<0.05 vs 
naïve). Surgery-induced cognitive dysfunction in WT is illustrated for 
comparison. Memory abnormality is shown in the auditory-cued test in mice 
trained with trace fear conditioning (B). There is a significant difference 
between the groups in auditory-cued-related freezing behavior, suggesting 
disruption of auditory-cued, hippocampal-dependent, retrieval of memories 
after surgery. No difference was shown in the baseline freezing behavior 
showing no signs of anxiety (*p<0.05 vs naïve). Data are expressed as mean 
± SEM (n = 10) and compared by one-way analysis of variance and Student-
Newman-Keuls method.  
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4.4.2 Systemic inflammation is not modified in TLR4-/-  
 
TLR4 signaling is now established and well characterized, especially in 
relationship to infection and LPS.  The possible involvement of TLR4 in other 
processes, such as aseptic inflammation or healing, still remains elusive and 
under investigation.  Different endogenous ligands are likely to bind to TLR4 
and activate downstream signaling, including HSPs, fibronectin extradomain A 
(tissue injury), and HMGB-1 (Miyake 2007).  Following tibia surgery, a number 
of mediators including cytokines, tissue factors, and acute-phase proteins can 
bind to the receptor.  Since no improvements following trace fear conditioning 
were reported after surgery, I sought to ascertain the relationship between 
inflammation and behavioral outcome following surgery.  Levels of IL-1β and 
IL-6 were measured by ELISA at 6 and 24 hours (figure 4.13A, B).  Despite an 
initial reduction in the levels of IL-1β at 6 hours (p<0.001 vs WT), no statistical 
differences between TLR4-/- and WT were reported at 24 hours post 
intervention (IL-1β: 23.57 ± 4.23 pg/ml and 30.88 ± 5.15 pg/ml; IL-6: 75.59 ± 
14.6 pg/ml and 27.15 ± 4.52 pg/ml) [WT values for comparison: IL-1β: 44.13 ± 
7.35 pg/ml and 36.89 ± 6.54 pg/ml; IL-6: 94.08 ± 15.68pg/ml and 27.21 ± 4.53 
pg/ml at 6 and 24 hours respectively].  Consistently with the previous data, no 
changes were reported after anesthesia in neither of these cytokines. 
Administration of ultra-pure LPS to TLR4-/-, which served as main ligand and 
activator of TLR4 signaling, resulted in no changes in pro-inflammatory 
cytokines as previously described (Poltorak et al. 1998; Qureshi et al. 1999; 
Medvedev et al. 2007) (figure 4.13C,D; p<0.001).  
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Figure 4-13: Surgery-induced systemic inflammation in TLR4-/-.  
IL-1β and IL-6 levels in plasma were measured by ELISA at 6 and 24 hours 
post-intervention. A reduction in IL-1β following surgery was observed at 6 
hours, however no statistically significant changes could be found at 24 hours 
(A, ++p<0.01 vs WT, *p<0.01 vs naïve at 6 hours). No changes in IL-6 were 
measured when comparing TLR4-/- and WT both at 6 and 24 hours (B, 
**p<0.01 vs naïve). LPS-induced systemic inflammation was not present in 
TLR4-/- animals compared to LPS injected WT, both looking at IL-1β and IL-6 
(C, D ++p<0.001 vs WT). No changes in systemic cytokines were reported 
following exposure to anesthesia only (C, D). Data are expressed as mean ± 
SEM (n = 6) and compared by two-way analysis of variance and Student-
Newman-Keuls method. 
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4.4.3 Neuroinflammation and microgliosis is marginally decreased 
 
In order to evaluate the effects of surgery on neuroinflammation, both IL-1β 
expression and microglia activation was measured in TLR4-/-. At 6 hours 
following surgery, TLR4-/- displayed a reduction in hippocampal IL-1β, but not 
a complete obliteration as seen both in MyD88-/- and IL-1R-/- (figure 4.14; 5.14 
± 1.29 pg/100µg of proteins, p<0.05 vs surgery WT and naïve groups). IL-1β 
expression in the hippocampus was not changed in TLR4 naïve animals (3.34 
± 0.39 pg/100µg of proteins). Values from WT animals undergoing tibia 
surgery are illustrated for comparison (5.98 ± 1.23 pg/100µg of proteins). 
 
 
 
Figure 4-14: Reduced, but not abolished, hippocampal IL-1β following 
surgery in TLR4-/-.  
Tissue collection was carried out 6 hours after treatment. Surgery in TLR4-/- 
resulted in an increased expression of IL-1β (*p<0.05 vs naïve). There was a 
significant difference between KO and WT after surgery (+p<0.05 for 
comparison between surgery KO vs surgery WT). Data are expressed as 
mean ± SEM (n = 6) and compared by two-way analysis of variance and 
Student-Newman-Keuls method.  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The partial amelioration observed at 6 hours both in plasma and hippocampal 
IL-1β prompted to understand the subsequent effects on microglia. At 24 
hours following surgery there was a significant amount of reactive microglia 
compared to untreated animals (p<0.05). Neither anesthesia only nor LPS 
groups showed signs of microgliosis at this time point (figure 4.15).  
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Figure 4-15: Microglia activation in TLR4-/-.  
Hippocampi were harvested 24 hours post intervention and stained with anti-
CD11b to indicate microglia activation following interventions. Animals were 
exposed to anesthesia only, underwent surgery of the tibia, or exposed to 
LPS.  Untreated animals served as naïve. Photomicrographs were blindly 
scored and microglia activation was graded on a scale 0 (lowest) – 3  
(highest). Reactive microgliosis was observed following surgery, but not in 
any of the other treatments (A – naïve, B – surgery, C anesthesia –, D – LPS) 
(pictures show CA1, scale bar 50 µm, 20X). Immunohistochemical grading (0-
3) (E) was presented for data illustration. Significant increase in reactive 
microgliosis was reported following surgery (p<0.05).  No changes were 
observed in any of the other treatments (n = 4). Non parametric data are 
presented with Kruskal-Wallis followed by Dunn’s test. 
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4.5 TLR2  
4.5.1 TLR2-/- only show mild improvement on systemic inflammation  
The second target amongst TLRs was TLR2. Similarly to TLR4, this receptor 
plays a dual role during infection and aseptic inflammation. TLR2 shares a 
conserved intracellular motif with TLR4 and are both associated with 
recognition of microbial ligands (Kurt-Jones et al. 2002; Yang et al. 2008). 
Even though the signaling pathway has been thoroughly investigated in the 
past years, endogenous triggers of TLR2 remain dubious. Recently, a role for 
TLR2 has been advanced in the recognition of DAMPs (hyaluraonic acid, 
HSPs, HMGB-1, uric acid), however its function and many endogenous 
triggers still remain undefined (Vabulas et al. 2002; Park et al. 2004; 
Scheibner et al. 2006).  In order to further understand the role of this receptor 
and its possible association with POCD, systemic inflammation was assessed 
following treatment.  Levels of IL-1β and IL-6 were measured by ELISA at 24 
hours (figure 4.16A, B; IL-1β: 20.6 ± 3.43 pg/ml, p<0.01 vs naïve; IL-6:  and 
19.98 ± 3.3 pg/ml) [WT values for comparison: IL-1β: 36.89 ± 6.54 pg/ml; IL-6: 
27.21 ± 4.53 pg/ml at 24 hours].  A reduction in the level of IL-1β was 
observed (p<0.05), however there was no significant difference when 
assessing IL-6. Consistently with the previous data, no changes were 
reported after anesthesia only in neither cytokines. LPS injection in TLR2-/- 
provided a strong positive control, cytokine levels reached similar values to 
treated WT (figure 4.16A, B; IL-1β: 65.77 ± 10.96 pg/ml; IL-6:  and 118.9 ± 
19.82 pg/ml, p<0.001 respectively) [WT values for comparison: IL-1β: 73.49 ± 
12.24 pg/ml; IL-6: 126.47 ± 21.07 pg/ml at 24 hours, p<0.001 respectively].  
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Figure 4-16: Surgery-induced systemic inflammation in TLR2-/-.  
IL-1β and IL-6 levels in plasma were measured by ELISA at 24 hours post-
intervention. A reduction in IL-1β following surgery was observed at 24 hours 
(A, +/*p<0.05 vs naïve and WT groups). No changes in IL-6 were measured 
at 24 hours (B, *p<0.01 vs naïve). LPS-induced systemic inflammation was 
present in TLR2-/- animals compared to LPS injected WT, with no differences 
compared to WT in IL-1β and IL-6 (p<0.001 vs naive). No changes in 
systemic cytokines were reported following exposure to anesthesia only. Data 
are expressed as mean ± SEM (n = 6) and compared by two-way analysis of 
variance and Student-Newman-Keuls method. 
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4.5.2 Attenuated microgliosis in TLR2-/-  
 
To further elucidate the immune-to-brain signaling following surgery, microglia 
activation was measured in TLR2-/-.  Mild microgliosis was observed at 24 
hours post intervention.  Cells featured clumped processed and amoeboid cell 
bodies. However, following LPS administration in TLR2-/-, significant 
microgliosis was observed (p<0.01), thus making the comparison with surgery 
less remarkable. No changes were observed following anesthesia exposure 
only (figure 4.17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 134 
 
 
 
 
Figure 4-17: Microglia activation in TRL2-/- 
Hippocampi were harvested 24 hours post intervention and stained with anti-
CD11b to indicate microglia activation following interventions. Animals were 
exposed to anesthesia only, underwent surgery of the tibia, or exposed to 
LPS.  Untreated animals served as naïve. Photomicrographs were blindly 
scored and microglia activation was graded on a scale 0 (lowest) – 3  
(highest). No signs of reactive microgliosis was observed following anesthesia 
exposure (A – naïve, C – anesthesia).  Animals undergoing tibia surgery 
showed mild signs of reactive microgliosis (i.e. enlarged cell bodies, B).  
Animals treated with LPS expressed clear signs of reactive microglia (D) 
(pictures show CA1, scale bar 50 µm, 20X).  Immunohistochemical grading 
(0-3) (E) was presented for data illustration. A significant increase in reactive 
microglia was observed in animals treated with LPS (**p<0.01 vs naïve and 
anesthesia groups).  Mild microgliosis was reported following surgery (n = 4). 
Non parametric data are presented with Kruskal-Wallis followed by Dunn’s 
test. 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 135 
 
Table 4-1: KOs summary 
 
 
Legend: bl : baseline; - - : significant reduction; - :mild reduction; -/+ : no 
difference; + : increase; ++ : significant increase; nd: not determined 
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4.6 Discussion  
Innate immunity is the most ancient and well conserved defence system 
shared throughout evolution from simple insects (Drosophila) to human 
beings (Kimbrell and Beutler 2001).  Its key function is to discriminate 
infectious non-self pathogens and non-infectious self in order to activate a first 
line defence mechanism that alerts and protects the host organism against a 
possible threat (Medzhitov and Janeway 2000; Matzinger 2002).  Recently, 
the role of PRRs has shifted from “microbial sensors” only to the so-called 
“danger signaling”, expanding their action also into non-infective signaling 
mechanisms.  
Sterile injury shares similarities and many symptoms of infection. The data 
here reported describe a pivotal role for MyD88 dependent signaling, in 
particular mediated by the IL-1R. The partial, but sufficient, reduction in pro-
inflammatory cytokines reported in both MyD88 and IL-1 KOs suggest that 
these pathways are pivotal in POCD-associated behavior.  However, since 
the inflammatory response was not completely abolished, this also prompts to 
understand whether non-MyD88 dependent signaling can mediate and 
perpetuate this inflammatory response.  Some of these components will be 
further analyzed in the following chapter.  Herein, I provide evidence for a 
minimal involvement of TLR4 in POCD-associated behavior and a marginal 
role for TLR2, which yet requires further understanding.  
As reported in the previous chapter, cytokines play an important role in 
mediating the inflammatory response after surgery. The innate immunity is 
rapidly triggered and the immune-to-brain signaling ultimately leads to CNS 
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changes and behavioral abnormalities.  Whether specific receptors / pathways 
can be defined in the context of POCD has yet not been investigated and the 
literature on aseptic inflammation and injury is still primordial.  Both TLRs and 
the IL-1 largely mediate their action via MyD88, however a non-MyD88 
signaling component has been recently suggested (Kenny and O'Neill 2008).  
I first investigated the response to surgery in MyD88-/- and these animals 
appeared protected against the inflammatory-induced behavioral abnormality.  
Levels of both pro-inflammatory cytokines, including IL-1β and IL-6, and 
neuroinflammatory markers were significantly reduced in these animals.  This 
suggests that this adaptor molecule exerts a pivotal role in surgery-induced 
behavioral abnormality. Humoral signaling and the possible recruitment of 
peripheral immune cells into the brain may account for the neuroinflammatory 
changes and POCD-associated behavior (Dantzer 2006; D'Mello et al. 2009).  
When MyD88 is absent, the danger signaling cannot perpetuate the 
inflammatory challenge, thus systemic cytokines are lower and reflect in an 
attenuated neuroinflammation and improved behavioral outcome.  
Recently a dual role for MyD88 and TLRs in activating the innate and adaptive 
immunity via dendritic cells has been described (Hou et al. 2008). Using 
conditional knockouts, which allow selective targeting of a population of cells 
(in this case dendritic cells), more specific answers can be obtained. This 
would be advantageous in this model of POCD and is something that will be 
pursued in the future.  Yet no evidence for a direct involvement of the 
adaptive immunity in POCD have been reported.  Initially I had an interest in 
IFN-γ, in particular to correlate POCD with a chronic – autoimmune scenario. 
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Preliminary data looking at plasma levels of IFN-γ were assayed up to one 
month postoperatively but with no success (figure 4.18).  
 
 
Figure 4-18: IFN-γ after surgery.  
IFN-γ levels in plasma were measured by ELISA at 1, 3, 7, and 30 days post-
intervention. No changes in the levels of IFN-γ were reported at any of the 
time-points. No changes were also reported following exposure to anesthesia 
only. A positive control was processed to confirm validity of the assay 
following manufacturer’s instructions. Data are expressed as mean ± SEM (n 
= 6). 
 
 
Even without characterizing specific cell types involved with POCD, these 
data demonstrate a pivotal role for MyD88 signaling. This led me to further 
investigate putative receptors associated with this molecule. TLR2, and TLR4, 
(and possibly TLR9) may be unique among TLR family members in their 
ability to recognize both exogenous and endogenous ligands (Ohashi et al. 
2000; Paterson et al. 2003; Akira and Takeda 2004; Kaczorowski et al. 2008). 
TLR4 has partially shared mechanisms that involve MyD88 whereas TLR2 
signaling relies entirely on this adaptor molecule (Barton and Medzhitov 2003; 
Akira et al. 2006). A series of studies have been conducted using TLR4 
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deficient mice looking at the danger signal after acute tissue injury including 
hemorrhagic shock (Barsness et al. 2004), cardiac (Oyama et al. 2004), and 
hepatic (Tsung et al. 2005) ischemia/reperfusion models, showing reduced 
inflammation and injury compared to wild types.  More recently, a correlation 
between endogenous proteins released after tissue injury and TLR4 has been 
suggested (Paterson et al. 2003; Mollen et al. 2006; Levy et al. 2007). 
Endogenous inducers not only engage with TLRs, but other PRRs are also 
involved in perpetuating and amplifying the inflammatory response (Medzhitov 
2008).  In the absence of TLR4, animals showed clear signs of POCD, 
similarly to WT animals.  TLR4 is classically involved with infection and sepsis 
(Poltorak et al. 1998; Qureshi et al. 1999), but has also been associated with 
aseptic inflammation (Kaczorowski et al., 2008; Levy et al., 2006; Paterson et 
al., 2003). Since the absence of TLR4 did not significantly impact on cytokine 
release and behavioral changes, this further corroborates the previous 
findings with the general antibiotic, enfloroxacin, suggesting that the effects 
reported in this model cannot be attributed to an infective origin. However, the 
importance of TLR4 has also been described in aseptic inflammation, danger 
signaling and tissue trauma (Ohashi et al. 2000; Smiley et al. 2001; Johnson 
et al. 2002).  In particular, TLR4 has been pivotally described following 
bilateral femur fracture. In this study chimeric mice with a point mutation in the 
intracellular TLR4 signaling domain were used, showing that TLR4 mutant 
were protected following fracture (Mollen et al. 2008). In this model of POCD I 
did not use chimeric mice but I also reported a decrease in systemic cytokines 
and neuroinflammation, however this reduction did not appear sufficient to 
protect the animals from the behavioral abnormality. Also, the anesthesia 
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technique used in the bilateral femur model used sodium pentobarbital, which 
has known anti-inflammatory effects via NFkB and MAPK signaling pathways 
(Yang et al. 2007).  Both TLR4 and TLR2 have also been studied in the 
context of acute brain injury, revealing a pivotal role for MyD88 but not for 
either of these receptors (Koedel et al. 2007). 
In summary, MyD88 signaling crucially affects POCD. The IL-1R, but not 
TLR2 or TLR4, appear to be a sufficient target in ameliorating this condition. 
However, further studies including other TLRs, conditional KOs or double-KOs 
might address more specific questions. These data further prove the 
complexity and multifactoriality of this phenomenon, suggesting that a 
sufficient, even if not complete, reduction in cytokines has protective effects 
on POCD-associated behavioral abnormality.  Because none of the analyzed 
receptors were able to fully abolish the inflammatory response, this yielded to 
further investigate whether putative MyD88-independent signaling affect 
POCD. Some of these mechanisms are explored in the following chapter.  
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5 Chapter 5: results  
5.1 RATIONALE  
Cytokines have broad physiological effects both on the periphery and in the 
CNS. As previously demonstrated, MyD88 and IL-1 have a pivotal role in 
mediating characteristic symptoms of sickness behavior as well as memory 
abnormalities and POCD-associated behavior.  Inflammation relies on 
multiple factors and immune cells often recruit and produce cytokines in 
response to different stimuli, making the inflammatory response characteristic 
for a given insult.  Aseptic inflammation, danger signaling and endogenous 
inducers not only engage with MyD88, but also other PRRs are involved in 
perpetuating and amplifying the inflammatory response (Medzhitov 2008).  
Both IL-1 and TNF have a broad range of effects with many synergistic 
interaction and both characterize many pathologies.  Many primary functions 
of the immune system are regulated by these cytokines, but their mechanisms 
of action in particular at the post-receptor level yet remain unclear (Saklatvala 
et al. 1996). 
TNF has a pivotal role in the initiation and amplification of the inflammatory 
cascade; it is involved in regulating chemokines and cytokines release, 
oxidative stress, recruitment of immune cells (leukocytes and neutrophils) and 
adhesion molecules, apoptosis, healing and tissue-specific repair mechanism 
(chondrocytes, osteoclasts, hepatocytes, neurons and adipocytes.) (McKellar 
et al. 2009). TNF also exerts neuromodulatory functions, in particular in 
regulating microglia and astrocytes activation in the brain. (Pan et al. 1997; 
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D'Mello et al. 2009) 
After having defined a role for MyD88 signaling in POCD, I sought to 
investigate whether other molecules / receptors could account for POCD-
associated dysfunctions.  Following the findings that the innate immunity is 
closely involved with POCD, my aim was to understand if specific initiators 
could be targeted upstream of the receptors downstream cascade.  TNF-α 
has a pivotal role in both directly and indirectly inducing other inflammatory 
markers, including cytokines, prostaglandins, nitric oxide, and adhesion 
molecules, making it a classic pleiotropic cytokine (Tchorzewski et al. 1993; 
McKellar et al. 2009).  Despite the technical limitations in measuring this 
cytokine in plasma, I previously reported a positive trend after 30 minutes 
following tibia surgery. However, previous work for this laboratory has 
reported TNF-α in the hippocampus at 24 hours following splenectomy by RT-
PCR, thus suggesting a putative role for this cytokine in the etiology of this 
phenomenon (Wan et al. 2007).  Hence, I hypothesized that TNF-α may 
represent a putative initiator of the inflammatory response in POCD. Thus I 
opted to use selective antibodies to antagonize TNF-α pre-emptively.  
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5.2 Anti-TNF ameliorates surgery-induced cognitive abnormality  
The first aim was to understand if the anti-TNF prophylaxis would have 
provided protection following surgery.  To assess the effect on POCD-
associated behavioral abnormality, trace fear conditioning was carried out as 
previously described.  Since one anti-TNF group was injected 18 hours before 
surgery, this occurred before the acquisition phase.  Thus, all other animals 
were injected with saline to account for any possible effect of the injection on 
learning capability.  Acquisition and establishment of working memory was 
achieved with no significant differences between groups, similar to what was 
reported before (figure 5.1).  
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Figure 5-1:  Training phase during trace fear conditioning.   
Animals were collegially trained and then subdivided in three groups: 
untreated (naïve), tibia fracture under inhaled isoflurane with administration of 
antiTNF 18 hours before surgery (antiTNF 18h) and tibia fracture under 
inhaled isoflurane with administration of antiTNF immediately after operation 
(antiTNF 0h). Baseline freezing at the time of first exposure of these animals 
in the context is very low, indicating low levels of stress (A). Figure B indicates 
the increase of freezing response from Tone 1 to Tone 2, indicating working 
memory. Figure C indicates the increase of freezing response from Trace 
Interval 1 to 2, an indicator of working memory. Figure D indicates the working 
memory freezing response to context between tone – shock pairings. All 
animals demonstrate an equal working memory performance (E). 
 
 
 
 
 
 
 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 145 
 
Immediately following training, animals were treated as follows. Mice in the 
surgical group received tibia surgery within 30 minutes after training. 
Prophylaxis with antiTNF was given 18 hours before surgery (antiTNF 18h) or 
the antibody was administered immediately after surgery still under 
anesthesia (antiTNF 0h).  Three days after treatment, rodents were taken 
back to the conditioning chamber and re-exposed to the same environment as 
during the acquisition phase. The contextual retrieval task revealed no 
significant changes in freezing behavior compared to the naïve littermates in 
either treatment, perhaps with a more defined effect following the preemptive 
administration. No changes were reported in the auditory-cued test (figure 
5.2B).  
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Figure 5-2: Effects of antiTNF on behavioral outcome.  
Adult mice underwent surgery of the tibia under inhaled isoflurane (surgery), 
or the same surgical procedure with preemptive administration of antiTNF 
18hours prior surgery (antiTNF surgery) or immediately after intervention 
(surgery antiTNF). Freezing to context after trace fear conditioning (A). Mice 
subjected to surgery exhibited reduced freezing to context when compared to 
naïve animals; in both cases, administration of antiTNF mitigated the 
contextual fear memory impairment (p<0.05). Hippocampal-dependent, 
surgery-induced memory impairment is shown in the auditory-cued test in 
mice trained with trace fear conditioning  (B). There is a significant difference 
between the groups in auditory-cued-related freezing behavior, suggesting 
disruption of auditory-cued, hippocampal-dependent, retrieval of memories 
after surgery. No difference was shown in the baseline freezing behavior or 
after administration of antiTNF (p<0.05). Data are expressed as mean ± SEM 
(n = 10) and compared by one-way analysis of variance and Student-
Newman-Keuls method. 
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5.3 Therapy with anti-TNF reduces systemic levels of IL-1 and IL-6  
The promising effects of anti-TNF therapy on POCD-associated behavior led 
me to investigate the effects in relationship to other cytokines, namely IL-1β 
and IL-6.  Due to the prolonged half-life of the antibody (>3 days) and the 
consistent results from the TFC assessment, I only focused on the 
prophylaxis 18 hours before surgery.  The effects on systemic cytokines were 
remarkable. Anti-TNF successfully reduced the amount of systemic IL-1β by 6 
hours after tibia fracture (fig A; 19.54 ± 3.26 pg/ml, p<0.01) and even further 
attenuated the response at 24 hours (10.22 ± 2.5 pg/ml, p<0.001).  In order to 
corroborate the findings, in particular to relate this observation to the 
specificity of the therapy, I delayed the administration of the antibody up to 6 
hours following surgery and re-measured the cytokine levels in plasma.  As 
expected, the delay did not reduce the amount of plasma IL-1β at either of 
these time points (figure 5.3A; 50.09 ± 8.35 pg/ml and 35.6 ± 5.93 pg/ml) [WT 
values from untreated animals after surgery are reported for comparison: 
44.13 ± 7.35 pg/ml and 36.89 ± 6.54 pg/ml]. To further corroborate the 
findings with IL-1β, I also assayed IL-6 as downstream effector from IL-1. 
Consistently, levels of IL-6 were similarly reduced both at 6 and 24 hours 
(figure 5.3B; 38.3 ± 6.38 pg/ml and 16 ± 2.6, p<0.01 and p<0.05 respectively) 
[WT values from untreated animals after surgery are reported for comparison: 
94.08 ± 15.68pg/ml and 27.21 ± 4.53 pg/ml]. Also, the delayed treatment with 
the antibody did not provide any reduction in IL-6 (91.83 ± 15.31 pg/ml and 
26.8 ± 4.47 pg/ml). 
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Figure 5-3: Effects of antiTNF on systemic IL-1β and IL-6.  
Adult mice received surgery of the tibia under inhaled isoflurane. Preemptive 
administration of antiTNF 18 hours before surgery significantly reduced levels 
of IL-1β both at 6 (**p<0.01) and 24 hours (***p<0.001) (A). Delayed 
administration of the antibody did not provide any reduction in plasma IL-1β.  
Levels of IL-6 were similarly reduced after prophylaxis: both at 6 and 24 hours 
there was a significant decrease (B; **p<0.01, *p<0.05 respectively).  Data 
are expressed as mean ± SEM (n = 6) and compared by one-way analysis of 
variance and Student-Newman-Keuls method. Sx=surgery, Ab=antibody, 
D=delayed administration of antibody 
 
 
 
 
5.4 Reduced neuroinflammation follows antiTNF prophylaxis 
From the action of the antibody on the systemic circulation, I then measured 
levels of IL-1β in the hippocampus. The novelty and interest of this 
experiment was to understand whether the action of the antibody on the 
periphery would also reflect in improved neuroinflammation. As both 
minocycline and the IL-1 Ra could freely diffuse in the brain and CNS, the 
antibody is limited in its ability of crossing the blood-brain barrier, thus 
allowing to speculate on the possible immune-to-brain signaling pathways 
(Gutierrez et al. 1994; Zhang et al. 2003; Skinner et al. 2009).  Interestingly, 
when hippocampal levels of IL-1β were measured by ELISA, there was no 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 149 
significant difference between animals treated with antiTNF and untreated 
counterparts (figure 5.4; 3.74 ± 0.23 pg/100µg of proteins). Values from WT 
animals following surgery are illustrated for comparison (5.98 ± 1.23 pg/100µg 
of proteins, p<0.01 vs naive).  
 
 
 
 
Figure 5-4: Reduced hippocampal IL-1β following antiTNF.  
Tissue collection was carried out 6 hours after treatment. Surgery with 
preemptive administration of antiTNF resulted in no changes in the expression 
of IL-1β compared to naïve animals (**p<0.01). A positive control from LPS (1 
mg/kg) treated animals was used to validate the readings. Data are expressed 
as mean ± SEM (n = 6) and compared by one-way analysis of variance and 
Student-Newman-Keuls method. 
 
 
 
 
This led to further investigations of the relationship with microglial activation. 
The relationship between central IL-1β and further microgliosis was 
strengthened by the effects of antiTNF in reducing the amount of reactive 
microglia following surgery (figure 5.5; p<0.05 vs surgery only).  
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Figure 5-5: Effects of antiTNF on reactive microgliosis in the 
hippocampus.  
Hippocampi were harvested at 24 hours after treatment and stained with anti-
CD11b to indicate microglia activation following interventions. 
Photomicrographs were blindly scored and microglia activation was graded on 
a scale 0 (lowest) – 3  (highest). No signs of reactive microgliosis were 
observed following antiTNF treatment (B) compare to untreated animals (A) 
(pictures show CA1, scale bar 50 µm, 20X).  LPS slides from WT were used 
as positive control (pictures show CA1, scale bar 50 µm, 20X).  
Immunohistochemical grading (0-3) (C) was presented for data illustration.  
Prophylaxis with antiTNF significantly reduced microglia activation at POD 1 
(*p<0.05 vs surgery) (n = 6). Non parametric data are presented with Kruskal-
Wallis followed by Dunn’s test. 
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To recapitulate these findings, I have shown that administration of TNF-α 
antibody reduces IL-1β both systemically and centrally.  This suggests that 
even though we cannot determine TNF-α in the circulation, this cytokine is an 
important player in mediating surgery-induced cognitive dysfunction. 
However, because either targeting of MyD88 or TNF-α produced only a 
reduction in inflammatory cytokines, but not a complete abolition, this 
intrigued me to identify whether the synergism of these cytokines, namely IL-1 
and TNF-α, could account for the inflammatory response. 
 
 
5.5 Role of TNF-α and IL-1.  
In order to answer this question I administered anti-TNF to MyD88-/-. As 
shown previously both MyD88-/- and IL-1R-/- displayed a detectable and similar 
amount of IL-1β, however when MyD88 received prophylaxis with the 
antibody and underwent surgery, levels of both IL-1β and IL-6 remained at 
baseline (figure 5.6A-B, p<0.001 and p<0.01 respectively versus MyD88-/- 
surgery only) [MyD88-/- levels following surgery at 6 and 24 hours are reported 
for comparison: IL-1β: 14.27 ± 2.4 pg/ml and 10.04 ± 1.7 pg/ml; IL-6: 19.79 ± 
3.23 pg/ml and 6.89 ± 1.15 pg/ml]. 
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Figure 5-6: Effect of prophylaxis in MyD88-/- on IL-1β and IL-6.  
Preemptive administration of anti-TNFα reduced the amount of systemic IL-1β 
as measure by ELISA to baseline both at 6 hours and 24 hours post 
intervention (A, **p<0.001, *p<0.01 compared to sx respectively). Levels of IL-
6 were also measured; there was a similar reduction with baseline values at 
both time points (B, **p<0.001, *p<0.01 compared to sx respectively). Data 
are expressed as mean ± SEM n = 6 and compared by two-way analysis of 
variance and Student-Newman-Keuls method.  
 
 
 
These findings from the MyD88-/- led to studies to reveal whether anti-TNF 
therapy could also protect TLR4-/-, which displayed signs of inflammation 
correlated to POCD behaviour.  Systemic inflammatory response following 
surgical intervention was abolished by pre-emptive administration of anti-TNF 
to TLR4-/-.  
Levels of both IL-1β and IL-6 were found at baseline (figure 5.7A, B) [TLR4-/- 
levels following surgery at 6 and 24 hours are reported for comparison:IL-1β: 
23.57 ± 4.23 pg/ml and 30.88 ± 5.15 pg/ml; IL-6: 75.59 ± 14.6 pg/ml and 
27.15 ± 4.52 pg/ml]. 
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Figure 5-7: Anti-TNFα prophylaxis in TLR4-/-.  
Adult TLR4-/- mice underwent surgery of the tibia under general anesthesia 
(Sx), or the same surgical procedure with anti-TNFα prophylaxis 18 hours 
prior to surgery (Ab). The control group was composed of TLR4-/- naïve 
animals. Preemptive administration of anti-TNFα reduced the amount of 
systemic IL-1β as measure by ELISA to baseline both at 6 hours and 24 
hours post intervention (A, **p<0.01 compared to sx respectively). There was 
a similar reduction in levels of IL-6, with values back to baseline at both time 
points (B, **p<0.001, *p<0.01 compared to sx respectively). Data are 
expressed as mean ± SEM n = 6 and compared by two-way analysis of 
variance and Student-Newman-Keuls method.  
   
 
Furthermore, as TLR4-/- displayed signs of neuroinflammation and 
microgliosis after surgery, this prompted to investigate the effects of the 
antiTNF prophylaxis on the CNS.  Anti-TNF was able to reduce the amount of 
hippocampal IL-1β at 6 hours following intervention (figure 5.8; 3.74 ± 0.42 
pg/100µg of proteins, p<0.01 vs surgery in TLR4-/-).   
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Also, at 24 hours post intervention there were no signs of reactive microgliosis 
(figure 5.9). 
 
 
 
Figure 5-8: Hippocampal IL-1 following prophylaxis in TLR4-/-.  
Tissue collection was carried out 6 hours after treatment. TLR4-/- showed 
signs of neuroinflammation following tibia surgery but levels IL-1β were 
reduced following anti-TNFα prophylaxis (*p<0.01 vs sx). Data are expressed 
as mean ± SEM, n = 6 and compared by one-way analysis of variance and 
Student-Newman-Keuls method.  
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Figure 5-9: Effects of antiTNF on reactive microgliosis in the 
hippocampus of TLR4-/-.  
Hippocampi were harvested at 24 hours after treatment and stained with anti-
CD11b to indicate microglia activation following interventions. 
Photomicrographs were blindly scored and microglia activation was graded on 
a scale 0 (lowest) – 3  (highest). Neither naïve (A) or mice treated with anti-
TNFα (C) showed evidence of reactive microgliosis. Reactive microglia were 
found in TLR4-/- undergoing surgery as previously described (B, **p<0.01 vs 
naïve and ab groups). (pictures show CA1, scale bar 50 µm, 20X). 
Immunohistochemical grading (0-3) (C) was presented for data illustration.  
Prophylaxis with antiTNF significantly reduced microglia activation at POD 1 
(+p<0.05 vs surgery) (n = 4). Non parametric data are presented with Kruskal-
Wallis followed by Dunn’s test. 
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5.6 Discussion   
These data first show that anti-TNFα monoclonal antibody reduce the 
inflammatory burden following surgery, through the elaboration of IL-1β. 
These data suggest a role for TNF signaling on cognitive dysfunction and as a 
putative initiator of the inflammatory cascade that characterizes POCD.  TNF 
targeting in WT was able to revert IL-1β to levels similarly to what observed in 
MyD88-/- after surgery. However, co-administration of anti-TNF to MyD88-/- or 
TLR4-/- completely abrogated the surgery-induced IL-1β response and 
downstream IL-6 production, suggesting a pivotal role for both these cytokines 
in the inflammatory response.  
The importance of IL-1β in POCD and cognitive dysfunctions has been 
ascertained in a number of reports (Wan et al. 2007; Rosczyk et al. 2008).  
This is the first demonstration that preemptive targeting of TNFα as an early 
marker during post-surgical inflammation suppresses generation of IL-1, 
strengthening the role of cytokines in the etiology of POCD. In order to define 
the origin of the IL-1 response, I also looked at MyD88-dependent signaling 
and TLR4.  
These data suggest a pivotal role of the initial peripheral response in the 
subsequent development of neuroinflammation and POCD-associated 
behavioral changes.  In spite of the limitations of antibodies to permeate the 
brain, prophylaxis with anti-TNFα is primarily affecting the systemic 
inflammation, but it also provided a significant reduction in both hippocampal 
IL-1β and microglia activation. Although neural afferents may account for 
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signs of CNS inflammation (Dantzer 1994), these data may reveal the 
importance of humoral signaling in immune-to-brain signaling. Peripheral and 
central reduction of IL-1β through TNFα improved the behavioral 
performance, further elucidating and proving the inflammatory origin of 
surgery-induced cognitive abnormalities.  
Due to the recent discoveries of independent MyD88 pathways in the IL-1 
signaling (Kenny and O'Neill 2008), I investigated the response following 
surgery in animals lacking expression of this key adaptor molecule. MyD88-/- 
showed a reduction, even if not complete, in IL-1β following surgical 
stimulation. Dampening of the inflammatory challenge appears sufficient to 
provide a beneficial effect in POCD-associated behavior following surgery in 
MyD88. It is possible that here we report a threshold effect in which a certain 
level of IL-1 is sufficient to trigger enough neuroinflammation to impact on 
memory functioning, thus making behavioral changes. Combination of anti-
TNFα prophylaxis to MyD88-/- was able to completely abrogate the response 
to IL-1β, suggesting a synergism with one another. The results from the TFC 
also suggest that the elimination of either cytokines will diminish cognitive 
dysfunction following surgical trauma (i.e. threshold effect).   
The demonstration of the importance of MyD88 signaling in POCD led to 
further investigate whether targeting of specific receptors could ameliorate 
POCD symptoms.  Due to the findings on the involvement of TLR4 during 
sterile inflammation and trauma (fracture) (Levy et al. 2006), I sought to also 
look at the inflammatory response in TLR4-/-. Both IL-1β response and 
cognitive dysfunction after surgical stimulation were not eliminated.  However, 
anti-TNFα prophylaxis was able to reduce the inflammatory challenge in 
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TLR4-/-, further proving the key role of TNFα in the generation of IL-1β through 
a MyD88 independent pathway following surgery. 
Herein I provide evidence for IL-1β working through MyD88 mechanism but, 
in addition, targeting of TNFα significantly ameliorates the cognitive 
dysfunction after surgery by reducing IL-1β.  Therapy with TNF inhibitors 
already offers beneficial effects in other settings such as rheumatoid arthritis 
(Taylor and Feldmann 2009).  Following a single preemptive administration 
we reported no evidence of infection or sickness behavior in this study, thus 
overcoming some of the limitations of these agents in facilitating postoperative 
complications, in particular infections.  Whether the beneficial effects reported 
in this model of POCD following anti-TNF therapy will be retained in the clinic 
yet remains to be seen. 
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6 Chapter 6: results   
6.1 RATIONALE   
Systemic infection produces physiological and behavioral changes both in 
humans and animals. The ensuing sickness behavior is characterized by a 
decline in cognitive function, fever, decreased food intake, somnolence, 
hyperalgesia, and general fatigue (Dantzer 2004).  Most of the symptomatic 
effects of infection can be correlated to neuroinflammation in different brain 
regions including the hippocampus, amygdala and limbic system (Annane 
2009).  
Cytokines have a pivotal role in orchestrating the inflammatory response after 
viral or bacteria infection and are essential in restoring homeostasis; these 
also affect behavior, especially memory and cognition (Pugh et al. 1998).  
LPS, comprising glycolipids from the outer membrane of Gram-negative 
bacteria, stimulates monocytes, macrophages, and neutrophils to produce 
cytokines and a plethora of other pro-inflammatory mediators.  Since the first 
description of IL-1β as the endogenous pyrogen, numerous functions of this 
cytokine have been described in controlling endocrine, immune, and nervous 
functions.  IL-1β is a classic mediator of the body’s response to inflammation 
and has a pivotal role in immune-to-brain signaling, especially in modulating 
memory functions (Rachal Pugh et al. 2001). This molecule can be 
considered the prototypic multifunctional cytokine mediating widespread 
physiologic effects on CNS functions but also in effecting symptoms and signs 
in many disease states (Dinarello 1996; Murray and Lynch 1998).  
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Learning and memory processes largely rely on the hippocampus and this 
brain region expresses the highest density of IL-1 binding sites, making it 
particularly vulnerable to the adverse consequences of neuroinflammation 
(Parnet et al. 1994; Gemma et al. 2005).  Although IL-1β is required for 
normal learning and memory processes, exogenous administration or 
excessive endogenous levels produce detrimental cognitive behavioral effects 
(Chen et al. 2008).  Synergistic interaction between IL-1β and other cytokines, 
such as TNF-α and IL-6, enhances this cognitive dysfunction (Allan et al. 
2005). Although microglia activation is observed in many different conditions 
ranging from neurodegenerative diseases, such as Alzheimer’s disease (AD), 
to surgery-related complications (postoperative cognitive dysfunction), the 
putative association between cytokine release, microglial activation, and 
hippocampal-dependent memory dysfunction remains elusive (Wan et al. 
2007).  
Here the effects of LPS on cognitive dysfunctions are reported; I sought to 
further define the putative association between cytokine production and 
microglial activation, and their impact on cognitive function. Also, this work 
facilitates a comparison of two models of cognitive dysfunction, namely the 
surgery (aseptic inflammation) versus a similar behavioral abnormality, but 
produced by infection. 
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6.2 Postoperative complication (infection) exacerbates POCD  
To elucidate the consequences of infection on learning and memory abilities, 
mice were exposed to lipopolysaccharide (LPS) one day following tibia 
surgery. I aimed to understand what would it be the effect of a superimposed 
complication, namely infective, in the setting of POCD and cognitive decline. 
Animals were conditioned during the training phase irrespectively of the 
treatment they received, as described previously. Establishment of learning 
and working memory was rapidly achieved with no significant differences 
between groups during the acquisition phase.  
Immediately following training, animals underwent tibia surgery.  One day 
following surgery, a group was exposed to an i.p. injection of LPS (1 mg/kg). 
Three days after surgery, rodents were returned to the conditioning chamber 
and re-exposed to the same environment, as the acquisition phase.  When 
exposed to this context, the contextual retrieval task revealed a significant 
reduction in freezing behavior compared to the naïve littermates or animals 
undergoing surgery (figure 6.1A).  Moreover, when the auditory-cued test was 
carried out two hours after the context retrieval task, a significant difference 
between surgical subjects and surgical with infection was found in auditory 
cued-dependent freezing, with no impairments in the overall baseline freezing 
(figure 6.1B). 
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Figure 6-1:  Hippocampal-dependent memory recall in surgery after LPS 
infection.  
Contextual fear response, as measured by freezing behavior, is impaired in 
animals receiving surgery followed by LPS exposure (1 mg/kg) compared to 
naïve and surgery groups (A)  (*p<0.05, ***p<0.01 vs naive group, ++p<0.05 
vs surgery group). Surgery-induced memory impairment is shown in the 
auditory-cued test in mice trained with trace fear conditioning (B). There is a 
significant difference between the groups in auditory-cued-related freezing 
behavior, suggesting disruption of auditory-cued, hippocampal-dependent, 
retrieval of memories after surgery. No difference was shown in the baseline 
freezing behavior showing no signs of anxiety (*p<0.05 vs naïve and 
anesthesia groups). Data are expressed as mean ± SEM (n = 10) and 
compared by one-way analysis of variance and Student-Newman-Keuls 
method and student t-test for comparison between surgery and surgery with 
LPS. 
 
These data aimed to reproduce a postoperative complication using LPS to 
induce a substantial and well characterized inflammatory response. Herein 
the data suggest an additive effect by exposing the animals to a complication 
following surgery, and current studies are investigating whether the 
association of these events is able to exacerbate, and sustain long-lasting, 
cognitive dysfunction.  
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The results with the addition of LPS led me to further investigate the 
inflammatory and behavioral responses in the absence of surgical 
intervention. While LPS has well-known effects on immunity and sickness 
behavior, the putative association between cytokine pathways, microglia and 
cognitive dysfunction still remains elusive.  LPS is perhaps a more defined 
insult compared to the complex variables present in surgery, making it a 
suitable model to further elaborate.  
 
 
6.2.1 Endotoxin-induced inflammation is modified by IL-1 Ra and in IL-
1R-/-  
In order to define the inflammatory pathway following systemic LPS 
administration, I sought to assess changes of pro-inflammatory cytokines in 
plasma. TNF-α release occurred very rapidly and transiently; after 30 minutes 
it was significantly increased (104.18 ± 7.36 pg/ml, p<0.01 versus naive), 
peaking at 2 hours and returning to normal at 6 hours post-injection (figure 
6.2A; p<0.001 versus naive).  LPS evoked a robust systemic response that 
induced further cytokine release.  Both IL-1β and IL-6 were significantly up 
regulated from 2 hours. IL-1β increased 4-fold and plasma levels continued to 
steadily increase until 24 hours (figure 6.2B; 73.49 ± 5.42 pg/ml, p<0.001 
versus control). IL-6 expression was highly elevated at 2 hours, decreasing at 
6 hours but still significantly detectable at 24 hours compared to naïve 
animals (figure 6.2C; 134.37 ± 8.43 pg/ml, p<0.01 versus control 
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respectively).  During this time, animals showed classic symptoms of sickness 
behavior (reduced motility, poor grooming, huddling, piloerection, back 
arching). Levels of HMGB1 at 2, 6, and 12 hours post LPS were no different 
from baseline levels; a 1.5-fold increase in HMGB1 was observed from 24 
hours after LPS and remained elevated up to day 3 (figure 6.2D; 25.77 ± 4.2 
pg/ml, p<0.01, p<0.001 versus control).  The systemic inflammatory response 
resolved after day 3 and all cytokine levels returned to baseline by day 7.   
 
 
Figure 6-2: Inflammatory response after LPS exposure.   
Mice were injected with LPS at time zero and plasma levels of TNFα, IL-1β, 
IL-6 and HMGB1 were measured by ELISA. TNFα was increased after 30 
minutes and peaked at 2 hours, returning to baseline thereafter (A; *p<0.01; 
***p<0.001 vs control). IL-1β was detected after 2 hours from LPS 
administration and levels continued to steadily increase until 24 hours (B; 
***p<0.001 vs control). IL-6 expression was highly elevated at 2 hours, 
decreasing at 6 hours but still significantly detectable at 24 hours compared to 
naïve animals (C; ***p<0.001; **p<0.01 vs control respectively). Levels of 
HMGB1 started to increase at day 1 and until day 3 (D; **p<0.01; ***p<0.001 
vs control). Data are expressed as mean ± SEM (n = 6) and compared by 
one-way analysis of variance and Student-Newman-Keuls method with 
Bonferroni corrections. 
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To assess the neuroinflammatory response to LPS we measured levels of IL-
1β and IL-6 mRNA expression in the hippocampus.  There was a 6.5-fold 
increase in IL-1β mRNA expression and a 15-fold increase in IL-6 in the 
hippocampus at 6 hours after LPS injection (figure 6.3; p<0.001 versus control 
respectively).  In both cases the expression returned to normal values by 24 
hours.   
 
 
Figure 6-3: IL-1β and IL-6 mRNA up regulation in the hippocampus. 
 Increased mRNA expression of IL-1β (A) and IL-6 (B) was found at 6 hours 
after peripheral LPS injection in the hippocampus of mice using qPCR 
(p<0.001 vs control respectively); mRNA expression returned to normal by 
day 1. Data are expressed as mean ± SEM (n = 6) and compared by one-way 
analysis of variance and Student-Newman-Keuls method.  
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The increase in IL-1β both in plasma and in the hippocampus led to 
investigate whether blocking the IL-1 receptor could ameliorate the symptoms 
of LPS-associated cognitive dysfunction.  A single preemptive dose of IL-1 Ra 
was able to significantly reduce plasma levels of IL-1β at 6 and 24 hours 
(figure 6.4A, 32.7 ± 5.45 pg/ml, 6.2 ± 1.03 pg/ml, p<0.01 and p<0.001 versus 
LPS respectively) [Untreated animals at 6 and 24 hours: 70.87 ± 5.09 pg/ml, 
73.49 ± 5.42 pg/ml].  Similarly, levels of IL-6 were also reduced at the same 
time-points (figure 6.4B; 91.02 ± 15.17 pg/ml, 14.05 ± 2.34 pg/ml, p<0.001, 
p<0.001 versus LPS respectively).   Corroboration of these data were 
achieved by injecting IL-1R-/- animals with the same dose of LPS and 
measuring cytokine expression in plasma. At 24 hours, time characterized by 
increased cytokines and clear sickness behavior, levels of IL-1β and IL-6 
were comparable to the wild type mice that received IL-1 Ra treatment (figure 
6.4A-B; p<0.001, p<0.01 versus LPS respectively).  IL-1 Ra treatment 
however had no effects on HMGB1 levels, which maintained a similar pattern 
after LPS injection only and were unmodified in IL-1R-/- too (figure 6.4C). 
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Figure 6-4: Blocking IL-1 reduces systemic cytokine release.  
Animals received LPS (LPS) or treatment with IL-1 Ra immediately before 
LPS exposure (RA). Plasma levels of IL-1β and IL-6 were measured by ELISA 
at 2, 6, and 24 hours.  Pre-emptive administration of IL-1Ra significantly 
reduced the amount of plasma IL-1β at 6 hours (A; *p<0.01 vs LPS) and 24 
hours (***p<0.001 vs LPS).  IL-6 followed a similar trend, with a strong 
decrease in plasma concentrates at 6 hours  (B; ***p<0.001 vs LPS) and at 
24 hours (**p<0.001 vs LPS).  To corroborate the findings, levels of IL-1β and 
IL-6 were measured in IL-1R-/- (A-B, ***p<0.001 and **p<0.01 vs LPS 
respectively). Blockade of IL-1 had no effects on HMGB1 release in plasma 
(C). Data are expressed as mean ± SEM, (n = 6) and compared by one-way 
and two-way (IL1R-/-) analysis of variance and Student-Newman-Keuls 
method with Bonferroni corrections. 
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6.2.2 IL-1 blockade reduces LPS-induced microglial activation 
 
The trascriptome findings prompted interest for other possible markers of 
neuroinflammation.  Microglia, the resident immunocompetent cells of the 
CNS, were significantly up regulated in LPS-injected animals.  Minimal 
immunoreactivity was reported in naïve animals in which cells maintained 
small cell bodies with thin and long ramified pseudopodia (figure 6.5A).  
Resting microglia shifted their state to a “reactive profile” after LPS exposure, 
acquiring an amoeboid morphology with hypertrophy of the cell body and 
retraction of the pseudopodia. Reactive microglia displayed morphological 
changes including increased cell body dimensions, shortened and clumpy 
processes with higher levels of CD11b immunoreactivity compared to naïve 
animals. Microglial activation was reported at days 1 and 3 post exposure 
(figure 6.5B,C; p<0.01, p<0.05 vs control), returning to the baseline resting 
state by day 7. Pre-treatment with IL-1Ra effectively reduced the number of 
reactive microglia at days 1 and 3 (figure 6.5E,F), with no changes at day 7.  
In order to corroborate these findings, we repeated the experiment using IL-
1R-/- animals and exposing them to LPS. These knockout animals did not 
exhibit microglial activation following LPS treatment (figure 6.5G,H,I). 
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Figure 6-5: Blocking IL-1 reduces microglia activation.  
Hippocampi were harvested at days 1, 3, 7 after LPS administration and 
stained with anti-CD11b. Pictures show CA1 (scale bar 50 µm, 20X) and 
photomicrographs were blindly scored and microglia activation was graded on 
a scale 0 (lowest) – 3  (highest). PANEL 1: LPS. Reactive microglia were 
found at days 1 and 3 after LPS injection (B-C) compared to naive (A). 
Resting microglia (box A, 40X) shifted to a “reactive state” (box B, 40X). 
PANEL 2: IL-1Ra. Reduction in the number of reactive microglia was 
observed after administering IL-1Ra both at days 1 and 3 (E-F), with no 
changes from controls (D).  PANEL 3: IL-1R-/-. Administration of LPS to IL-1R-
/- did not induce microglia activation at any time point assessed (G-H-I). 
Immunohistochemical grading (0-3) illustrates panels 1, 2, and 3. One day 
after LPS administration we found clear microgliosis, which was attenuated by 
IL-1Ra treatment (day 1 ** p < 0.001 vs control, day 3 * p < 0.05 vs control).  
Significant reduction in microgliosis was found both after IL-1 Ra 
administration and in IL-1R-/- (n = 4). Non parametric data are presented with 
Kruskal-Wallis followed by Dunn’s test. 
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6.2.3 Hippocampal-dependent cognitive dysfunction following LPS   
To relate the inflammatory response to hippocampal memory functioning, 
trace fear conditioning was used, in which mice are trained to associate a 
tone with a noxious stimulation (foot shock).  The brief gap between the tone 
termination and the shock onset allows assessment of hippocampal integrity 
(Chowdhury et al. 2005; Comery et al. 2005).  The high level of freezing seen 
in the naïve animals is indicative of good learning and memory retention. 
Contextual fear response shows a reduced immobility (freezing) at day 3, 
revealing hippocampal-dependent memory impairment (figure 6.6A; p<0.005 
vs naïve trained).  Pre-treatment with IL-1 Ra significantly ameliorated this 
cognitive dysfunction (figure 6.6B; p<0.05 vs LPS). No significant differences 
in the auditory – cued freezing were reported. 
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Figure 6-6: Contextual fear response is ameliorated by pre-emptive IL-1 
Ra.  
Within thirty minutes following training, mice were injected with LPS.  Three 
days later, rodents were exposed to the same context in which fear 
conditioning was previously carried out. Contextual fear response reveals a 
clear hippocampal-dependent memory impairment (A, ** p < 0.005 vs naive).  
Pre-treatment with IL-1Ra abolished the main symptoms of sickness behavior 
and significantly ameliorates the memory retention at day 3 (+ p < 0.05 vs 
LPS). No changes in freezing were reported in the tone test (B). Data are 
expressed as mean ± SEM (n = 9 for acute behavior) and compared by one-
way analysis of variance and Student-Newman-Keuls method. 
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6.3 Discussion  
These data show that a sustained inflammatory challenge leads to 
neuroinflammation, microglial activation and hippocampal-mediated cognitive 
dysfunction. By blocking the IL-1 receptor, the feed-forward process that 
amplifies the inflammatory cascade is attenuated thereby reducing microglial 
activation and reversing the behavioral abnormality after endotoxemia. In the 
context of POCD, the additive effect provided by LPS exposure following 
surgery correlates with the findings of increased severity and prolonged 
cognitive dysfunction in humans (Moller et al. 1998; Abildstrom et al. 2000; 
Monk et al. 2008). 
Cytokines play an important role in mediating the inflammatory response after 
infection or aseptic traumatic injury. The innate immunity is rapidly triggered 
after LPS, primarily via activation of toll-like receptor 4, TLR-4 (Hoshino et al. 
1999). Activation of TLR-4 induces a multitude of pro-inflammatory cytokines 
via activation of transcription factors, NFκB (Andreakos et al. 2004). This 
prompt response provides a favorable environment for the synthesis and up 
regulation of both IL-1β and IL-6, which together contribute to the 
perpetuation of the inflammatory challenge.  Also the rapid increase in TNF-α 
following LPS, which is reported as present already after 30 minutes, 
promotes synthesis of other cytokines and the initiation of the acute-phase 
response. It has been shown that IL-1β can bind receptors and translocate 
through the intact blood-brain barrier (BBB) (Van Dam et al. 1993).  Neural 
afferents are known to be a fast and reliable pathway in the immune-to-brain 
signaling. Vagal-mediated signaling can rapidly induce brain cytokines and 
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manifest the classic symptoms of the acute phase response, including 
neuroinflammation (Dantzer 1994).  As we have reported a significant 
increase in both IL-1β and IL-6 mRNA transcription at 6 hours in the 
hippocampus, the neuronal route may be the likely pathway to trigger the 
early activation of these genes and the initial changes in the CNS. Vagotomy 
was previously shown to partially attenuate sickness behavior both after LPS 
and IL-1β administration (Hansen et al. 1998), but not in the context of 
hippocampal-dependent cognitive dysfunction.  However, recently has been 
also shown that peripheral monocytes can enter the brain causing sickness 
behavior.  This process is strongly supported by TNF-α signaling, especially in 
activating microglia and recruiting active monocytes into the CNS (D'Mello et 
al. 2009).  
Reactive microglia in the hippocampus interfere with memory processing. 
Peripheral cytokines affect brain homeostasis leading to microglia activation.  
Within the brain, cytokines interact with microglia cells.  Pro-inflammatory 
cytokines can directly interact with many of the pattern recognition receptors 
(PRRs) expressed on the surface of these cells (Aloisi 2001).  Upon 
activation, microglia exhibit discernible morphologic changes and secrete 
cytokines, reactive oxygen species (ROS), excitotoxins (such as calcium and 
glutamate) and neurotoxins such as amyloid – β (Hanisch and Kettenmann 
2007).  Activated microglia also inhibit neurogenesis in the hippocampus 
following endotoxemia, thereby exacerbating the extent of injury on memory 
processing (Monje et al. 2003).  
To assess memory retention we used trace fear conditioning in which mice 
are trained to associate a foot shock with a given environment or tone 
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(Fanselow 1980). The extent to which an animal freezes to a context is largely 
dependent on the hippocampus (Maren et al. 1997). Hippocampal-dependent 
memory impairment was evident after 3 days post-LPS.  Residual 
inflammation, primarily via reactive microglia, is possibly associated with this 
second phase behavioral abnormality.  At these time points, levels of HMGB1 
were also elevated and prompted us to further investigate the role of these 
factors in the development of cognitive dysfunction.  
Targeting IL-1 ameliorates the cognitive abnormality by reducing microglia but 
does not affect HMGB1.  IL-1β has a pivotal role in sustaining the 
neuroinflammatory response and closely interacts with memory processing 
and LTP (Vereker et al. 2000; Barrientos et al. 2002).  Self-regulation and 
inhibition of IL-1β is normally achieved with the neutralizing action of 
endogenous IL-1Ra, which directly competes to the binding of the receptor 
(Arend 1991; Dinarello 2005). Transcription of endogenous IL-1Ra would 
normally occur temporally delayed from the synthesis of IL-1, thus following 
pharmacological intervention we aimed to block the receptor a priori impeding 
binding and limiting the damage mediated by the effector molecule. When the 
IL-1 receptor is disabled, either blocked pharmacologically (IL-1Ra) or by 
genetic intervention (IL-1R-/-), the inflammatory response is not sustained as 
reflected by lower cytokine release and microglia activation, thus ameliorating 
the cognitive dysfunction as reported here.  Treatment with IL-1Ra provides a 
significant improvement in cognitive dysfunction, confirming the crucial role of 
IL-1β in memory processes and behavior.  However, since IL-1Ra is able to 
translocate directly into the brain (Skinner et al. 2009), we are unable to 
discriminate whether peripheral cytokines and/or de-novo production in the 
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CNS account for this cognitive dysfunction.  Although there was a temporal 
correlation between microglia activation and late-release of HMGB1, neither 
IL-1Ra nor IL-1R-/- changes levels of in this cytokine.  This evidence supports 
the notion that blocking IL-1 is sufficient to reduce the microglia activation and 
ameliorate the memory abnormality.  However other receptors may be 
involved in sustaining this inflammatory challenge (figure 6.7); for example 
HMGB1 has been shown to activate TLRs and receptor for advanced 
glycation end-products (RAGE) and it has been reported as a key late pro-
inflammatory mediator in sepsis, with considerable pathological potential 
(Wang et al. 1999; van Zoelen et al. 2009).   
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Figure 6-7: Putative signaling mechanism.  
1) TLR-4.  Activation of TLR-4 by LPS activates downstream signaling to 
induce gene transcription of pro-inflammatory cytokines (TNFα, IL-1, IL-6) and 
NF-κB activation.   
2) IL-1R.  The initial synthesis of IL-1β by TLRs signals to the IL-1R, engaging 
in a positive feedback loop to produces more IL-1.  Blocking this receptor with 
preemptive IL-1Ra interferes with this amplification process, impeding binding 
and preventing cleavage and further processing by caspase-1.  Other 
receptors are also involved in this inflammatory cascade, including RAGE. In 
this study the selective blockade of the IL-1R did not interfere with this 
alternative pathway.   
3) Cytokines, in particular IL-1β, enter the CNS both via humoral and neuronal 
pathways.  These changes are promptly sensed in the brain, leading to 
microglia activation.   
4) Reactive microglia perpetuate the inflammatory response and further 
produce neurotoxic agents causing memory impairment and abnormal 
behavior.  Chemotaxis and production of pro-inflammatory cytokines directly 
affect synaptic plasticity, inhibiting LTP and promoting long-term depression 
(LTD) in different hippocampal circuits.  Targeting IL-1 and the resulting 
microglia activation appear to provide a beneficial effect in the context of 
cognitive dysfunctions and possible neurotoxicity. 
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Interestingly, if we compare the profile of HMGB-1 during infection or in 
aseptic inflammation, there are striking differences (figure 6.8). These 
discrepancies support the concept that this cytokine plays a different role 
accordingly.  Surgery relies on the activation of the “danger signaling” and 
DAMPs, including HMGB-1, heath-shock proteins (HSPs), and tissue factors 
(Lotze and Tracey 2005; Zedler and Faist 2006).  In this setting HMGB-1 is 
quickly released soon after the mechanical damage and tissue necrosis, and 
may be responsible for perpetuating the inflammatory response both acting on 
TLRs and MyD88-independent signaling (i.e. RAGE) (Erlandsson Harris and 
Andersson 2004; Park et al. 2004; Harris and Raucci 2006; Bianchi 2007; 
Muhammad et al. 2008).  Following infection or sepsis, HMGB-1 has a 
different role and its activation is time-delayed and possibly sustained by 
already pre-elevated cytokines and circulating macrophages (Wang et al. 
2001; Andersson and Tracey 2003; Czura and Tracey 2003).  Advance 
glycation end-products (HMGB-1 and some S100 proteins) bind to RAGE 
leading to downstream activation of MAPK and nuclear translocation of NFkB, 
thus releasing further cytokine (Erlandsson Harris and Andersson 2004; 
Bianchi 2007).  HMGB-1 can bind to both RAGE and TLR4 to mediate 
inflammation, coagulation activation and neutrophil recruitment (Yu et al. 
2006; van Zoelen et al. 2008). These results first account for an involvement 
of RAGE signaling in POCD, further highlighting that infection is not a 
confounding factor in this model of POCD.  
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Figure 6-8: HMGB-1 in surgery and infection.  
Mice either received tibia surgery under general anesthesia (A), i.p. LPS (1 
mg/kg) (B), or isoflurane only (C). Levels of HMGB-1 were sampled at 
different time-points. Following surgery, a positive trend was already observed 
after 1 hours post incision and levels peaked at 6 hours (A; 34.69 ± 5.78 
pg/ml, ***p<0.001 vs control).  By 24 hours levels returned to baseline.  
If animals were exposed to LPS, HMGB-1 was undetectable before 24 hours. 
Levels were increase after 1 day, and remained up regulated up to 3 days 
post exposure (B; 25.77 ± 4.2 pg/ml, **p<0.01, ***p<0.001 vs control 
respectively).  
No changes were observed after exposure to anesthesia only (C) Data are 
expressed as mean ± SEM (n = 6) and compared by one-way analysis of 
variance and Student-Newman-Keuls method with Bonferroni corrections. 
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In summary, the beneficial effects on cognition reported in this study by 
targeting IL-1, preemptively, are encouraging. However, it is not possible to 
extrapolate these benefits to the setting of cognitive dysfunction that 
accompanies severe sepsis with multiple organ failure. In that clinical scenario 
there are complex inflammatory responses that are difficult to reverse 
(Riedemann et al. 2003). Clinical trials targeting IL-1 have been unconvincing 
in improving mortality rate, especially in sepsis (Marshall 2003). In this 
attempt to untangle the complexity of this condition, anti-cytokine therapy 
appears to be able to ameliorate the associated cognitive dysfunction. 
Inflammation clearly plays a pivotal role in mediating physiological as well as 
behavioral changes after LPS-exposure. Further studies are yet needed to 
ascertain whether selective targeting of other cytokine receptors can 
effectively prevent or ameliorate both the degree and length of cognitive 
decline.  
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7 Chapter 7: General discussion and conclusion  
Postoperative complications are a major concern for the patient’s quality of 
life.  As the name suggests, complication from the Latin complicare, reflects in 
a number of tangled events and factors able to jeopardize an entire system, 
ultimately leading to death.  The immune system is considered a fail-safe 
mechanism playing a pivotal role in maintaining and ensuring a correct 
homeostasis and protection to the organs. However, if dysregulated, 
cytokines may cause damage, and themselves, may be therapeutic targets in 
disease states.  
In this modest attempt of clarifying the complexity of postoperative cognitive 
dysfunction (POCD), new pathways and molecules have been unveiled, 
alongside a potential for translating this research from the bench to the 
bedside.  The multifactorial etiology of POCD has been described from many 
clinical trials, but studies have often been underpowered and anecdotal 
(Newman et al. 2007). Problems concerning cognitive domains have also 
been neglected and underestimated in the past; dementia and 
neurodegeneration are pivotal topics in medicine and neuroscience and 
require much more understanding. 
Because both age and surgery are two main risk factors in POCD, pandemics 
are portended by the increasing aging population and the likelihood of those 
of advanced age requiring surgery and anesthesia. With cardiac and 
orthopedic procedures manifesting the highest incidence of cognitive 
abnormality, we opted to reproduce a clinical routine orthopaedic procedure 
using a mouse model to better dissect some of the underlying factors of 
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POCD.  The pivotal interest of this thesis has evolved around the 
inflammatory response. Evidence for the involvement of inflammation in 
POCD are limited and often associated to the type of surgery. Cytokines and 
acute phase proteins are used as readouts to assess the extent of injury and 
the effects of surgical insults on the immune system. However, the putative 
association between these molecules and cognitive dysfunction has not been 
thoroughly studied.  Work from this laboratory has first demonstrated the 
involvement of cytokines in surgery-induced cognitive abnormalities using a 
rat model of POCD. Herein, these data demonstrate that inflammation plays a 
pivotal role in mediating cognitive dysfunctions in mice and that by targeting 
specific pathways, or molecules, the inflammation can be attenuated, thus 
improving the cognitive disability.  Starting from the initial anti-inflammatory 
effects provided by minocycline, I have been able to describe the involvement 
of specific MyD88 dependent signaling pathways as well as independent 
markers such as TNF-α and HMGB-1, which appear to have a role in POCD. 
What has been reported here though raises further questions and novel 
issues to be addressed. In particular, assessing clinical patients after non-
cardiac surgery the incidence of POCD is about 10% at 3 month post-
discharge (Moller et al. 1998). Why “only” 10% of all patients have this 
phenomenon has been a daunting question where I have perceived limitations 
from the animal model. Cognitive domains and human cognition are extremely 
complex; the concept of cognitive reserve has been applied to POCD and this 
may explain why some people appear protected, perhaps by a more active 
neuronal network and synaptic plasticity.  Indeed, these theories are possibly 
too challenging to be investigated in mice. However, this may also reflect the 
Ph.D. Thesis                                                                                                                                                            Niccolò Terrando _ 
 
 182 
inadequacy of tests being applied in the human system. Genetic 
polymorphism may be also a “discriminative” factor in identifying susceptible 
individuals.  In this setting, animal models may offer added value by allowing 
targeting of specific genes either by knocking/out techniques.  Prime 
candidates in this field include APOe4 and CRP (Abildstrom et al. 2004; 
Mathew et al. 2007). However, the new findings reported in this thesis may 
also prompt reasons for assessing polymorphisms in MyD88 and possibly 
TLRs.  In a new era based on genetic testing and novel diagnostic tools, 
genotyping may add value in helping people with higher risks, upon 
identification of reliable biomarkers.  Inflammation and cytokines are 
implicated in a number of disease states ranging from cardiovascular 
diseases (atherosclerosis, stroke, ischemia), rheumatoid arthritis, sepsis and 
cancer. Polymorphisms, deletions, and single nucleotide polymorphisms in 
inflammatory regulatory genes are thought to play a pivotal role in the 
pathophysiology of these conditions. Variations in the promoter region of TNF 
have been associated with higher susceptibility to infectious diseases, sepsis, 
and ischemic stroke (Hill 1999; Mira et al. 1999; Wang et al. 2009). Similarly, 
allele frequencies and genotype distribution of the IL-1 superfamily associate 
with susceptibility and differential outcome in severe sepsis (Fang et al. 1999). 
Studies on the role of genes in surgery and inflammation are yet very limited 
but the data reported in this thesis suggest a pivotal role for both TNF-α and 
IL-1 in surgery-induced cognitive dysfunction. Individuals with mutations in 
these genes may be at higher risk for cognitive disturbances following surgical 
stimulation.  This knowledge should pave the way for the use immune-based 
therapies in personalized medicine.  
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The data reported here also suggest a pivotal role for MyD88 signaling in the 
etiology of cognitive abnormality.  The role of this adaptor molecule in 
inflammation and cytokine production has been thoroughly detailed in the 
past, but novel pathways and alternative functions have been recently 
proposed.  Studies that associate these classical inflammatory mediators with 
memory and behavioral abnormalities are very limited, especially in the 
context of surgery and aseptic inflammation.  Herein a role for MyD88-
dependent signaling in POCD has been described.  IL-1 appears to have a 
pivotal role in the development of surgery-induced cognitive abnormality.  I 
found surprising the limited effects of TLRs on POCD-associated inflammation 
and behavior.  The complexity of POCD may still require TLRs activation, but 
the absence of both TLR2 and TLR4 appears insufficient to provide beneficial 
effects following surgical stimulation.  This may be consistent with the 
threshold theory established following the experiments with anti-TNF 
prophylaxis. TNF-α clearly has a pivotal role in regulating the inflammatory 
response; early targeting of this molecule has provided beneficial effects both 
in terms of inflammation and behavioral outcome. Targeting TNF-α in this 
model has also strengthened the relationship between IL-1 and POCD, 
perhaps at an earliest time-point compared to administration of IL-1 Ra.  
Therapies with either anti-TNF-α or IL-1 Ra appear to protect against the 
cognitive dysfunction, however by targeting both molecules inflammation is 
fully abolished.  This provides an insight on how MyD88-dependent and 
independent pathways synergise, further demonstrating the concept of 
threshold theory and how levels of pro-inflammatory cytokines closely 
regulate cognitive abnormality. If the inflammatory challenge following surgery 
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is sufficient to overcome a threshold, this leads to memory loss via sustained 
effects on the brain and hippocampus. Individual targeting of MyD88, IL-1 and 
TNF-α is able to prevent cytokines to reach this target, thus the effects on the 
CNS are minimal and no signs of behavioral abnormality are reported.  
Anti-cytokine therapy here provided beneficial effects on POCD-associated 
behavior. Targeting of IL-1 either via MyD88-dependent pathways, genetic 
obliteration of the IL-1R, antagonism with the IL-1 Ra or antiTNF prophylaxis 
appear to reduce the overall inflammation and the associated cognitive 
abnormality.  This is in line with the central role of IL-1 in sickness behavior 
and PAMPs-induced hippocampal dependent memory dysfunction, but also 
suggests a pivotal role for TNF-α in POCD.  Prophylaxis, with IL-1 Ra or anti-
TNF antibodies, is an amenable therapeutic option to be exploited in the 
clinical setting.  Yet the use of anti-cytokines therapy is controversial, in 
particular with anti-TNF.  Clinical trials in septic patients have not been as 
convincing as expected and there was only a minor improvement in mortality 
following therapy (Marshall 2003). It is possible that by administering these 
reagents, patients may be at higher risk for opportunistic infections and further 
complication after surgery. However most of the randomised clinical trials 
have not reported any differences in the incidence of infections in patients 
with anti-TNF treatment (Keane et al. 2001). Furthermore, anti-TNF has been 
the first cytokine to be validated as therapy for rheumatoid arthritis, where it 
continues to offer clear benefits to the patients (Brennan et al. 1989; Taylor 
and Feldmann 2009). In this thesis a single dose of anti-TNF was able to 
impart beneficial effects. Blocking cytokines may be a successful strategy 
able to dampen the inflammatory response, however cytokines are also 
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involved with the homeostatic and healing process following inflammation and 
trauma (Gerstenfeld et al. 2003). Following administration of IL-1 Ra, TNF-α 
antibody, or in MyD88-/- there was no evidence for impaired healing process 
following tibial fracture (personal conversation with Professor Jagdeep 
Nanchahal – unpublished data). Identification of vulnerable individuals who 
could benefit from these therapeutic options will be crucial in order to exploit 
these findings into the clinic. 
As each individual may present with a different pattern of cytokine / 
inflammation, the concept of “cytokine disequilibrium” can be applied to POCD 
(figure 7.1). In the context of this thesis, I have demonstrated for instance how 
patterns of cytokines are defined by a given stimulus (infectious or aseptic 
injury).  The magnitude of cytokines response, the time-course for the 
increase of each mediator and the specific molecules that are detected 
dramatically differ in each setting, making them distinct. In my opinion this is 
the knowledge that needs to be applied, and, although we tend to generalize 
providing “overall views” these may not reflect the individual.  This knowledge 
should enable more therapeutic options as well as tailored-specific treatments 
according to each individual. 
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Figure 7-1: Cytokine disequilibrium  
Modified from (Feldmann et al. 1996)    
In my PhD studies I have proven the role of cytokines in inducing POCD. 
However, what induces cytokine production still needs to be investigated. 
Candidate pathways may include HMGB-1 and RAGE signaling. RAGE 
signaling has been associated with inflammation, oxidative stress, and 
metabolic dysfunctions (Lu et al. 2004; Torreggiani et al. 2009). Alternatively, 
surgical stress and reactive oxygen species are likely to up regulate cytokines 
after surgery, thus perpetuating the inflammatory challenge. The putative 
involvement of advanced glycation endproduct and their association also with 
diet and metabolism may prompt for other risk factors in POCD, which may 
include obesity and metabolic syndrome.  Adipocytes are able to secrete 
factors and recruit chemokines, adhesion molecules, cytokines (TNF-α, IL-1β, 
IL-6 and monocyte chemoattractant protein 1 – MCP1), thus being active 
interfaces of the inflammatory response (Loffreda et al. 1998; Curat et al. 
2004). As we have corroborated the crucial role of inflammation in POCD, 
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these factors should now be accounted for. Inhibitors of RAGE as putative 
activators of Aβ pathogenic pathways are also targets of ongoing clinical trials 
for dementia and Alzheimer's disease (AD), thus they may represent viable 
therapies also for cognitive dysfunctions (Mucke 2009). 
The association between POCD and further degeneration (i.e AD) has been 
speculated but yet there is no evidence for a continuum between the two 
phenomena.  This yields interest for the actual mechanisms underlying CNS 
inflammation and neurodegeneration; are microglia playing “good cop, bad 
cop” in these settings, what are the immune-to-brain signaling pathways 
responsible for this neuroinflammation, what are the significant risk factors to 
assess.  
With the increased vulnerability of the elderly and a classic role for anesthesia 
as inducer of cognitive disturbances, there is a vivid debate on the effects of 
anesthetic agents on individuals.  Neurodegeneration or AD-like symptoms 
caused by anesthesia have been reported, however the causative role of 
anesthetics in POCD has not been confirmed (Rasmussen et al. 2003; Culley 
et al. 2007). This work has reported no clear effects of isoflurane, a clinically 
used anesthetic agent, on the inflammatory cascade or POCD-associated 
behavior.  However, it is possible that different anesthetic agents may provide 
different outcomes to susceptible patients.  Intravenous anesthesia using 
propofol, a widely used anesthetic agent for induction and maintenance of 
anesthesia, showed improved surgical response and faster recovery time 
compared to isoflurane, thus reducing POCD in the elderly (Tan 2009). 
Anesthetic agents also closely interact with the immune system acting as 
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immunomodulators; propofol has renowned affects as an anti-inflammatory 
agent (Chen et al. 2005). This suggests that even if we have not found a 
direct effect of isoflurane on POCD-associated behavior, this does not 
preclude a role for anesthesia in cognitive dysfunctions.  
Many questions still require answers; it has been a privilege to work on this 
project at this stage and I think this thesis has confirmed previous theories, 
revealed new findings and progressed towards a better management for this 
condition in the clinical setting. Whether the selective targeting of cytokines, or 
receptors, can effectively prevent or ameliorate cognitive dysfunction yet 
remains to be seen. 
 
 
 
8 Future work 
The results of this body of work have suggested a number of possible 
subsequent experiments to explore POCD’s mechanisms. These experiments 
have the potential to further both preclinical knowledge as well as directly 
impacting on clinical practice, through the use of alternative therapeutic 
strategies.  
Some questions that remain to be answered: 
•  to better define the immune-to-brain to communication in POCD, in 
particular how systemic cytokines can elicit neuroinflammatory processes.  
The role of microglia requires better understanding especially in the 
identification of their origin (infiltrating macrophages or microglia) and role 
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in the CNS (as harmful or protective cells).  
• to explore the evidence for a direct link between surgery-induced 
neuroinflammation and the development and/or exacerbation of AD. 
Surgery can alter physiological processes in the host organism; in patients 
at risk from developing AD (i.e. with preexisting mild cognitive 
impairments), surgery may act as a “co-stimulus” able to prime the system 
and trigger both POCD and early-AD features in such susceptible 
individuals. 
• test novel therapeutic interventions designed to mitigate cognitive 
dysfunction in clinical trials, based upon these preclinical data. 
• further investigate the relationship between postoperative complications 
for example infection and co-morbidities such as rheumatoid arthritis and 
cancer, and their association with severity and duration of POCD in 
particular. 
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